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KAI SCHULZE – ULTRA-PROCESSED FOODS AND 
CARDIOMETABOLIC HEALTH – PHD ABSTRACT 
The overall aim of my thesis was to investigate the associations between ultra-processed food 
consumption (UPF) and cardiometabolic health at the individual and the population-level, while 
adhering to methodological principles such as incorporating and presenting a multiverse of 
statistical results and interpreting statistical hypothesis testing in a non-dichotomous way. I 
addressed these aims in three studies: a systematic review and meta-analysis of 41 prospective 
cohort studies, an ecological, longitudinal cross-country comparison, and a prospective analysis 
in the UK EPIC-Norfolk cohort. The research presented in this dissertation revealed consistent 
associations between UPFs and adverse cardiometabolic health.  
The results of the systematic review and meta-analyses of chapter 2 provided the first 
systematic analysis of published nutritional epidemiology studies from the perspective of food 
processing. I defined UPF consumption more broadly and identified studies in which UPF 
consumption had been termed in several different but related ways, such as fast, convenience, 
or Western foods. I combined those diets and dietary pattern studies that were characterized 
by a higher relative intake of UPFs in non-linear and summary random-effects meta-analysis 
estimates. Higher intakes of UPFs were associated with both an increased risk of cardiovascular 
diseases (CVD) and type 2 diabetes mellitus (T2DM).  
Higher sales of UPF were associated with an increased risk of adiposity and diabetes mellitus in 
the country-level analysis in chapter 3, using data from 76 countries across all five continents 
over 16 years. The panel analysis demonstrated that a strong and consistent association existed 
between the sales of UPFs at the food system level and adiposity and diabetes prevalence in 
low-to-middle-income countries (LMICs) for children, adolescent, and adult populations, as well 
as for both sexes separately. This finding adds value to the literature because no previous study 
had systematically investigated these associations in countries in which often a lack of individual 
data exists and had estimated associations for LMICs and high-income countries (HICs) 
separately. However, the analysis did not establish an association between UPF and adiposity in 
HICs, which was surprising, given that previous studies indicating an association at the individual 
level were mostly from HICs. The lack of variability in UPF data from HICs during the study period 
were likely a key reason for the lack of estimated associations in HICs. As a consequence of the 
many combinations of data processing and analytical methods and the variability of point 
estimates and P-values, no particular set of point estimates was emphasized, but the consistency 
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of findings indicate that the expansion of global adiposity and diabetes since 2000 can partially 
be attributed to the increased sales of UPFs, at the level of the food system or country. 
The associations that were found in the meta-analysis and the panel study were replicated in 
prospective analyses of detailed data from over 17,000 individuals in the EPIC-Norfolk cohort, 
yielding associations between increased UPF intake and adiposity as well as risk of T2DM and 
CVD. This study demonstrated that the way UPF intake is operationalized can fundamentally 
influence results. Previous UPF studies had only expressed UPFs as weight or the proportion of 
food weight, with the justification that energy measures would not capture the non-calorific 
components of UPFs with potentially adverse effects on health. Guided by previous nutritional 
epidemiological research to adjust for total energy intake, I modelled UPF and disease risks in 
five different ways. The analyses revealed that these different approaches affect the statistical 
results, but also that they affect the results differently for different diseases. For example, the 
differences between measures of UPF intake based on energy and weight were much more 
pronounced for T2DM as an outcome than for CVD, suggesting that potentially different 
mechanisms relating to dietary energy and other factors common to UPFs might be responsible 
for different outcomes. 
Chapter four was also the first research to comprehensively test the associations between UPF 
and three important cardiometabolic disease outcomes (adiposity, T2DM, and CVD) in a 
prospective cohort with a long follow-up period. The findings of an almost consistent positive 
association provide the strongest evidence to date that UPFs are positively associated with 
adverse risk of cardiometabolic health. The secondary analyses of eight different food groups 
and outcomes indicated that greater consumption of ultra-processed meat, fish, and eggs; fast 
foods; and SSBs are associated with an increased risk of T2DM and CVD, whereas consumption 
of ultra-processed fruits and vegetables, milk and diary, fats, and breads and cereals might not 
be associated with an increased risk of disease. Body weight is likely a very important mediator 
of the association between UPF and T2DM and CVD, while increased total energy intake through 
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‘The doctor of the future will give no medicine but will instruct his patient in the care of the 
human frame, in diet and in the cause and prevention of disease.’ 
(Thomas Edison, ca. 1903) 
In 2018, more than 2.5 billion adults and 400 million children - nearly 40% of the global 
population – were overweight or obese and therefore at risk of developing type 2 diabetes 
mellitus (T2DM).1 Since 1980, global obesity prevalence has doubled, and diabetes prevalence 
quadrupled, while cardiovascular diseases (CVD) remain the leading cause of death worldwide.2 
The associated annual economic burden of overweight, obesity, diabetes, and CVD on global 
health-care systems and the wider global economy has been estimated to exceed US$3.5 trillion 
each year.1,3–6 While this “slow-motion disaster” (Margaret Chan)7 now encompasses countries 
at almost all stages of development, the issue is likely to intensify if the current trends continues, 
given that no country has been able to reverse its obesity pandemic in all age groups.8  
Suboptimal nutrition is a leading risk factor of these three related conditions, in high-income 
countries and increasingly in low- to middle-income countries as well.3,9 Despite decades of 
debates and nutrition recommendations, global efforts to prevent diet-related chronic diseases 
can reasonably be considered a failure. Nutrition did not have its own Millennium Development 
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Goal and is still not part of the Sustainable Development Goals in a holistic manner, as Goal 
number two – zero hunger – captures only one aspect of malnutrition.10   
In the past decade, the relationship between the global food system and diet-related conditions 
and diseases has become better understood. Globalization and the emergence of globalized 
food and beverage corporations have changed the nature of food systems with mass-produced 
and highly- or ultra-processed foods (UPFs) beginning to predominate. When I set out the plan 
for my PhD in 2015, little systematic research had been undertaken about the associations 
between UPFs and cardiometabolic health, especially regarding T2DM and CVD. The research 
included in this dissertation contributes to filling these gaps in the evidence through 
investigating UPFs from different perspectives and in different analyses. In this introductory 
chapter, I will provide the background needed to meet these aims and will introduce the 
concepts that are used throughout the thesis.  
The first part will define the three cardiometabolic health outcomes included: adiposity, T2DM, 
CVD, and briefly summarize their global trends and risk factors. Secondly, I will give a short 
history of food processing, introduce and discuss the NOVA classification that will be used 
throughout the PhD to classify foods according to their degree of food processing, and briefly 
review key evidence from previous epidemiological and public health research on food 
processing. Finally, I will discuss reasons for the replication crisis in science, and outline the 
methodological approaches taken in this PhD to address these. 
1.1 Definition and epidemiology of cardiometabolic health 
1.1.1 Defining and classifying adiposity, T2DM, and CVD 
1.1.1.1 Classifications of body weight  
Adiposity or obesity is a condition characterized by excessive body fat that can have adverse 
health effects and is officially recognized as a disease by the American and Canadian Medical 
Associations as well as by few countries such as Portugal.11 At present, the most commonly used 
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measurement determines the weight relative to height as the body mass index (BMI), calculated 
by dividing the weight (in kilogram) by the square of the height (in meters).12 A given adult BMI 
can be classified into categories ranging from underweight (BMI < 18.5) to morbidly obese (BMI 
>= 40). A BMI between 18.5 and 24.9 kg/m2 corresponds to a healthy weight, a BMI between 
25.0 and 29.9 kg/m2 is considered overweight, and a BMI of ≥30.0 kg/m2 is defined as obese. 
Obesity itself is again classified separately: Class 1 (or mild) obesity is considered between a BMI 
of 30.0 and 34.9 kg/m2, 35.0 to 39.9 kg/m2 is class 2 (or moderate) obesity, and ≥40.0 kg/m2 is 
classified as class 3 (or severe) obesity.13 
Different BMI cut-offs for different ethnicities have been discussed in previous research. After 
20 years of following initially healthy women, the Nurses’ Health Study in the United States (US) 
has demonstrated that, at the same BMI, Asians had a more than double risk of developing 
T2DM than whites, and Hispanics and Blacks had a higher risk of disease as well, albeit to a lesser 
extent.14 Reasons remain a matter of scientific debate, but a likely explanation is the distribution 
and percentage of body fat, as well as lean body mass.  
The distribution of body fat is clinically relevant and can be very variable. For example, for two 
individuals of the same BMI, one can be metabolically healthy obese, whereas the other could 
have numerous metabolic abnormalities, including insulin resistance, dyslipidaemia, 
hypertension, etc.15 Higher amounts of visceral fat, for example, which surrounds the organs 
and is indicated by a higher waist circumference or waist-to-hip ratio, is associated with adverse 
cardiovascular outcomes and metabolic syndrome.16 At the same BMI, Asians have 3 to 5 
percent higher total body fat and are more likely to develop abdominal obesity, which might 
partially explain the higher risk of T2DM and CVD.17 Conversely, studies have shown that at the 
same BMI, blacks have a lower body fat and higher lean muscle mass than whites.18,19 Due to a 
lack of scientific agreement and the variability of observed risks at the same BMI within different 
Asian populations, alternative cut-off points for Asian populations have not been generally 
adopted or officially recommended by the World Health Organization (WHO).20 However, with 
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the emergence of new evidence, several entities have started to use different cut-offs. For 
example, China and Japan define overweight and obesity as a BMI of 24 (or higher) and as a BMI 
of 28 (or higher), respectively.21  
Given these debates, additional measurements such as waist circumference, fat-mass 
percentage, or waist-to-hip ratio are used in research to discriminate further the distribution of 
fat and source of adiposity. A waist circumference of >= 80 cm in European women and >= 94 in 
European men or >= 80 and >= 90 cm in South Asians, Chinese, and Japanese women and men, 
respectively, is defined as indicating an increased cardiovascular risk.16,22,23 Further research has 
found waist-to-height ratio (as a measure of ‘central’ obesity) to be a better single predictor of 
‘early health risks’ than BMI and waist-circumference.24 However, these predictive properties 
were not tested in the context of multivariable modelling. Furthermore, comparisons between 
different measures of adiposity have displayed high correlations between BMI and other indices 
of body adiposity (over 0.8 in all cases)25. Thus, at the population-level, BMI indicates obesity 
well and continues to be the most commonly used measure of obesity, despite some advantages 
of alternative measurements at the individual level.26  
Body weight and adiposity in children are classified using different definitions than in adults due 
to the variation of body composition between different age periods and sexes. Generally 
accepted as the reference definition for children up to the age of five years are the Child Growth 
Standards by the WHO, which are derived from data from children of all world regions that were 
born and raised under optimal conditions.27 The WHO growth reference data complements the 
growth standards with data for children and adolescents of ages 5-19 years. Some countries 
publish and use country-specific reference estimates which are derived from historic data on 
the development of children in that country. In the US, for example, the Centers for Disease 
Control and Prevention use the WHO standards for children younger than two years but have 
different cut-off points for overweight and obesity expressed as percentiles of the BMI 
distribution in older age brackets.28  
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1.1.1.2 Classification and diagnosis of diabetes mellitus 
Type 1 diabetes mellitus (T1DM) is a severe and lifelong condition where the immune system 
damages the cells that produce insulin, which in turn causes high blood glucose levels that can 
lead to various adverse health conditions and early death.29 The sudden commencement of 
T1DM and, consequently, the usually fast contact with the health care system enable a correct 
recording of new cases. The main aetiological factors of T1DM include genetic susceptibility and 
environmental factors especially during the early years of life, whereas diet has only a minor 
role in the aetiology of T1DM.29,30 Since diet is the main subject-matter of this PhD, T1DM will 
not be examined. However, due to reasons of data availability, it was not possible to 
differentiate between type 1 and type 2 diabetes in the analyses of chapter 3.  
Type 2 diabetes mellitus is a largely preventable condition.31 In T2DM, either the insulin 
producing beta cells in the pancreas do not produce enough insulin, or the cells of the muscles, 
fat, and liver do not react enough to insulin and cannot take up glucose from the blood, or both. 
The classification and diagnosis of T2DM is challenging due to its slow development and unclear 
starting point, a lack of definite and clear-cut metabolic signals, and an elongated pre-detection 
period.32 An accurate time of onset is therefore hard to determine and a significant number of 
undiagnosed cases exists, the proportion varying by place, time, and population. Three test 
methods for detecting T2DM are common in epidemiological research - the oral glucose 
tolerance test, fasting plasma glucose tests, and tests for the concentration of glycated 
haemoglobin (HbA1c test). In 2006, WHO criteria recommended diagnosis of T2DM based on 
symptoms of diabetes mellitus (i.e. polyuria or polydipsia) and one of the three following 
criteria: a random venous plasma glucose concentration of ≥ 11.1 mmol/l, a fasting plasma 
glucose concentration of ≥ 7.0 mmol/l (whole blood ≥ 6.1 mmol/l), or a two-hour post-challenge 
glucose of ≥ 11.1 mmol/l using a 75g anhydrous glucose in an oral glucose tolerance test. The 
cut-off diagnostic criteria for the glycated haemoglobin (HbA1c) test as defined by the WHO are 
HbA1c levels of ≥ 48 mmol/mol or 6.5%.  
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The diagnostic accuracy of these different tests remains a matter of continuing debate. For 
example, a study that was presented recently at the Endocrine Society’s annual meeting 2019 
indicated that diabetes diagnoses defined solely by HbA1c are highly unreliable, with a strong 
tendency for underestimation of the prevalence of diabetes and overestimation of normal 
glucose tolerance.33 Additionally, the measurement of fasting glucose alone has been found to 
underestimate the prevalence of diabetes by 20-25%.34 For this and other reasons, some 
researchers have argued that the global and national diabetes prevalence rates that are 
published regularly by the International Diabetes Federation (IDF) and the WHO underestimate 
actual prevalence rates.35 
1.1.1.3 Classification of cardiovascular disease 
CVD is a group of disorders of the heart and blood vessels which comprise a number of sub-
diseases: coronary heart disease (blockage of blood vessels supplying the heart muscle), 
cerebrovascular diseases (blockage of blood vessels supplying the brain), peripheral arterial 
disease (blockage of blood vessels supplying arms and legs), rheumatic heart disease (heart and 
heart valve damage from rheumatic fever), congenital heart disease (malfunction of heart 
structure from birth), and deep vein thrombosis and pulmonary embolism (blood clots in the leg 
veins that can dislodge to heart and lungs).36,37 
The classification and diagnosis of cardiovascular disease will, depending on the suspected type, 
involve a series physical tests such as, blood tests, chest x-ray, electrocardiogram, Holter 
monitoring, echocardiogram, stress tests, cardiac catherization, cardiac computerized 
tomography scan, or cardiac magnetic resonance imaging. CVD outcomes investigated in the 
subsequent chapters are specified by ICD9 codes 401-448 or ICD10 codes I10-I79. Extensively 
listing over 100 disease classifications for these CVD outcomes would be beyond the scope of 
this introduction; however, all data on CVD incidence or mortality that is used in this PhD is 
based on objective diagnoses by trained medical personnel.  
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1.1.2 Overview of global trends in adiposity, T2DM, and CVD  
Globally increasing rates of overweight, obesity and T2DM are major drivers of the pandemic of 
non-communicable diseases (NCDs) pandemic.38  
Figure 1.1 Trends in obesity prevalence 
In adults (top), and children and adolescents (bottom) between 1975 and 2015, data from NCD RisC 
2016 and 2017.2,39 
The first signs of the obesity epidemic were visible in high-income countries (HICs), especially in 
Europe and the United States (see Figure 1.1.).16  
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In 1975, the age-standardized adult obesity prevalence rates were 0.9% in low-income countries 
(LICs), 1.9 in low-to-middle income countries (LMICs), 4.3% in upper-middle income countries 
(UMICs), and 8.6% in HICs, while the global prevalence rate was 4.7%. The gap between HICs 
and the other regions was more pronounced in children and adolescents, where the prevalence 
Figure 1.2 Trends in T2DM prevalence 
In adults between 1990 and 2015, data from NCD RisC (2016).2 
Figure 1.3 Trends in cardiovascular disease prevalence  
In adults between 1990 and 2015, data from NCD RisC (2016).2 
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was 3.2% in HICs and below 0.5% elsewhere with an overall global prevalence of 0.8%. Although 
obesity prevalence has changed dramatically in both adult and children and adolescents in the 
last 40 years, changes happened with slightly different trajectories in these two populations.  
Whereas the tripartite structure of HICs, UMICs, and LMICs and LICs continued in adult obesity 
over time, the obesity prevalence of children in UMICs has almost caught up with that of HICs. 
It should be noted that there is considerable disparity between sexes and the countries within 
income groups. For example, surveys have shown prevalence rates of 6.2% and 4.0% in French 
women and men (1994-1996), while in the Czech Republic (which is also a high income country) 
the prevalence was 32.2% for women and 30.0% for men at the same time.40 Differences occur 
also between countries and sexes in the low-income setting: in Eritrea, the obesity prevalence 
is 2.0% in men and 7.6% in women, while Ghanaian women have 16.6% obesity prevalence, 
whereas 4.5% of the Ghanaian men are obese.39 
The global increase in diabetes mellitus prevalence came to a halt in 2005 because of the 
declining prevalence in UMICs and LMICs, while the prevalence continued to increase in HICs 
until 2010 and in LICs until today (see Fig 1.2). Different from obesity, the highest prevalence 
rates are currently not in high-income countries. In 2016, the estimates for LICs, LMICs, UMICs, 
and HICs are 4.3%, 6.0%, 5.3%, and 5.0% respectively, implying that globally over 400 million 
individuals currently have a largely preventable condition. If impaired glucose tolerance (IGT) is 
considered as well, another 350 million individuals are added to the total number affected.41 
When both diabetes and IGT in adult populations are considered, the global prevalence in 2017 
was estimated at 16.1% of adults aged between 20 and 79 years. Limitations in screening and 
diagnosis implicate uncertainty in the estimates as well as a high proportion of people living with 
undiagnosed diabetes, which has been estimated to be an additional 212 million people 
globally.42  
In 2015, cardiovascular diseases were the prime cause of mortality – 17.7 million individuals died 
in 2015 (31% of all deaths globally), and 75% of those deaths took place outside of HICs. The 
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trends of age-standardized cardiovascular disease prevalence differ from obesity and diabetes 
mellitus (see Figure 1.3). Globally, the prevalence of CVD has fallen slightly from 7.4% in 1990 to 
7.1% in 2016, which was mostly driven by the decline in HICs from 9.4% to 7.9%, while the 
prevalence in the other income groups has been slowly increasing. Out of all premature deaths 
(under the age of 70), a third are caused by cardiovascular diseases. Another notable difference, 
compared to obesity and diabetes, is the high prevalence of CVD in LICs which has almost fully 
converged to HIC levels with 7.7% in 2016. Rates in LMICs and UMICs do not substantially differ 
and have risen from both 6.5% in 1990 to 6.7% and 6.9%, respectively.  
The differing trends between obesity and diabetes on the one hand and CVDs on the other hand 
need some further context. After a gradual increase over 60 years, the decline in age-
standardized CVD prevalence and mortality rates became first apparent in the 1970s; 
throughout the industrialized world, for example, mortality from coronary heart disease and 
stroke had decreased to about one-third of their 1960s values by 2000. Modelling studies have 
demonstrated that this remarkable reduction was partially due to significant improvements in 
prevention and treatment, which included a steep fall in cigarette smoking, progress in 
treatment and control of hypertension, broader use of statins to decrease cholesterol levels, as 
well as development and use of stents and thrombolysis in coronary syndromes to limit and 
prevent infarctions.43 However, the evidence does not exhaustively explain the decline, and 
furthermore, first signs of reversal in certain populations are emerging. Globally, the decline 
seems to have abated for now.  
After having described global trends of the three cardiometabolic health conditions, the next 
section will briefly describe some of the important risk factors of these three related conditions.  
1.1.3 Risk factors for adiposity, T2DM, and CVD  
Risk factors for cardiometabolic health can be conceptualized along two dimensions: first, along 
modifiable and non-modifiable risk factors, and secondly along three broad “level-groupings” of 
individual, socio-economic, and environmental risk factors. Some important risk factors are 
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summarized in Figure 1.4. Risk factors rarely occur in isolation and often interact and cluster in 
individuals.44 For example, at a fundamental level, changes in body weight result from an 
imbalance between calories consumed and calories spent, which is the result of individual 
dietary behaviours. Unhealthy individual food choices (e.g. foods with high calorific value, high 
palatability, but low nutrient density) might affect the calorie intake, but the individual choices 
themselves can partially be the result of socioeconomic factors such as income and education, 
or environmental risk factors such as living in an area with little access to healthy foods (so called 
‘food deserts’) or a social environment that promotes obesogenic behaviours.16  
Non-modifiable risk factors for obesity include age, sex, ethnicity, genetics, and family history of 
obesity. Modifiable risk factors include dietary factors such as total energy intake, physical 
activity, a sedentary lifestyle, little or too much sleep, mental health (e.g. depression or stress), 
or drugs. As mentioned, important socioeconomic risk factors are income and education, and in 
terms of environmental risk factors the geographic location (i.e. the built environment) and 
social networks are important. Additionally, recent research suggests that environmental 
pathogens such as viruses or other organisms that affect the microbiome play a role in obesity. 
Global increases in T2DM are closely tied to increasing rates of obesity in adults, children and 
adolescents, given that obesity and overweight have been found to be the strongest predictor 
of T2DM in prospective epidemiological studies.45 Studies of the European Prospective 
Investigation into Cancer (EPIC) have also demonstrated that the effect of weight changes on 
T2DM is more pronounced for younger adults than weight changes after the age of 40.45 
However, weight gain does not affect the T2DM risk of all individuals in the same way. As was 
introduced above regarding ethnic differences, the existence of a ‘metabolically obese’ 
phenotype has been proposed as an explanation for the disparity between obesity and T2DM in 
Asian populations.46 
Higher levels of visceral fat and abdominal adiposity have been demonstrated to be independent 
risk factors for insulin resistance, T2DM, and other cardiovascular disease factors.31 Yet, some 
 
     25 
debate exists about whether non-alcoholic fatty liver disease or visceral fat is a better predictor 
of T2DM. It has been argued that fat accumulation in the liver determines hepatic insulin 
resistance and beta-cell dysfunction, and a meta-analysis of prospective cohorts has shown that 
non-alcoholic fatty liver was more strongly associated with insulin resistance than abdominal 
fat.45,47 All the risk factors mentioned for obesity are also risk factors for T2DM. Additionally, 
smoking, hypertension, inflammation, age, family history of diabetes, and intrauterine 
environment are determinants that influence the risk of diabetes.45,47 
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Figure 1.2 Important non-modifiable and modifiable risk factors of adiposity, T2DM, and CVD 
CVD risk factors not only include all the non-modifiable and modifiable risk factors of adiposity 
and T2DM; the two outcomes are significant risk factors for CVD themselves. Around 70% of 
individuals at risk of CVD have several risk factors that interact in a synergistic manner which can 
increase an individual’s aggregate risk from four-fold with one risk factor to 60-fold in the 
presence of five risk factors.44 
Thus, adverse cardiometabolic health is the result of a complex interaction of different risk 
factors and conditions that have the potential to reinforce and modify each other. While it is 
 
26 
critical to recognize that any attempt to improve cardiometabolic health focusing on only one 
factor is likely to fail, it is important to understand the relative importance of each of these risk 
factors. In epidemiology and public health research, comparative risk assessments (CRA) provide 
a structured approach to estimate the relative importance of different risk factors.9,48 The most 
recent and systematic efforts undertaken at the global, regional, and national level are the CRAs 
of the Global Burden of Disease Study (GBD) 2017. The first publication estimated levels and 
trends in exposure, attributable deaths, and attributable disability-adjusted life-years (DALYs) 
for 84 behavioural, environmental and occupational, and metabolic risks or groups of risks from 
1990 to 2017.49 Overall, dietary risks were attributable to approximately 9.1 (of the total 34) 
million global deaths in 2017 and led to 255 million (of the total 1.2 billion) DALYs. The large 
majority (approximately > 90%) of these deaths and DALYs were for cardiometabolic and related 
conditions. If one was to count high fasting plasma glucose and high BMI as risk factors that are 
closely diet-related as well, diet and diet-related risk factors are, with smoking, short gestation 
for birthweight and alcohol use, among the globally leading risk factors for deaths and DALYs. A 
second recent GBD publication has evaluated the consumption of major foods and nutrients 
across 195 countries and has quantified the relative impact of their suboptimal intake on NCD 
mortality and morbidity.50 The main dietary risk factors were diets low in whole grains, high in 
sodium, low in fruits, low in nuts and seeds, and low in vegetables, fibre, and legumes. In 
summary, multiple risk factors influence adiposity, T2DM, and CVD in a complex manner. 
Adiposity is a main risk factor for T2DM itself, and both are important risk factors for CVD.  
Diet is therefore a leading risk factor for all three conditions. A major component of modern 
diets are UPFs, and as the next section will argue, these foods combine many nutritionally 
advantageous properties that have previously been associated with adverse cardiometabolic 
health.  
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1.2 Ultra-processed foods: food processing, the NOVA classification, and 
a brief review of research 
This section will briefly introduce food processing, present a classification scheme that is 
currently used in nutritional epidemiology and public health research to classify foods according 
to the degree of food processing, discuss the concept, and review some of the key literature on 
UPFs. 
1.2.1 The four phases of food processing  
Various food preparation, preservation, cooking, and processing techniques have been a central 
part of human evolution and have affected the development of populations and civilizations.51,52 
Overall, the progress of food processing can be divided into four phases. The first phase was 
characterized by a relatively slow evolution of techniques over thousands of years, moving away 
from the early hunter-gatherer cultures to early settlements in cities, in which food was mostly 
provided from surrounding areas.52 This involved the development of basic tools with which 
mostly fresh foods were preserved through drying, salting, and smoking, etc. An important 
exception was the production of bread, which was produced based on flour that was made in 
water- or animal powered mills.53 
The second phase started with the industrial revolution in the late 18th century and influenced 
food processing via multiple innovations and developments. Coal and steam engines and 
machines transformed transportation and drastically removed barriers to trade, influencing the 
price and the availability of food ingredients such as fats, salt, and sugars, as well as flours and 
spices that were previously only available in specific regions.54 Also, the characteristics and 
properties of certain macronutrients (such as protein) and micronutrients (such as minerals) 
were discovered, and the first effort in establishing nutrition as a biochemical discipline 




The different types of food processing invented during the 1800s until the mid-1950 have been 
described in great detail elsewhere.56,57 In summary, a whole new set of industrial food 
technologies led to the development of new, mass-produced industrial food products that, in 
many ways, are the ancestors of the foods we still consume today. Confectionary, buns and 
cakes, breakfast cereals, soft drinks, condensed milk, and industrial breads entered the food 
system on a mass-scale for the first time during this period. Interestingly, given the logistical 
challenges to provide food for soldiers during the 2nd World War, military research formed the 
fundament for various new food processing developments that were the basis for a whole range 
of commercial products after the war.58, i Another key development during this period was the 
mass-introduction of the refrigerator for private households. This transformed food storage and 
safety and enabled a range of new types of processed foods based on, for example, dairy 
ingredients such as ice cream or desserts.  
The third phase begins in the 1950s and is characterized by two main developments. First, food 
science and technology advanced further and food companies began to focus on the 
development of convenience products that were easy to prepare or almost ready-to-eat. Initially 
food companies targeted middle-class working wives and mothers, but later wider parts of 
society (and situations of daily life) were addressed. Regionally, this affected most countries of 
Western (and Northern) Europe and North America, partially because those were the most 
affluent and economically most rapidly developing regions at the time, partially because in these 
regions research and technological change enabled the development of food technology, but 
also because these were the regions in which most modern food corporations originated and 
the capital for expansion and investment existed. Secondly, a new type of economic 
globalization and trade integration began with the establishment of the Bretton-Woods system 
in 1946 (to prevent Economic depression and war) and the General Agreement on Tariffs and 
 
i For example, the ‘finger-staining dust on Cheetos’ can be traced back to a dehydrated, compressed 
‘jungle’ cheese that was invented by government scientists in 1943 in the United States.58  
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Trade (GATT, predecessor of the World Trade Organization) in 1947 to rationalize trade among 
nations.59,60 In HICs, diets started to change in a way that is commonly referred to as the 
‘nutrition transition’, which is a shift in the food system away from home and artisanal prepared 
foods and dishes towards ready-to-consume and pre-prepared meals and drinks.61  
Note that some authors date the beginning of the third phase to the 1980s, in which ‘a 
revolution that has transformed food systems and supplies and dietary patterns in most 
countries and settings in just over one generation’ began.62 This refers to a comprehensive global 
integration of international food systems and the advent of multinational food and beverage 
corporations as global players. However, I would argue that this is misguided for two reasons. 
First, it neglects the new nature of the established system post World War II that was 
qualitatively different from the international system before the second World War (due to 
GATT). Secondly, the new food processing technologies that were developed after 1945 that led 
to the nutrition transition in HICs warrant a separate phase. In that sense, the developments in 
food systems of HICs after the second World War were too different to be conceptionally 
combined with the second period that started with industrialization, whereas the fourth phase 
(comprehensive global integration of food systems) was itself different enough to be considered 
separately.  
Thus, I argue that the fourth phase of food processing began in the 1980s. The participation of 
over 123 countries in the Uruguay rounds of the GATT between 1986 and 1993 was 
unprecedented in terms of numbers. But the effects of these negotiations were not seen until 
the 1990s, when the WTO was established, and the integration of most participating countries 
into global trade and the international financial system came into effect. This was the moment 
at which food and beverage corporations really became global entities, triggering the nutrition 
transition on all continents, often as the result of an accession into international trade and 
finance systems of a given country. This transformed (and is still transforming) the global food 
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system into a system that increasingly supplies and markets mass-produced, branded, highly- or 
ultra-processed food and drink products.59,63–65   
There is a far-reaching difference between foods prepared before the nutrition transition and 
modern day ready-to-eat products. Dishes made at home were dominant in foods that were 
minimally processed and often nutrient-rich. By comparison, ready-to-eat and ultra-processed 
foods are mostly products of industrial components that contain few whole foods and are often 
characterized by a combination of unhealthy properties.66 The next section will introduce and 
discuss the NOVA classification – a scheme to classify the degree of food processing which is 
currently used in the epidemiological and public health literature and throughout the chapters 
of this PhD. 
1.2.2 Definition and discussion of NOVA 
1.2.2.1 Introduction of the NOVA classification scheme 
In 2009, Carlos Monteiro from the Center for Epidemiological Studies in Health and Nutrition at 
the University of Sao Paolo published a commentary criticizing the practice in nutrition and 
health to either focus on nutrients or on food and drinks.67 He argued that an overlooked issue 
in both research and policy was food processing and suggested three groups of processed foods. 
This publication was the precursor of the NOVA classification, and subsequent publications 
further developed the definitions and extended the classification scheme by splitting the third 
group into ‘processed’ and ‘ultra-processed’.62,68  
Currently, the NOVA system classifies foods into four groups according to the nature, extent, 
and purpose of industrial food processing.69,70 This PhD focuses on the fourth NOVA group ‘ultra-
processed foods’ (UPFs), defined as predominantly industrial formulations of typically more than 
five ingredients.  
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NOVA-
Group 






Unprocessed (or natural) foods are edible parts of plants (seeds, fruits, leaves, stems, roots) 
or of animals (muscle, offal, eggs, milk), and fungi, algae and water, after separation from 
nature. Minimally processed foods are natural foods altered by processes that include 
removal of inedible or unwanted parts, and drying, crushing, grinding, fractioning, filtering, 
roasting, boiling, non-alcoholic fermentation, pasteurization, refrigeration, chilling, freezing, 
placing in containers and vacuum-packaging. These processes are designed to preserve 
natural foods, to make them suitable for storage, or to make them safe or edible or more 
pleasant to consume. Many unprocessed or minimally processed foods are prepared and 
cooked at home or in restaurant kitchens in combination with processed culinary ingredients 





Processed culinary ingredients, such as oils, butter, sugar and salt, are substances derived 
from Group 1 foods or from nature by processes that include pressing, refining, grinding, 
milling and drying. The purpose of such processes is to make durable products that are 
suitable for use in home and restaurant kitchens to prepare, season and cook Group 1 foods 
and to make with them varied and enjoyable hand-made dishes and meals, such as stews, 
soups and broths, salads, breads, preserves, drinks and desserts. They are not meant to be 
consumed by themselves and are normally used in combination with Group 1 foods to make 




Processed foods, such as bottled vegetables, canned fish, fruits in syrup, cheeses and freshly 
made breads, are made essentially by adding salt, oil, sugar or other substances from Group 
2 to Group 1 foods. Processes include various preservation or cooking methods, and, in the 
case of breads and cheese, non-alcoholic fermentation. Most processed foods have two or 
three ingredients and are recognizable as modified versions of Group 1 foods. They are edible 
by themselves or, more usually, in combination with other foods. The purpose of processing 






Ultra-processed foods, such as soft drinks, sweet or savoury packaged snacks, reconstituted 
meat products and pre-prepared frozen dishes, are not modified foods but formulations made 
mostly or entirely from substances derived from foods and additives, with little if any intact 
Group 1 food. 
Ingredients of these formulations usually include those also used in processed foods, such as 
sugars, oils, fats or salt. But ultra-processed products also include other sources of energy and 
nutrients not normally used in culinary preparations. Some of these are directly extracted 
from foods, such as casein, lactose, whey and gluten. Many are derived from further 
processing of food constituents, such as hydrogenated or interesterified oils, hydrolysed 
proteins, soya protein isolate, maltodextrin, invert sugar and high-fructose corn syrup. 
Additives in ultra-processed foods include some also used in processed foods, such as 
preservatives, antioxidants and stabilizers. Classes of additives found only in ultra-processed 
products include those used to imitate or enhance the sensory qualities of foods or to disguise 
unpalatable aspects of the final product. These additives include dyes and other colours, 
colour stabilizers; flavours, flavour enhancers, non-sugar sweeteners; and processing aids 
such as carbonating, firming, bulking and anti-bulking, de-foaming, anti-caking and glazing 
agents, emulsifiers, sequestrants and humectants. A multitude of sequences of processes is 
used to combine the usually many ingredients and to create the final product (hence ‘ultra-
processed’). The processes include several with no domestic equivalents, such as 
hydrogenation and hydrolysation, extrusion and moulding, and pre-processing for frying. 
The overall purpose of ultra-processing is to create branded, convenient (durable, ready to 
consume), attractive (hyper-palatable) and highly profitable (low-cost ingredients) food 
products designed to displace all other food groups. Ultra-processed food products are usually 
packaged attractively and marketed intensively. 
Table 1.1 NOVA-classification  
Taken from Monteiro CA, Cannon G, Moubarac JC, Levy RB, Louzada MLC, Jaime PC. The UN Decade of 




These include, for example, industrially produced ice cream, candy, confectionery, desserts, 
biscuits and cookies; sodas and sweetened drinks; instant packaged noodles and soups; sweet 
or savoury packaged snacks; sugary milk and fruit drinks; energy drinks; ready-to-eat meals; and 
sausages, burgers, hot dogs, meat balls, poultry, nuggets or other transformed meat products 
with added preservatives other than salt (such as nitrites). Foods that are predominantly made 
from conventional culinary ingredients (such as fats, oils, and sugars) in combination with 
uncommon ingredients such as “hydrogenated or interesterified oils, hydrolysed proteins, soy 
protein isolate, maltodextrin, invert sugar and high fructose corn syrup, artificial colours, colour 
stabilisers, flavours, flavour enhancers, or non-sugar sweeteners” are also ultra-processed.70  
According to NOVA, UPFs are classified in contrast to the other three groups. The first group 
includes “un- or minimally processed foods” that are fresh or processed without any additional 
ingredients such as salts, sugars, oils, or fats, and fruits and vegetables, grains, nuts, seeds, fresh 
and pasteurized milk, natural yogurt with no added sugar or artificial sweeteners, pulses, pasta, 
rice, eggs. The second group encompasses “processed culinary ingredients” derived from the 
first group or from nature and can include additives to conserve the original properties (salt, 
sugar, vegetable oils, butter, and other substances to convert group one foods into culinary 
preparations). The third group are “processed foods” – relatively simple foods which are often 
made by adding sugar, salt or other group 2 ingredients to un- or minimally processed foods 
(canned or bottled vegetables; fruits in syrup; legumes; salted or sugared nuts and seeds; 
cheeses; freshly made breads). There are various potential characteristics and pathways by 
which greater consumption of UPFs could cause adverse cardiometabolic health outcomes. The 
next section reviews the main characteristics of UPFs and how these could adversely affect 
cardiometabolic health.   
1.2.2.2 Putting NOVA in context  
The NOVA classification was not the first to look at the processing of foods. At least four other 
food classification systems that incorporate food processing have been published and 
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empirically applied. One, developed by the International Agency for Research on Cancer, 
classified foods into one of three levels of processing (‘non-processed’, ‘modestly or moderately 
processed’, ‘processed’), and was applied in two publications using data from the European 
Prospective Investigation into Cancer and Nutrition (EPIC) study.71,72 The first estimated the 
contribution of highly industrially processed foods to nutrient intakes and patterns, finding that 
highly industrially processed foods dominate diets and nutrient patterns in Nordic and central 
European countries, while the second publication found associations between highly processed 
food intake and plasma elaidic acid levels, which is biomarker of industrial trans fatty acids in 
diets.73 Another classification has been formulated by a ‘joint task force’ of the US Academy of 
Nutrition and Dietetics, the American Society for Nutrition, the Institute of Food Technologists, 
and the International Food Information Council in the US, categorizing foods into five categories 
(‘minimally processed’; ‘foods processed for preservation’; ‘mixtures of combined ingredients’; 
‘ready-to-eat processed foods’; and ‘prepared foods/meals’). It was applied once in a paper 
using data from the US National Health and Nutrition Examination Survey to determine the 
energy and nutrient contributions from processed foods, finding that minimally processed foods 
contributed high levels of nutrients but little energy, while ‘ready-to-eat’ foods provided a lot of 
energy but little fibre.74  
A classification system by the Mexican National Institute of Public Health divided foods and 
products into three categories (‘modern industrialized’, ‘industrialized traditional’, and ‘non-
industrialized’).75 It has been used to estimate the relative energy contribution of the three 
groups in 1-4 year olds (more than 39% of total energy was provided by both categories of 
industrialized foods together) and to determine factor that predict higher intake of 
industrialized foods (higher income, urban residence, monetary support from government).75,76 
Another classification using three categories (‘unprocessed’, ‘primary or partially processed’, 
‘highly processed’) has been devised by the International Food Policy Research Institute in 
Guatemala and has been applied to examine the contribution of processed food products to 
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prevalence of overweight and obesity, finding that a that increases of household expenditures 
on ‘partially processed foods’ by 10% increased the BMI of members of the household by almost 
4%. An increase in highly processed foods increased the BMI slightly more, by 4.25%.77 
These four classifications as well as the NOVA classification have been qualitatively evaluated in 
a systematic review of food classification systems, and to my knowledge, this is the only 
publication that has attempted to compare and rate food processing classification systems in 
the context of Epidemiology and Public Health.62 The quality of all five systems was evaluated 
using the five criteria specificity, coherence, clarity, comprehensiveness, and workability, and 
rated each criterion and how well it was met with zero (not at all) to three points (completely). 
The US system was rated worst (5 points), followed by the Guatemalan (7), European (9), and 
Mexican (10) classification systems. NOVA received 13 points and was considered strongest in 
terms of quality.  
There are two points worthy of note regarding this publication. First, two of the co-authors were 
involved in the development of the NOVA system, which questions the neutrality and 
unbiasedness of the review. Secondly, the methods and how the assessments were derived and 
undertaken is unclear. Because of a possible conviction of the superiority of NOVA at the design 
phase of the study by the authors, it is possible that the criteria to assess the classifications were 
defined in a way that would ensure a higher rating for the NOVA classification. This is particularly 
likely with regards to the criterion ‘specificity’, which demands a strong differentiation between 
industrial and home-made methods of processing in the classification, a distinction that has 
been an emphasis of the proponents of NOVA. The other criteria seem less specific to NOVA. 
For example, whether the system covers all types of foods, whether it can be applied to data 
from household or population-based nutrition surveys, whether it is clearly defined, or whether 
the food groups are related to one another logically (internal coherence) are sensible questions 
designed to capture internal validity aspects. Nevertheless, it is still possible that assessments 
were undertaken to favour the NOVA classification.  
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While there is no way of knowing whether this was the case, my own assessment of the five 
classifications comes to a similar conclusion. I will focus on one or two key aspects of each 
classification that to me demonstrate their inferiority. The Guatemalan and European 
classifications lack differentiation due to having only three groups. Combining foods such as 
vegetable oils, rice, pasta, crisps, pizza in one ‘processed food’ category seriously limits 
applicability as these are hardly comparable foods with very different nutritional characteristics. 
The Guatemalan classification also lacks proper explanations of the first and second food groups. 
The US classification is simply difficult to apply, as many foods could easily be placed into 
multiple categories. A frozen pizza, for example, could be classified into the ‘ready-to-eat 
processed’ group just as well as into the ‘prepared foods/meals’ group, and I would argue that 
this would apply to many foods. Finally, the Mexican classification that was ranked second 
highest in the review has issues in terms of its generalisability – the distinction between ‘modern 
industrialized’, ‘non-industrialized’, ‘industrialized traditional’, and ‘locally made traditional 
foods’ might make sense in the context of Mexico, but are, in my view, very difficult to apply in 
countries such as the UK, Germany, France or the US, in which the nutrition transition has been 
mostly completed and in which traditional foods that are locally made would be difficult to 
identify. In sum, despite questionable methods in the review of food classification systems, I 
agree with the general conclusion of the paper and judge the NOVA classification to be the 
superior food processing classification for the application in nutrition studies, from those that I 
have reviewed.   
Apart from explicit food classifications, food processing has also implicitly been a part of 
previous nutrition research, in the context of dietary pattern studies. The epidemiological 
literature on modern dietary patterns sometimes refers to food processing. For example, a 
report on obesity and cancer prevention has referred to ‘Western dietary patterns’ that are 
‘energy-dense, and increasingly made up from processed foods’, including ‘fatty or sugary foods 
such as processed meats, pastries, baked goods, confectionery, sugared and often also alcoholic 
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drinks’62,78 Studies of this type of dietary pattern have been undertaken in many countries and 
have associated these dietary patterns with obesity, T2DM, and CVD outcomes, as well as 
mortality.79–84 These diets are usually defined by a higher relative intake of processed meats, 
refined grains, savoury snacks, chocolates and sweets. They also sometimes include 
unprocessed or little processed foods of animal origin such as milk, meat, and eggs. Other similar 
dietary patterns that have a different name but mean fundamentally the similar type of diet are 
fast food, convenience, and ready-to-eat dietary patterns.85–88 All these studies were a posteriori 
approaches in which the name of the dietary pattern was determined after the pattern was 
empirically derived from the data, and this type of study has been found to be internally valid.89 
Thus, several previous nutrition studies have dealt with the issue of food processing implicitly, 
and hence carry some information about the relationship between food processing and disease 
risks that have previously not been explored. This observation is the basis for the systematic 
review and meta-analysis that will follow in chapter 2.  
1.2.2.3 Characteristics of UPFs and UPF-cardiometabolic health pathways  
UPFs could affect cardiometabolic health in multiple ways, and this section briefly summarizes 
how different characteristics of UPFs can negatively affect adiposity, T2DM, and CVD outcomes.  
Obesity is a disorder of the energy homeostasis system which is influenced by diet through 
multiple pathways, including brain reward, satiety, glucose-insulin responses, and energy intake 
and expenditure.3,90,91 Previous research has shown that diets high in refined carbohydrates and 
fats lead to rapid and pronounced weight gain.92,93 UPFs are often characterized by a 
combination of high levels of refined carbohydrates and fats, are often highly energy-dense and 
usually contain flavours and food additives that affect reward and satiety systems along the gut-
brain axis; a causal link with obesity is thus plausible.3,91 Consequently, in the first conducted 
randomized controlled trial (RCT) of ad libitum UPF versus unprocessed food consumption, 
participants in the UPF group consumed on average about 500 calories more than participants 
in the unprocessed group, and this was due to increased fat and carbohydrate but not protein 
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intake.94 Participants in the UPF group also gained 0.8 kg body weight over a two-week period, 
while participants in the unprocessed group lost 1.1 kg (P < 0.001). One systematic review has 
investigated the association between UPF intake and body fat in children and adolescents 
previously.95 It reported small but positive associations, mostly based on cross-sectional designs, 
but found a lack of comparability of the studies included. 
In studies from different countries, UPFs have been found to contain higher levels of sugar, 
sodium, unhealthy fats (saturated and trans fats from partially hydrogenated oils), energy, and 
less content of fibre and various micronutrients.96–103 UPFs have also been found to be less 
satiating and have a higher glycaemic load than minimally or unprocessed foods.104 Current 
research indicates that high intakes of sugar and unhealthy fats, low intakes of dietary fibre, and 
high intake of foods with a high glycaemic index negatively affect the development of insulin 
resistance and T2DM.105–109   
Multiple additional pathways might associate increased CVD risk with UPFs. Diets high in UPFs 
tend to contain lower levels of fruits, vegetables, nuts and seeds, whole grains, and higher levels 
of fats and dietary sodium.97,110–112 These characteristics have previously been associated with 
increased risk of CVD.3,113 While recent research on dietary fats has de-emphasized the role of 
saturated fats,114–118 trans fats have been associated with increased CVD risk, especially total 
CHD and CHD mortality risk.119,120 Furthermore, recent research has shown how toxic lipid 
peroxidation products (such as α,β,4-hydroxy-2-trans-nonenal [4-HNE]) are produced during the 
heating process of polyunsaturated frying oils that are used to produce fast foods and other 
UPFs.121,122 These toxic aldehydes are implicated in the pathogenesis of various cardiovascular 
(and neurodegenerative) diseases via multiple cell processes such as oxidative stress signalling, 
cell proliferation, transformation or cell death.122–126 CVD has a more complex aetiology in which, 
depending on disease subtype, non-nutritional risk factors may play a relatively more important 
role than in the aetiology of T2DM. Regarding both CVD and T2DM, an additional pathway 
explaining diet-disease associations could be the relationship between diets and the gut 
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microbiome. A large body of research supports the hypothesis that Western diets and UPFs 
affect changes in the gut microbiome which are associated with obesity and metabolic diseases, 
possibly through the pathways of gut dysbiosis (microbial imbalance or maladaptation) and 
inflammation.127 
1.2.2.4 A brief overview of the literature on UPFs using the NOVA system 
Studies on UPFs usually investigate one or more of the following three aspects: firstly, estimating 
the nutritional content and the dietary quality of diets high in UPFs; secondly, measuring the 
level and geographic distribution of UPFs in regions, countries, or specific food locations (i.e. 
supermarkets); and thirdly estimating UPF-disease associations.  
Most studies that estimate the level of UPF consumption use data from epidemiological studies 
and household surveys. Data from these study types suggests that UPFs contribute to between 
30% and 60% of total energy intake. For example, UPFs represent 30% of total energy intake in 
Brazil, about 60% in Canada, 58% in the US, 59% in Norway, 57% in the UK, 55% in Sweden, 30% 
in Chile, 60% in New Zealand, 59% in Belgium, and 52% in Spain.98,101,103,110,128–132 Some studies 
estimate consumption and consumption trends based on food purchasing or sales data (as far 
as I know, exclusively based on data from the Euromonitor Passport Global Market Information 
Database). Here, UPFs are usually expressed as weight in kilograms per capita per year. Some 
publications have anecdotally shown the development of sales of certain food groups.133–135 One 
publication has displayed the trends in UPFs sales in Latin America, while another very recent 
study has shown how UPF sales have developed since 2002 in 80 countries.136,137  
Prior to 2016, a number of small cross-sectional studies had associated UPF intake with body 
fat, adiposity, and metabolic syndrome.128,130,138,139 Beginning in 2016, the first longitudinal 
studies on UPFs and diseases appeared. UPFs were associated with obesity and overweight, then 
with hypertension, lipid profile in children, and T1DM and celiac disease.140–143 
In 2018, the first UPF study on cancer risk was published, demonstrating small but positive 
associations, and in 2019, one prospective cohort on cardiovascular diseases and two 
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publications on UPFs and overall mortality followed.98,144–146 Finally, in 2019, the first 
randomized-controlled trial on ad libitum UPFs intake and weight change followed, 
demonstrating a strong increase both in energy intake as well as a drastic weight change.147  
There are three shortcomings of the literature that I have addressed in this thesis and were 
notably more prevalent and visible at the start of my PhD than they are now, due to the 
significant growth of interest in this area over the past 3 years. First, as outlined above in the 
section on the context of NOVA, there is value and information in previous dietary pattern 
studies about the disease risk of diets that are high in UPFs. No systematic review regarding 
cardio-metabolic health had been undertaken nor was any information synthesized in a meta-
analysis. A second shortcoming is the almost complete lack of information from regions which 
have recently gone through a nutrition transition or are still in a phase of transitioning. Except a 
few studies from Brazil, little was known empirically about UPFs in LMICs, but those are the 
regions that have recently been most exposed to UPFs and are the main drivers behind the 
global adiposity and diabetes crises. Thirdly, no study on UPFs has so far investigated whether 
there is a difference in estimated disease risk when UPFs are operationalized in different ways. 
For example, all studies that estimate the share of UPFs in overall diet measure UPFs as energy. 
However, all the studies that estimate disease association use weight-based measures of UPF 
intake, and it is unclear whether results would differ or not using different metrics. Finally, no 
study has estimated the risks between UPF intake and T2DM in a prospective cohort.  
1.3 Methodological considerations 
Since I started my PhD in 2015, discussions about the ‘replication crisis’, chance, P-values, and 
significance testing have become central to scientific debates, in part triggered by papers that 
reported alarmingly low reproducibility rates in diverse fields such as Psychology, Experimental 
Economics, and Cancer Biology.148–151 In 2016, a survey among 1,500 researchers across the 
globe found that 52% of researchers believe that there is a significant reproducibility crisis, while 
38% believed that there is a slight crisis.150 A number of reasons at structural and individual levels 
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have been suggested, including incentives in research to ‘publish or perish’, as well as 
individuals’ and research groups’ failure to adhere to good scientific practices.151–153 In this 
context, some authors have challenged study methods and approaches in nutritional 
epidemiology, questioning whether the discipline in the current state should inform dietary 
guidelines and policy.154–157 Most critical points relate to the difficulty to properly account for 
confounding among the different nutrients, clinical outcomes, and other variables; the 
limitations of dietary assessment tools and challenge to measure diets accurately; suboptimal 
and potentially selective research reporting; and the difficulty to detect small effect sizes reliably 
for nutritional risk factors and nutrition-related interventions. The proposed solution by some 
authors has been to largely replace nonrandomized studies and use randomized studies in 
human nutrition research going forward. From my perspective, most of these issues have been 
at the core of methodological debates in epidemiology and nutritional science. Statistical and 
conceptual solutions are available and are already implemented to varying degrees, which is 
part of the reason why I disagree with the overall conclusion to fundamentally deemphasize 
nonrandomized studies. I will touch on some of the main points in the final discussion. Two 
aspects that influence reproducibility and can be addressed by individual researchers, however, 
are less frequently discussed about in the field of nutrition – the concepts ‘researcher degrees 
of freedom’, and P-values and ‘null-hypothesis significance testing’.   
1.3.1 Researcher degrees of freedom  
A key observation from the statistical literature is that results can be dependent on so-called 
‘researcher degrees of freedom’ – or the data processing and analytical choices that individual 
researchers can make – even in the absence of selection on statistical significance and in the 
presence of pre-specification of analysis plans.158–161 To demonstrate this, 29 teams 
independently prespecified 29 analyses of the same dataset for the same research question, 
yielding 21 unique combinations of covariates and a wide range of results.162 In a similar manner, 
a replication study identified key data processing steps for which equivalent choices existed to 
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construct alternative datasets and apply the same data analysis as the original article, yielding 
fundamentally different results.163 Wicherts et al. (2016) have systematised this and have 
presented a list of 34 types of researcher degrees of freedom across the main study phases 
hypothesizing, design, collection, analyses, and reporting. If multiple defendable and reasonable 
combinations of data generating, processing, and analytical choices exist, researchers can 
increase transparency by a) making these choices explicit and b) displaying the results of 
combinations of equally defendable choices of data processing and data analysis in what has 
been termed a ‘multiverse analysis’.153,161,163  
1.3.2 P-values and null-hypothesis significance testing  
A second problem that has fundamentally contributed to the reproducibility crisis is the 
erroneous interpretation of P-values and ‘null-hypothesis significance testing’ (NHST) which has 
led to the misleading practice of dichotomizing P-values below 0.05 as significant and above 0.05 
as not significant. There are two aspects of NHST that demonstrate that this narrow 
interpretation is wrong. First, it has been repeatedly demonstrated that ‘the difference of 
between “significant” and “not significant” is not significant itself’.160,161,163–165 Even apparently 
different P-values such as 0.03 and 0.1 can, in many situations, simply be explained by sampling 
variability and do not necessarily represent real features of the underlying parameters. Focusing 
on confidence intervals as they are commonly applied does not necessarily help – a lower 
confidence interval (CI) (of, i.e. a hazard ratio (HR)) of 0.97 with a P-value of 0.07 (at the 95% 
level) is statistically indistinguishable from a lower CI of 1.04 with a P-value of 0.04, yet, the latter 
case would be reported as an association whereas the former would often not.  
The second problematic aspect of P-values and statistical significance is the focus on null 
hypotheses, treating all other assumptions that are used to calculate the P-value to be correct.166 
The P-value tests all the assumptions about how the data were generated, including the entire 
statistical model, and not only the hypothesis of interest. However, these assumptions usually 
encompass more than is usually understood and presented as modelling assumptions. For 
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example, one assumption is that intermediate results from analysis were not used to determine 
which results and which analyses would be presented, or that no contingencies in the data 
processing exist in the construction of the data. An (in my opinion) accurate definition has been 
provided by Greenland et al. (2016): ‘[…] the P-value is seen as a continuous measure of the 
compatibility between the data and the entire model used to compute it, ranging from 0 for 
complete incompatibility to 1 for perfect compatibility, and in this sense may be viewed as 
measuring the fit of the model to the data.’167 Thus, a low P-value does not necessarily imply a 
low possibility of a chance finding, if considered in isolation, and the value of a narrow 
dichotomous focus on NHST can be misleading.  
1.3.3 Approach taken in my PhD 
On the basis of this discussion and the published literature, besides the specific analytical 
approaches of each chapter, I oriented the work in this PhD according to three overarching 
methodological principles:  
• Incorporation of potentially equivalent data processing and analytical choices in the 
planning, conduct, and reporting of the study. Reporting of multiple combinations of 
equivalent choices if these combinations are likely to influence the results (i.e. multiverse 
analysis).  
• A continuous rather than dichotomous interpretation of P-values in the context of the 
totality of model assumptions. No ‘selection on statistical significance’.  
• Maximization of transparency on data processing and data analysis, as well as enabling 
replicability as much as possible through publication of complete Stata analysis code as well 
as dataset used (where possible).   
My thinking about these methodological issues and the decision to use these principles was 
neither linear nor finished before I began executing my empirical analyses. Rather, at different 
points during my PhD, both the scientific field and I were at different stages of these scientific 
discussions (for example, I discovered the above definition of P-values only in late 2018). The 
implications for the approaches taken throughout the PhD is that the three main chapters 
adhere to these principles in slightly different ways. Additionally, this difference is also the result 
of two other factors: firstly, what type of statistical method was needed to perform the analyses 
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partially determined how researcher degrees of freedom and NHST were approached; secondly, 
and importantly, the established methodological conventions and reporting standards of 
scientific journals also influenced my reporting and writing. I had certain target journals in mind 
while conducting and writing the different chapters, and thus had to balance my thinking with 
the methods and reporting practices of journals. In the overall discussion at the end of the PhD, 
I will summarize and critically discuss the approaches used in the overarching context of this 
thesis.  
1.4 Aims and research questions 
To improve cardiometabolic health and decrease adiposity and risk of T2DM and CVD, a better 
understanding of UPF-disease associations is needed, as well as an expansion of knowledge on 
‘what it is about UPFs’ that explains potentially increased risks of disease. In addition, greater 
knowledge about the global distribution, trends, and disease associations, as well as how 
research on UPFs connects to previous nutrition research is needed. Furthermore, I will attempt 
to demonstrate some principles or ‘best practices’ that can make research more reproducible 
and transparent.  
Given these identified gaps in the evidence, this PhD investigates the associations between UPFs 
and cardiometabolic health. Chapter 2 investigates previous nutrition studies from an UPF 
perspective by systematically searching the literature, identifying prospective cohort studies 
that estimate disease risks of diets or dietary pattern defined by higher relative intakes of UPFs, 
and estimating associations between UPFs and adiposity, T2DM, and CVD in meta-analyses.  
The third chapter explores trends of sales of UPFs at the country level for 76 countries between 
2001 and 2016 and estimates the associations between UPF sales and adiposity and diabetes for 
children and adolescents and adults, as well as for females and males and low-to-middle income 
and high-income countries separately.  
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The fourth chapter examines associations between UPFs and the three outcomes in the 
prospective cohort study of EPIC-Norfolk. Its starting point is the fact that consumption of UPFs, 
as defined by the NOVA classification, can be operationalized in several ways. In these analyses 
I estimate disease risks and associations for five different ways of operationalizing the NOVA 
classification.   
The specific research questions across the three chapters are outlined below:  
Chapter 2 – Assessing associations between UPFs and cardiometabolic health in previous 
nutrition studies: 
• Is increased UPF intake associated with increased risk of adiposity, T2DM, and CVD? 
• Are these associations linear or do they follow a non-linear form? 
Chapter 3 – Displaying global trends in UPFs and assessing country-level associations between 
UPFs and adiposity and diabetes mellitus in 76 countries: 
• What are the global trends in UPFs between 2001 and 2016? 
• Are increased sales of UPFs associated with adiposity and diabetes mellitus? 
• Is there a difference between LMICs and HICs?  
Chapter 4 – Assessing associations between UPFs and cardiometabolic health in EPIC-Norfolk:  
• Are UPFs associated with T2DM, CVD, and adiposity in EPIC-Norfolk? 
• Are estimated UPF-outcome associations different when UPFs are measured as weight 
compared to UPFs measured as energy? 
• What are the relative contributions of ultra-processed food groups to UPF 
measurements as weight and energy?  
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To my knowledge, no systematic review of the associations between UPFs and cardiometabolic 
health outcomes exists. Despite this paucity of research on UPFs defined according to NOVA, 
substantial other research has been conducted on highly- or ultra-processed foods, albeit under 
different definitions, as was described in chapter 1. Analyses of fast, convenience, junk, or 
western foods differ in terminology, but capture fundamentally similar types of readily 
consumable and highly palatable foods with nutritionally disadvantageous profiles that in most 
cases would be classified as ultra-processed according to the NOVA classification. The aim of this 
systematic review was to identify prospective diet and dietary pattern cohort studies 
characterized by higher relative intakes of UPFs as reflected by NOVA and that reported 
cardiometabolic health risk estimates. I then aimed to synthesize those estimates in a non-linear 
dose-response and summary meta-analysis. 
2.2 Contributions 
Kai Schulze (KS), Jean Adams (JA), and Martin White (MW) designed the study with inputs from 
Fumiaki Imamura (FI). KS, Katrine Eijlerskov (KE), Rebecca Love (RL), Tarra Penney (TP), Hannah 
Forde (HF), Eleanor Winpenny (EW), MW, and JA performed the search, screen, review, 
selection, and data extraction process. KS performed the analysis and FI gave feedback and input 
on the analytical approach. KS drafted the manuscript. JA, MW, and FI contributed to the 
interpretation of the results and critically reviewed the chapter.   
2.3 Methods 
2.3.1 Search strategy  
I followed the MOOSE guidelines for conducting and reporting of systematic reviews and meta-
analyses of observational studies.168,169 I performed a systematic search using PubMed, Embase, 
CINAHL, and Cochrane Library up to October 2018, using a wide range of search terms (Table 
2.1). The search strategy was independently reviewed by an experienced medical librarian at 
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the University of Cambridge (Isla Kuhn). Furthermore, I searched the reference lists of relevant 
reviews.95,113,170–174  
2.3.2 Study selection 
I included prospective cohort studies of the association between diets defined by a higher 
absolute or relative intake of UPFs and risk of three health outcomes (obesity, incident type two 
diabetes mellitus, and incidence of any cardiovascular event) published in English and excluded 
abstract only publications and grey literature. To be included, the dietary exposure had to be 
defined by at least three ultra-processed foods or food groups according to group four of the 
NOVA classification (Table 1.1).69,70 Studies that used data-driven (a posteriori) approaches to 
derive dietary patterns had to be defined by at least three ultra-processed foods or food groups 
with factor loadings of ≥ .2 to be included. This number was informed by a qualitative review of 
previous literature and chosen for reasons of practicality – including every study with two or less 
UPFs would have implied including a large number of studies with diets that were most definitely 
not characterized by UPFs, whereas only including studies with four, five, or more UPFs would 
have excluded studies with little detailed dietary information which, for example, were explicitly 
defined by three UPF food groups as a proxy for a diet high in UPFs. Adjusted estimates of 
hazard, odds, or risk ratios for two or more non-referent categories or a continuous range of the 
exposure had to be available for non-linear analyses, either with 95% confidence intervals or 




Table 2.1 Search terms (adapted for each database) 
MeSH or Emtree or “Exploding terms” are not included here but were included as appropriate for the 
respective databases. 
  Search terms 1 (dietary exposure – processed / ultra-processed foods): 
a) (“processed” or “ultraprocessed” or “ultra-processed” or “convenience” or “snack” or “fast” 
or “junk” or “packaged” or “chilled” or “frozen” or “refined” or “canned” or “industrial*” or 
(ready#prepared) or (ready#eat) or “ready-to-eat” or “energy-dense” or “western*”) 
b) (“food” or “foods” or “product” or “products” or “meal*” or “food product*” or “foodstuff*” or 
“diet” or “diets”) 
c) Search: a) adjacent by maximum of four words with b) 
d) (“snack*” or “ready#meal*” or “confectionary” or “bread*” or “baked good*” or 
“pizza*” or “ice#cream*” or “biscuit*” or “breakfast cereal*” or “cake*” or “cookie*” or 
“pie*”) 
e) Search: c) or d) 
 
Search terms 2 (association, relationship, link): 
 
(“relation*” or “related” or “association*” or “associated” or correlation*” or “correlated” 
or “connection*” or “connected” or “links” or “link” or “linked”) 
 
Search terms 3 (obesity): 
 
(“obes*” or “overweight” or “overweight” or “BMI” or “body mass” or “body fat” or “body 
composition” or “body weight” or “body shape” or “waist circumference” or “abdominal fat” 
or “adiposity” or “waist circumference” or “skinfold” or “skin fold” or “waist to hip ratio” or 
“waist-hip ratio” or “waist to height ratio” or “waist-height ratio” or “weight adj2 gain” or 
“weight adj2 loss” or “weight adj2 loss” or “weight adj2 change”) 
 
Search terms 4 (diabetes): 
 
a) (“diabetes”) AND (“type 2” or “type two” or “type ii” or “type II” or “non-insulin dependent”) 
b) (“T2DM” or “prediabet*” or “pre-diabetes” or “prediabetic state” or “pre-diabetic” or 
“glucose intolerance” or “glucose intolerant” or “IGT” or “IFG”) 
c) (“impaired fasting”) AND (“glucose” or “glycaemi*” or “glycemi*” or “bloodglucose” or 
“blood glucose”) 
d) Search: a) or b) or c) 
e)  
Search terms 5 (cardiovascular diseases): 
 
a) (“cardiovascular disease*” or “CVD” or “coronary heart disease*” or “CHD” or 
“coronary disease*” or “cerebrovascular disease* or “heart disease*” or “myocardial 
infarction” or 
“myocardial ischemia” or “acute coronary syndrome” or “stroke” or “haemorrhagic stroke” 
or “ischemic stroke” or “ischemic heart disease” or “ischaemic heart disease” or “blood 
pressure” or “hypertension” or “cholesterol” or “triglycerides” or “carotid intima media 
thickness” or “C- reactive protein”) 
Search terms 6 (Exclusion of animal and in vitro studies): 
 
a) (“animals” or “rat” or “rats” or “mouse” or “mice” or “animal study” or “animal studies” 
or “in vitro”) 
b) (“human”) [i.e. MeSh terms for “human studies”] 




a) (1 AND 2 AND (3 OR 4 OR 5)) NOT 6 
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Studies that reported relative risks with a referent category that was not comparable were 
excluded (for example a different dietary pattern such as ‘healthy’ instead of the lowest intake 
of the UPF dietary pattern); only studies with populations that were free of the outcome of 
interest at baseline (i.e. no T2DM for studies with T2DM as outcome, etc.) were included. If more 
than one relevant publication from the same cohort existed, the study that included the largest 
number of adverse cardiometabolic events was included. Reference lists of included 
publications were examined for additional relevant studies. The selection process for each 
article was independently performed by the first author (KS) and one co-author (JA, KE, HF, RL, 
TP, EW).   
2.3.3 Data extraction and study quality  
Using a standardized extraction form, I extracted information on: author and publication, 
cohort, included participants, dietary assessment method, dietary pattern method, relevant 
UPFs included, outcome and ascertainment, and risk estimates. The full list of the 24 items that 
were extracted for each study is provided in Table 2.2. 
When risk estimates were extracted, statistical models that had the greatest degree of control 
for potential confounding were preferred. An exception to this rule was made with the 
adjustment of potential intermediate variables such as, for example, components of metabolic 
syndrome when T2DM risk was estimated, or hypertension and serum cholesterol levels when 
CVD endpoints such as incident CHD or CVD were estimated. If the alternative model was 
adjusted only for age while the multivariable model included other confounders as well, the 
multivariable model with intermediates was chosen. Stratified estimates were extracted 
whenever possible. The data extraction process was independently performed by the first 
author (KS) and one co-author (JA, KE, HF, RL, TP, EW, MW). Discrepancies were discussed and 
resolved by consensus. If all the information was not available in an identified publication, 
related publications were searched and examined. If the desired information could not be 
retrieved, data were requested from authors through a standardized form. The quality of each 
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study was assessed according to the Newcastle-Ottawa scale175, independently by the first 
author (KS) and one co-author (JA, MW).   
1) author names; 
2) year and country of publication; 
3) study cohort name; 
4) recruitment and follow-up period (range and/or mean/median years); 
5) cohort definition (inclusion / exclusion criteria; selection process; 
6) inclusion / exclusion criteria of study population (details / n); 
7) number of participants; 
8) sex of participants; 
9) age range of study population; 
10) ethnicity of study population (% of each if multiple); 
11) dietary assessment method (including number of items); 
12) dietary pattern method (a priori, a posteriori, reduced-rank, etc.); 
13) name of dietary pattern; 
14) list of UPF items with loadings >= .2 (or number of UPF items defining the diet); 
15) total number of food items / groups with loadings of >= .2 (if a posteriori); 
16) type of outcome; 
17) outcome ascertainment method; 
18) total number of cases; 
19) total person-time or total number of participants at risk at baseline; 
20) percentile ranges (exposure categories); 
21) midpoint-value for each percentile range (dose); 
22) category-specific number of cases; 
23) category-specific number of non-cases (for case-control studies), person-years (for incidence 
rate data), and number of participants at risk at baseline (for cumulative incidence data); 
24) category-specific risk estimates including upper and lower uncertainty intervals. 
Table 2.2 List of data extracted from each study  
2.3.4 Statistical analysis 
Outcomes evaluated in the quantitative analysis included incidence of T2DM and incidence of 
and mortality from any CVD event. Adiposity outcomes were narratively synthesised due to the 
lack of comparability of risk estimates. For dose-response analyses, the risk estimates of each 
non-referent exposure category were assumed to represent the midpoint dose of the category 
percentile ranges, expressed in percentiles of the exposure distribution. For example, the risk 
estimates of the second quintile relative to the first quintile represented the 30th versus 10th 
percentile range, the estimate from the third quintile relative to the first represented the 50th 
versus 10th percentile range, and so on.  
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Two-stage random-effects dose-response meta-analyses were performed to examine linear and 
non-linear relationships between UPF exposure and cardiometabolic health risks. In the first 
stage, the generalized-least-squares method reported by Greenland and Orsini was used to 
calculate study-specific coefficients based on risk estimates, confidence intervals, cases, and 
person-time of all referent and non-referent exposure categories.176–178 In the second stage, 
non-linear associations were estimated using multivariate random-effects meta-analysis with 
restricted cubic splines of three knots at 10th, 50th, and 90th percentiles of the intake 
distribution, according to recommended percentiles by Harrell (2001).178–180 P-values for overall 
association and non-linear association were generated accordingly. 
As a secondary analysis, random-effects models were used to calculate summary relative risks 
for highest versus lowest categories of exposure.181 The random-effects models additionally 
included those studies which met the inclusion criteria but for which I was unable to obtain risk 
estimates other than the highest versus lowest exposure category. Heterogeneity was assessed 
using the Q-test and the I2 statistic, with the heterogeneity estimate being calculated from the 
inverse-variance fixed-effect model.182 I2 values of ≤25%, ≤50%, ≤75%, and >75% were 
interpreted as indicating no, little, moderate, and significant heterogeneity respectively. Small 
study effects, such as publication bias, were assessed by inspection of funnel plots for 
asymmetry and Egger’s test and Begg’s test.183,184 A sensitivity analysis by exclusion of one study 
at a time was performed to assess the stability of results. To assess the evidence of 
heterogeneity of associations by length of follow-up, number of participants, or study quality, 
meta-regression was performed.  
95% confidence intervals were calculated for the relative risk estimates in the dose-response 
and summary meta-analyses. P-values were reported for the Q-test, Egger’s test, Begg’s test, 
meta-regression, overall association, and tests of non-linearity. As outlined in chapter 1, I 
recognize that the choice of any particular threshold to determine statistical significance is 
arbitrary.165,185 To guide interpretation, however, I interpret p-values ≤ 0.005 as strong 
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evidence185,186, p-values > 0.005 & ≤ 0.05 as moderate evidence, p-values > 0.05 and ≤ 0.1 as 
weak evidence, and p-values > 0.1 as no evidence against the null-hypothesis. All analyses were 
performed in Stata, version 15.1 (StataCorp LLC, College Station, Texas, USA). The full extracted 
data, the dataset for the meta-analysis, the MOOSE checklist, and the Stata code for all analyses 
are available at https://github.com/kai-schulze/upf_slrma. 
2.4 Results  
2.4.1 Search results and study and diet characteristics  
The process of identification and study selection is summarized in Figure 2.1. From a total of 
14,495 records identified I screened the full text of 157 articles, of which 116 were excluded. A 
list of the excluded studies and reasons for the exclusion is provided in Appendix Table 1. Four 
additional studies that met the inclusion criteria were identified by hand searching the reference 
lists of the articles that were full-text reviewed. I included a total of 41 publications from 30 
cohorts comprising over 33,220 cardiometabolic health events among 1,054,475 participants.79–
83,85,86,88,140,141,143,187–217  
Table 2.3 summarizes some key characteristics of studies included in the review and analysis, 
and Appendix Table 2 shows the main characteristics for each included publication. Twenty 
studies were conducted in Europe, fifteen in North America, five were from Asia, and one was 
from South America. The study sizes ranged from 427 to 129,501 participants and had a mean 
follow-up of 9.18 years. Out of nine possible points, the average study quality of the studies was 
5.4, nine studies had a high study quality (> 6 points), 24 studies were of moderate study quality 
(4-6 points), and eight studies were judged to be of low quality (see appendix table 3 for details). 
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Figure 2.1 Search and selection process of prospective cohort studies evaluating the 





































14495 Records identified through databases and other sources: 
   5517  Medline 
   6043  Embase 
   1763  Cochrane Library   
   1156  CINAHL  
   16  Other sources  
 
9474 Titles and abstracts screened after removal of duplicates  
  9321 Records excluded (subject not relevant) 
153 Full-text articles assessed for eligibility 
116 Records excluded  
   40 No UPF food or UPF-DP exposure of subject 
   33 Cross-sectional / retrospective study designs 
   11 Superior publication from same cohort available 
   11 Review or qualitative publication 
     8 Subjects not disease-free at baseline 
     5 No cardiometabolic health outcome 
     5 Risk estimates reference category not comparable 
     1 Exposure level negligible 
     1 Population with special dietary needs 
     1 Commentary 
4 Articles identified through hand searching of reference   
lists additionally full-text reviewed 
41 Articles included in the review 
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Characteristic  All outcomes 
Studies (risk estimates), n: 41 (51) 
CVD events, n: 16763 
T2DM events, n:  9620 
Adiposity events, n:  >6837* 
Participants, n: 1,054,475 
Studies by geographical location, n:  
 Europe 20 
 North America 15 
 Asia 5 
 South America 1 
Studies by study size, n:  
 >= 100.000 2 
 10000-<100.000 15 
 1000-<10000 21 
 <1000 3 
Study size:   
 Mean (n) 25718 
 Range (min-max) 427-129501 
Duration of follow-up:  
 Mean (years) 9.18 
 Range of follow-up (years) 2-28.5 
Names of diets or dietary patterns:  
 Western  15 
 Sweet 7 
 Fast-foods 5 
 Ultra-processed foods according to NOVA   2 
 Unnamed  4 
 Energy-dense 2 
 Fats & processed Meats  2 
 Junk and convenience  1 
 Other 3 
Average number of UPFs in dietary patterns (min-max): 7.63 (3-33) 
Approaches to derive dietary pattern:   
 Number of a posteriori dietary patterns 35 
 Number of a priori dietary patterns 6 
Average loading† of UPFs in a posteriori dietary patterns (min-max): 0.39 (0.21-0.63) 
Average % of UPFs with a loading of > 0.2 of total number of food groups / items 
with loadings of > 0.2 (min-max):  
46.7%  
(21.7%-87.5%) 
Categorization of exposures:  
 Quartiles 15 
 Quintiles  12 
 Continuous  9 
 Tertiles 5 
Average study quality of maximum 9 (min-max): 5.4 (3-8) 
* Some adiposity studies reported aggregated estimates from which no information on singular events could be 
derived  
† Factor loadings in factor analyses or component coefficients in principal component analyses express the 
correlation between the original variables (i.e. food groups) and the underlying factors (i.e. Western dietary 
pattern). 
 Table 2.3 Key characteristics of included studies and diets and dietary patterns 
Chapter 2: Associations between ultra-processed food intake and cardiometabolic health: A systematic 
review and meta-analysis 
     55 
The main sources of heterogeneity between studies related to representativeness of exposed 
cohorts (some were restricted to specific populations such as civil servants); adjustment for 
confounding factors such as socio-economic status, health-related behaviours, and family 
history; the degree to which the exposure represented all ultra-processed foods; and the 
comparability of measures of adiposity outcomes (e.g. BMI, fat-free-mass, fat-mass-index, etc.). 
2.4.2 Ultra-processed food intake and cardiovascular disease risk 
I included 18 risk estimates from 16 publications in the non-linear dose-response analysis and 
an additional five risk estimates from four publications in the summary random-effects meta-
analysis of highest versus lowest UPF intake or UPF dietary patterns score category and CVD risk, 
with 16,763 CVD events among 595,288 participants.79–81,83,88,140,188–191,196–198,201,202,204,206,208,214,218 
In the non-linear analyses, the lowest reference category was the 10th percentile of the UPF 
intake or UPF dietary pattern score distribution. There was weak evidence of non-linearity 
(P=0.068) and a slightly convex non-linear relationship between UPF intake or UPF dietary 
patterns score category and CVD risk was observed (Figure 2.2, top). Table 2.4 shows the relative 
risk estimates and confidence intervals from the non-linear dose-response analysis for selected 
dose values. The summary relative risk for the highest versus lowest UPF intake or UPF dietary 
pattern score category was 1.18 (95% CI, 1.09-1.27; P-value for overall association <0.001; I2 
=42.3%, PHeterogeneity=0.018; Figure 2.2, bottom). There was no evidence of publication bias with 
Egger’s test (P=0.597) and Begg’s test (P=0.285), and the funnel-plot exhibited symmetry 









Figure 2.2 Ultra-processed food intake and cardiovascular disease risk  
Top: Non-linear dose-response random-effects meta-analysis modelled with restricted cubic splines with 
lowest measured intake (10%) as reference intake. 95% confidence intervals (dashed lines) and linear 
dose-response point estimates as dotted lines. Bottom: Random-effects meta-analysis of highest versus 
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Table 2.4 Ultra-processed food intake and CVD and T2DM Risk 
Non-linear dose-response meta-analysis of CVD and T2DM associated with intake of UPFs for selected 
intake percentiles. 
2.4.3 Ultra-processed food intake and risk of type 2 diabetes mellitus 
I included nine risk estimates from eight publications in the non-linear dose-response analysis 
and one additional estimate in the summary random-effects meta-analysis of highest versus 
lowest UPF intake or UPF dietary patterns score category and incident T2DM risk, with a 
combined 9,620 T2DM events among 368,579 participants.82,193,195,203,210,212,217,219,220 There was 
no evidence of non-linearity (P=0.313), and the summary relative risk for the highest versus 
lowest UPF intake or UPF dietary patterns score category was 1.46 (95% CI, 1.23-1.68; P-value 
for overall association <0.001; I2 =77.2%, PHeterogeneity <0.001; Figure 2.3, bottom). There was no 
evidence of publication bias with Egger’s test (P=0.569) and Begg’s test (P=0.371), and the 







Ultra-processed food intake 
percentile 
Relative risks (95% CI) 
CVD T2DM 
10 1.00 1.00 
12.5 1.01 (1.00-1.01) 1.01 (1.01-1.02) 
30 1.06 (1.00-1.07) 1.10 (1.07-1.19) 
50 1.12 (1.01-1.15) 1.21 (1.15-1.37) 
70 1.18 (1.07-1.25) 1.34 (1.23-1.53) 
87.5 1.24 (1.13-1.37) 1.46 (1.28-1.67) 











Figure 2.3 Ultra-processed food intake and Type 2 diabetes mellitus risk  
Top: Non-linear dose-response random-effects meta-analysis modelled with restricted cubic splines with 
lowest measured intake (10%) as reference intake. 95% confidence intervals (dashed lines) and linear 
dose-response point estimates dotted lines. Bottom: Random-effects meta-analysis of highest versus 
lowest UPF intake or UPF dietary patterns score category and T2DM risk. 
2.4.4 Ultra-processed food consumption and adiposity  
I included twelve studies with 90,608 participants in the narrative synthesis of the association 
between UPF intake and adiposity.84–86,141,187,192,194,207,209,211,215,216 Five studies reported 
coefficients from linear regressions, five from odds and hazard ratios, and two from mean 
changes of adiposity outcomes (Table 2.5). These inconsistencies regarding the types of 
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estimates of association precluded any quantitative summary of evidence. Half of the studies 
reported small risk estimates with wide uncertainty intervals that included the 
null;86,194,207,209,215,216 the remainder reported that increased intake of UPFs was associated with 
increased risk of adiposity.  
Publication Population Exposure Type of estimate 
Estimate (CI / 
SE*) 




coefficient of: SD¥ increase 
in DP (z-score) and fat mass 
index (z-score) 
0.06 (0.03; 0.10) 





coefficient of: change in 
DP-score and change in 
BMI categories (normal to 
overweight/obese) 
-0.15 (-0.5; 0.19) 
Voortmann, 2016 Children Western DP 
Lin. regression beta-
coefficient of: FMI and DP-
score; Q4 vs. Q1 
-0.01 (-0.11; 0.09) 




coefficient of: DP-score and 
change in BMI; Q3 vs. Q1 






coefficient of: DP-score and 
change in BMI (z-score); 









Sweet and salty 
foods DP 
OR of: DP-score and weight 
status (BMI >= 85th 
percentile) 
0.97 (0.83; 1.14) 
0.86 (0.72; 1.03) 
0.92 (0 .71; 1.19) 








OR of: consumption of HPS 
and any weight gain; Q5 vs. 
Q1 
1.21 (1.03; 1.42) 
Pala, 2013 Children 
Sweet and fat 
DP 
OR of: DP-score and 
overweight / obesity; Q3 
vs. Q1 




Sweet DP OR of: BMI > 30 & DP-score 
3.8 (0.97; 14.94) 
1.63 (0.45; 5.87) 
Mendonca, 2016 Adults 
Consumption 
of UPF (NOVA) 
HR for UPF consumption 
and incident overweight & 
obesity; Q4 vs. Q1 




cheese DP Mean change in BMI during 
follow-up (10 years) 
9.04 (1.03 (SE)) 
White girls Fast food DP 6.24 (0.32 (SE)) 
Schulze, 2006 Adults Western DP 
Mean weight change during 
follow up (8 years) 
7.45 (0.12 (SE) 
Table 2.5 Summary of estimates of association of adiposity studies 
* SE = standard error; ꝉ DP = dietary pattern; ¥ SD = standard deviation. 
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Three of the four studies with adult populations reported positive association, while only three 
of eight studies with children populations did. Six of the eight adiposity studies with a sample 
size of under 5,000 participants reported large uncertainty and no association, while three of 
the four largest studies did find an association. 
2.4.5 Meta-regression and sensitivity analyses  
Figure 2.4 Meta-regression analyses of CVD and T2DM risks 
Meta-regression of follow-up time, number of participants, and study quality on log relative risk estimates 
of studies. Left panels: CVD risk; right panels: T2DM risk. Solid lines represent the meta-regression slope 
of the change in log relative risk estimates for increasing levels of stratification variables. Size of the data 
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I examined potential heterogeneity by length of follow-up time, number of participants, and 
study quality performing a meta-regression of the log of relative risks (Figure 2.4). Regarding 
CVD, I found no evidence for heterogeneity by follow-up time (P=0.622), number of participants 
(P=0.981), or study quality (P=0.552). Regarding T2DM, there was also no evidence to suggest 
heterogeneity by follow-up time (P=0.394), number of participants (P=0.130), or study quality 
(P=0.459). 
When each study was excluded from the summary meta-analysis of CVD, no study changed the 
overall summary relative risk estimate by more than ±0.02 (i.e. from 1.18 to 1.20), and only one 
study changed the I2 by more than ± 5% (Chan 2013m, -11%, Table 2.6). In the summary meta-
analysis of UPF and T2DM risk, the exclusion of the study with the highest risk estimate212 
resulted in the largest reduction in the summary risk estimate, from 1.46 (95% CI, 1.23 to 1.68) 
to 1.37 (95% CI, 1.18 to 1.57) (Table 2.7). The exclusion of the study with the lowest risk 
estimates (Nanri 2013, RR for females 0.81 [95% CI, 0.61-1.08]) resulted in the largest increase 
in the summary risk estimate from 1.46 to 1.51 (95% CI, 1.34-1.68). Notably, excluding this study 
also reduced the heterogeneity from I2 = 77.2% (significant heterogeneity) to I2 = 49.5% (little 
heterogeneity), indicating this study as the source of the high heterogeneity of the overall 













Excluded study Estimates  
Fung 2004b 
1.17 (95% confidence interval 1.08 to 1.26; P-value for overall association 
<0.001; I2 =40.7%, PHeterogeneity=0.025) 
Hu 2000 
1.17 (95% confidence interval 1.08 to 1.25; P-value for overall association 
<0.001; I2 =38.3%, PHeterogeneity=0.036) 
McNaughton 2009 
1.17 (95% confidence interval 1.08 to 1.26; P-value for overall association 
<0.001; I2 =41.8%, PHeterogeneity=0.022) 
Mertens 2017 
1.17 (95% confidence interval 1.08 to 1.27; P-value for overall association 
<0.001; I2 =42.3%, PHeterogeneity=0.020) 
Varraso 2012m 
1.17 (95% confidence interval 1.08 to 1.26; P-value for overall association 
<0.001; I2 =40.3%, PHeterogeneity=0.027) 
Atkins 2016 
1.18 (95% confidence interval 1.08 to 1.27; P-value for overall association 
<0.001; I2 = 44.0%, PHeterogeneity= 0.015) 
Barrington 2016 
1.18 (95% confidence interval 1.09 to 1.28; P-value for overall association 
<0.001; I2 = 44.9%, PHeterogeneity= 0.018) 
Denova-Gutierrez 
2016 
1.18 (95% confidence interval 1.09 to 1.27; P-value for overall association 
<0.001; I2 = 41.3%, PHeterogeneity= 0.023) 
Heidemann 2008 
1.18 (95% confidence interval 1.08 to 1.28; P-value for overall association 
<0.001; I2 =44.6%, PHeterogeneity=0.019) 
Hlebowicz 2011f 
1.18 (95% confidence interval 1.09 to 1.27; P-value for overall association 
<0.001; I2 =42.0%, PHeterogeneity=0.021) 
Hlebowicz 2011m 
1.18 (95% confidence interval 1.09 to 1.28; P-value for overall association 
<0.001; I2 =44.8%, PHeterogeneity=0.013) 
Mendonca 2017 
1.18 (95% confidence interval 1.08 to 1.28; P-value for overall association 
<0.001; I2 =44.3%, PHeterogeneity=0.014) 
Mohammadifard 
2017 
1.18 (95% confidence interval 1.09 to 1.27; P-value for overall association 
<0.001; I2 =44.9%, PHeterogeneity=0.013) 
Nettleton 2009 
1.18 (95% confidence interval 1.09 to 1.27; P-value for overall association 
<0.001; I2 =43.2%, PHeterogeneity=0.017) 
Odegaard 2014 
1.18 (95% confidence interval 1.08 to 1.28; P-value for overall association 
<0.001; I2 =43.9%, PHeterogeneity=0.015) 
Shikany 2015 
1.18 (95% confidence interval 1.09 to 1.28; P-value for overall association 
<0.001; I2 =44.9%, PHeterogeneity=0.012) 
Chan 2013f 
1.19 (95% confidence interval 1.10 to 1.28; P-value for overall association 
<0.001; I2 = 43.2%, PHeterogeneity= 0.017) 
Martinez-Gonzales 
2015 
1.19 (95% confidence interval 1.09 to 1.28; P-value for overall association 
<0.001; I2 =44.4%, PHeterogeneity=0.014) 
Osler 2002 
1.19 (95% confidence interval 1.09 to 1.29; P-value for overall association 
<0.001; I2 =43.4%, PHeterogeneity=0.016) 
Varraso 2012f 
1.19 (95% confidence interval 1.09 to 1.28; P-value for overall association 
<0.001; I2 =44.9%, PHeterogeneity=0.013) 
Chan 2013m 
1.20 (95% confidence interval 1.11 to 1.28; P-value for overall association 
<0.001; I2 = 31.3%, PHeterogeneity= 0.081) 
Guallar-Castillion 
2012 
1.20 (95% confidence interval 1.11 to 1.29; P-value for overall association 
<0.001; I2 =39.3%, PHeterogeneity=0.031) 
Stricker 2013 
1.20 (95% confidence interval 1.11 to 1.29; P-value for overall association 
<0.001; I2 =37.1%, PHeterogeneity=0.042) 
Table 2.6 Summary meta-analyses of UPF and CVD risk with exclusion of each study at a time 
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Excluded study  Estimates  
Schulze 2005 
1.37 (95% confidence interval 1.18 to 1.57; P-value for overall association 
<0.001; I2 = 69.8%, PHeterogeneity = 0.001) 
Dominguez 2014 
1.44 (95% confidence interval 1.21 to 1.67; P-value for overall association 
<0.001; I2 = 79.2%, PHeterogeneity < 0.001) 
Odegaard 2012 
1.44 (95% confidence interval 1.23 to 1.76; P-value for overall association 
<0.001; I2 = 79.6%, PHeterogeneity < 0.001) 
VanDam 2002 
1.44 (95% confidence interval 1.20 to 1.69; P-value for overall association 
<0.001; I2 = 78.2%, PHeterogeneity < 0.001) 
Zhang 2006 
1.44 (95% confidence interval 1.20 to 1.68; P-value for overall association 
<0.001; I2 = 79.0%, PHeterogeneity < 0.001) 
Mcnaughton 2008 
1.45 (95% confidence interval 1.21 to 1.69; P-value for overall association 
<0.001; I2 = 79.4%, PHeterogeneity < 0.001) 
Fung 2004a 
1.46 (95% confidence interval 1.21 to 1.72; P-value for overall association 
<0.001; I2 = 78.9%, PHeterogeneity < 0.001) 
Reeds 2016 
1.47 (95% confidence interval 1.22 to 1.72; P-value for overall association 
<0.001; I2 = 79.7%, PHeterogeneity < 0.001) 
Nanri 2013m 
1.50 (95% confidence interval 1.21 to 1.78; P-value for overall association 
<0.001; I2 = 79.7%, PHeterogeneity < 0.001) 
Hlebowicz 2011f 
1.51 (95% confidence interval 1.34 to 1.68; P-value for overall association 
<0.001; I2 = 49.5%, PHeterogeneity < 0.045) 
Hlebowicz 2011m 
1.37 (95% confidence interval 1.18 to 1.57; P-value for overall association 
<0.001; I2 = 69.8%, PHeterogeneity = 0.001) 
Table 2.7 Summary meta-analyses of UPF and T2DM Risk with exclusion of each study at a 
time 
2.5 Discussion 
Diets and dietary patterns characterized by higher relative intake of UPFs compared with lower 
intake were associated with an increased risk of CVD and T2DM. There was weak evidence of a 
non-linear relationship between UPF consumption and CVD risk. No evidence for publication 
bias was found, and there was no evidence for heterogeneity by length of follow-up, number of 
participants or study quality for either outcome. The overall risk estimates regarding CVD and 
T2DM were robust to the exclusion of single studies, and the high heterogeneity in the T2DM 
risk estimates was driven by one study with a very low risk estimate. While inconsistencies in 
the estimates of association of the adiposity studies precluded a quantitative synthesis of the 
findings, the narrative review revealed mixed findings with half of the studies showing a positive 
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association, while the other half did not find an association, and those were studies of children 
populations.   
2.5.1 Interpretation and comparison with other studies 
To my knowledge, this is the first study that has systematically investigated prospective diet and 
dietary pattern cohort studies from an UPF perspective and summarized those in non-linear 
dose-response and summary random-effects meta-analyses. One previous prospective cohort 
has found a positive association with hypertension,140 and one very recent study has 
demonstrated a small but positive association with cardiovascular diseases.144 The hypothesis 
and pathways that were introduced in the first chapter all apply here and can be briefly 
repeated: UPFs have been found to contain higher levels of sugar, sodium, unhealthy fats 
(saturated and trans fats) (from partially hydrogenated oils), energy, and less fibre and various 
micronutrients.96–103 UPFs have also been found to be less satiating and have a higher glycaemic 
load than minimally or unprocessed foods.104 Current research indicates that high intakes of 
sugar, unhealthy fats, little dietary fibre, and foods with a high glycaemic index negatively affect 
the development of insulin resistance and T2DM.105–109 If the observed greater risk of T2DM with 
increasing intakes of UPFs is a causal association, it is likely the result of the combination of these 
nutritional risk factors. 
Regarding CVD, the diets included in this review that were high in UPFs contained lower levels 
of fruits, vegetables, nuts and seeds, whole grains, and higher levels of fats and dietary 
sodium.97,110–112 These characteristics have previously been associated with increased risk of 
CVD.3,113 Also, trans fats were a still a widely used ingredient during the study period of most of 
the cohorts (1990’s and 2000’s). Trans fats have been associated with increased CVD risk, 
especially total CHD and CHD mortality risk.119,120 CVD has a more complex aetiology in which, 
depending on disease subtype, non-nutritional risk factors may play a relatively more important 
role than in the aetiology of T2DM.  
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This could explain why the estimated relative risks between UPFs and CVD were smaller and 
possibly have a slightly different functional form than in the association between UPFs and 
T2DM. Regarding both CVD and T2DM, one pathway explaining diet-disease associations could 
be the relationship between diets and the gut microbiome. A large body of research supports 
the hypothesis that Western diets and UPFs affect changes in the gut microbiome which are 
associated with obesity and metabolic diseases, possibly through the pathways of gut dysbiosis 
(microbial imbalance or maladaptation) and inflammation.127  
Current research indicates a positive association between UPFs and adiposity, as outlined in the 
background chapter. One systematic review has investigated the association between UPF 
intake and body fat in children and adolescents previously.95 It reported small but positive 
associations, mostly based on cross-sectional designs, and found a lack of comparability of the 
studies included, which was repeated in my findings. The positive associations found in the study 
of adults confirms previous research from an RCT of ad libitum UPF versus unprocessed food 
consumption showing a strong positive causal effect of UPF intake on adiposity.94 
2.5.2 Limitations 
Most of the studies included in the analyses did not specifically investigate the degree of 
processing of foods. Hence, the extent to which the dietary exposure captured UPF consumption 
as defined by NOVA differed between the studies. While some studies classified dietary data 
according to a priori classifications, most included studies investigated dietary patterns 
empirically derived by factor analysis or similar methods.89,221,222 A major limitation of these 
data-driven studies was that they did not contain information about the average consumption 
of included food groups. Hence, on an absolute scale, exact conclusions about the comparability 
of the exposures of the studies included are limited and statements about absolute levels of UPF 
consumption and associated risks are not possible in this study. However, studies of overall diets 
or dietary patterns have been found to be reproducible and internally valid.223–226 Since 
individual dietary pattern scores are based on actual intakes in data-driven a posteriori studies, 
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individuals with higher dietary pattern scores truly have higher relative intakes of the foods that 
a given dietary pattern is defined by. Most included studies used a posteriori dietary patterns 
defined by higher intakes of UPFs (or were a priori studies of the NOVA classification). Hence, 
the relative exposure (of higher versus lower intakes of UPF) between included studies is 
comparable, despite the variability of absolute UPF consumption levels between studies, which, 
however, is likely low given that most studies were high-income populations with broadly 
comparable levels of UPF consumption patterns in the population. Moreover, in comparison to 
nutrition studies of single food groups or nutrients, dietary pattern studies reduce the risk of 
nutritional confounding from other unhealthy or healthy non-UPF food items, although some 
risk for confounding remains.  
Residual confounding could have influenced the results. Although all included studies adjusted 
for confounding and risk estimates that were adjusted according to predefined criteria were 
extracted, violations of the ‘ignorability’ assumption (a lack of overlap or lack of balance in 
covariate structure between more and less exposed participants) are plausible and can imply 
erroneous covariate-adjusted estimates and confidence intervals.227–229 When relative risks are 
small at high levels of exposure – as is the case here regarding CVD – residual confounding is 
likely to bias the estimates upwards, and confidence intervals do not adequately reflect the 
uncertainty around the estimates.  
Measurement error in the assessment of diet and covariates also could have influenced the 
results. If there was measurement error in the exposure, the relative risks in the published 
studies may have been influenced by regression dilution bias, which attenuates the estimated 
disease risk association.230 However, given that there might have been measurement error in 
the covariates as well, it is unclear in which direction the observed association could have been 
biased.  
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2.5.3 Implications for policy and future research 
Although one RCT on UPFs and adiposity exists,147 further RCTs are needed to test the effects of 
overall diets high in UPFs on short-term outcomes, particularly cardiometabolic biomarkers, as 
long-term RCTs will not be feasible. More prospective cohort studies on UPFs and CVD and T2DM 
should be undertaken to solidify and broaden the evidence base. Future studies should also 
always report the range of intake of UPFs to enable comparisons across studies. Further research 
should also be undertaken especially in the context of low-to-middle income and emerging 
countries. To increase comparability between studies of adiposity, less common measures such 
as fat-mass-indices or mean weight changes between should be avoided; usage of common 
metrics such as age-dependent and potentially ethnicity-specific BMI or z-score of BMI would 
be preferable. Odds and hazard ratios (and their updates231) should be used to measure 
strengths of associations instead of measures such as linear regressions. Interventions to reduce 
consumption of UPFs may offer promising strategies to reduce the risk of T2DM and CVD. Such 
interventions would have wider reach, greater impact and equity if delivered at population-
level.232 Chapter 4 as well as the overall discussion will discuss the implications of the findings 
for research and policy in much greater detail.  
2.6 Conclusion 
In these meta-analyses, any intake compared with the lowest intake of UPFs was consistently 
associated with a greater risk of T2DM and high levels of UPF intake compared with the lowest 
intake were associated with an increased risk of CVD. UPF consumption was associated in most 




3 ULTRA-PROCESSED FOODS AND 
ADIPOSITY AND DIABETES MELLITUS 
A PANEL ANALYSIS OF 76 COUNTRIES BETWEEN 
2001 AND 2016  
Co-Authors: JA and MW.  








Chapter 3: Ultra-processed foods and adiposity and diabetes mellitus: A panel analysis of 76 countries 
69 
3.1  Introduction  
The findings of the previous chapter have indicated that overall, UPFs are likely associated with 
T2DM and CVD. These studies with individual-level data are less susceptible to measurement 
error and other biases than those using aggregate data. However, individual-level data cannot 
quantify associations between changes in the overall food system and population-level trends 
of adiposity and diabetes on a global scale.233 Furthermore, in regions in which the most rapid 
transitions of food systems are taking place (currently mostly low-to-middle income countries), 
individual-level data is often unavailable or inadequate to quantify the effects of changing diets 
on health.234 Accordingly, only few studies in the last chapter were performed in the context of 
low-to-middle income countries.  
A recent systematic review concluded that food sales and purchase data have become a valuable 
tool for public health research in areas in which traditional methods of dietary assessments are 
limited, such as consistently measuring shifts in the food supply.235 Changes in sales of UPFs at 
the country-level are anecdotally associated with health-outcomes.135 One previous study 
reported trends in sales of UPF food groups, finding positive associations with adult adiposity. 
However, it only analysed one population and outcome combination (adult adiposity), did not 
present trends of UPFs for each country, did not investigate diabetes, did not estimate 
associations for children and adolescent populations which are increasingly at risk of diabetes 
and adiposity, or reported findings by income category.137 Performing analyses by classes of 
income separately might be insightful given that countries of different levels of income are at 
different stages of the nutrition transition – performing aggregate analyses for all countries at 
the same time could potentially conceal differences in association for a given period of time.  
The aim of the research reported in this chapter was thus to estimate the longitudinal 
associations between sales of UPF products and the prevalence of adiposity and diabetes 
mellitus in 76 countries for the years 2001 to 2016 for both sexes of adult, children and 
adolescent populations, and present results for all countries and LMICs and HICs separately.  
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In studying the relationship between UFPs and adiposity or diabetes at population level, multiple 
choices regarding outcome selection, analytical strategy, or exposure definition are possible. As 
outlined in chapter 1, a key observation of research on the ‘replication challenge’ in the 
biomedical and social sciences149,236,237 is that results can be highly dependent on so-called 
‘researcher degrees of freedom’ - or the data processing and analytical choices that individual 
researchers make - even when analyses are pre-specified and selection on statistical significance 
is absent.158–161 Since multiple plausible combinations of outcomes, exposure definitions, 
covariates, and modelling strategies exist to address the study aims, I conducted a ‘multiverse 
analysis’. I first describe global levels of UPF sales, graphically explore unadjusted bivariate 
associations between UPFs and adiposity and diabetes mellitus, and finally estimate associations 
between UPF and adiposity and diabetes mellitus prevalence in multivariable regression models. 
3.2 Contributions 
KS conceived and designed the study. JA and MW contributed to the study design. KS compiled 
and analyzed the data. KS, JA, and MW interpreted the data. KS wrote the manuscript, and MW 
and JA revised the manuscript. All authors approve the final version of the manuscript. 
3.3 Methods  
3.3.1 Data sources and food classification according to the level of processing 
I identified country-level time-series data available in officially published sources for 40 high-
income countries (HICs) and 36 low-to-middle income countries (LMICs) between 2001 and 
2016. Details of variable definitions, data sources, income classification, and included countries 
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Table 3.1 Variable definitions and data sources 
Variables Definition Data Source  
Outcomes 
Mean BMI of 
adults and children 
and adolescents 
Age-standardized mean BMI, by sex NCD-RisC238 
Prevalence of 
overweight in 
adults and children 
and adolescents 
Age-standardized population prevalence of overweight (more 
than 1 SD to 
2 SD above the median BMI), by sex  
NCD-RisC238 
Prevalence of 
obesity in adults 
and children and 
adolescents 
Age-standardized population prevalence of overweight (more 




Age-standardized population prevalence of diabetes mellitus, by 
sex.  
 





Combined sales of the following foods: Fruits, vegetables, starchy 






Combined sales of the following foods: Oils and fats, butter and 





Combined sales of the following foods: Frozen yoghurt, processed 
meat and seafood, yoghurt products, sour milk products, 




foods (NOVA 4) 
Combined sales of the following foods: Breakfast cereals, sweet 
and savoury snacks (Chips/crisps, corn chips, pretzels, sweet 
snacks, salted nuts), confectionery (chocolates, sweets, pastilles, 
jellies), sugar confectionary, ice creams, frozen desserts, biscuit 
and snack bars, baked goods (packaged), frozen products (pizza, 
ready meals, others), soups, ready meals, sauces, dressings and 
condiments, spreads, carbonates (carbonates drinks), sweetened 





(% of total) 
Urban population refers to people living in urban areas as defined 






Dietary energy consumption per capita refers to the amount of 
food, expressed in kilocalories (kcal) per day, available for each 





(litres per capita) 
Pure litres of alcohol consumed per adult aged 15 years or older, 
per capita  
Global Burden of 




(litres per capita) 
Amount cigarettes consumed, per capita 
Global Burden of 




Sex-specific age-standardized prevalence of insufficient physical 
activity among adults for the year 2016 from the WHO, which was 
defined as the percentage of the population attaining less than 150 
minutes moderate-intensity physical activity. Data was based on 




GDP per capita Gross domestic product as purchasing power parity World Bank240 
Income 
classification 
Countries with a gross national income of over US$ 12,476 per 
capita were classified as high-income and countries with a gross 
national income of over US$ 1025 and under US$ 12,476 per capita 
in 2001 were classified as low-to-middle-income.245 All countries 




Briefly, I obtained data on age-standardised body-mass index (BMI) and overweight and obesity 
population prevalences (in children, adolescents, and adults), as well as age-standardised sex-
specific adult diabetes mellitus prevalence data from the NCD Risk Factor Collaboration 
database (NCD-RisC).2,39 Food sales data were taken from the Passport Global Market 
Information Database by Euromonitor International, an independent provider of strategic 
market research that estimates annual country-level sales of fresh and packaged foods in retail 
environments (e.g. supermarkets, grocery shops) and foodservices locations (i.e. full service and 
take-out restaurants) based on local and regional statistics from trade sources, national 
statistics, and company reports.239 Data on the sales of 42 different food groups were classified 
into four categories of food processing according to the NOVA classification, see Table 1.1 for 
the NOVA classification and Table 3.1 for the classification of Euromonitor data according to 
NOVA. For the descriptive analyses, the NOVA variables were converted into grams or litres per 
day (for solids and liquids respectively) per person using annual population data from the World 
Bank.240   
There could be a lag period between changes in UPFs at the food system level and changes in 
the outcomes studied here because population-level adiposity and DM in a given year is not only 
affected by the food that was sold and consumed in that specific year, but also of the foods that 
were consumed in the previous years. Lagged dependent variables would have reduced the 
observations available for analysis substantially; to be able to take lag periods into account, I 
created additional UPF exposure variables with moving averages.246,247 The first variable 
contained the two-year moving average values of the years t and t-1, and the second variable 
included the three-year moving average value of the years and t, t-1, and t-2, and so on. Since the 
lag period between changes in the food system and type two diabetes onset are expected to be 
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Name  
Algeria, Argentina, Australia, Austria, Azerbaijan, Belarus, Bolivia, Bosnia-Herzegovina, Brazil, Bulgaria, 
Cameroon, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, 
Ecuador, Egypt, Estonia, Finland, France, Georgia, Germany, Greece, Guatemala, Hungary, India, Indonesia, Iran, 
Ireland, Israel, Italy, Japan, Kazakhstan, Latvia, Lithuania, Macedonia, Malaysia, Mexico, Morocco, Netherlands, 
New Zealand, Nigeria, Norway, Pakistan, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, 
Serbia, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Tunisia, 
Turkey, United States, Ukraine, United Arab Emirates, United Kingdom, Uruguay, Uzbekistan, Venezuela 
Table 3.2 List of included countries  
Covariate data was derived from multiple sources. The domestic supply of alcohol per adult age 
15 years and over was taken from the Global Burden of Disease Study 2016 Covariates248 and 
overall dietary energy availability (kilocalories (kcal) per person per day) from food balance 
sheets of the Food and Agriculture Organization Statistical Division.241 As a cross-country 
indicator of physical activity, I used sex-specific age-standardized prevalence of insufficient 
physical activity243,244, and GDP per capita as well as the percentage of population living in urban 
areas were retrieved from the World Bank.240 The final dataset included all countries for which 
food exposure data was available for the entire period; four countries were excluded. There 
were no missing values for other variables except for insufficient physical activity for three 
countries (3.9%), and I imputed those values to the median value of the country-group (LMIC or 
HIC) to which the country belonged.  
3.3.2 Empirical strategy  
Previous studies found that UPF sales have plateaued or even decreased in some HICs, while 
sales continue to increase in LMICs in Asia and Latin America; I thus planned to explore and 
estimate associations for HICs and LMICs separately.249,250 To explore unadjusted longitudinal 
bivariate associations and identify specific countries with strong associations, I calculated 
relative changes in the UPF sales per capita per day and outcome variables for each country 
between 2001 and 2016, with the reference values for each variable set at ‘100’ for the year 
2001. I explored country-level changes in bivariate plots and added a quadratic prediction of the 
outcome variable using linear regressions. The data for analyses were hierarchically structured 
country-level panel data with 16 annual observations for each country. This type of data 
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structure is a special case of multi-level data in which country-years (lower level-1) data are 
nested or clustered within countries (higher level-2) over time.  
To guide the modelling specifications, I performed a series of econometric tests to assess the 
statistical properties of the dataset. Woolridge’s test251 indicated the presence of 
autocorrelation within countries; Greene’s test252 suggested heteroscedastic residuals after a 
fixed-effects regression; findings from Pesaran’s test253 implied cross-sectional dependence of 
the errors; while Frees’254 and Friedman’s tests255 did not; and both the Levin-Lin-Chu and the 
Im-Pesaran-Shin tests256 suggested the absence of a unit-root of the panel dataset. 
As the first estimation strategy, I performed a fixed-effects regression that accounted for 
heteroscedastic, auto-correlated (or clustered), and cross-sectionally dependent standard 
errors,257 using the following equation, shown in its demeaned form:258  
(𝑦𝑖𝑡 − 𝑦𝑖) = 𝛽𝑊(𝑥𝑖𝑡 − x𝑖) + (𝜖𝑖𝑡 −  𝜖𝑖𝑡) 
The subscript 𝑖 indicates level 2 (country) and 𝑡 denotes level 1 (years). 𝑦𝑖𝑡  is the outcome that 
varies between and within countries and 𝑦𝑖  is the country-mean of the outcome. 𝑥𝑖𝑡  is a 
covariate that varies between and within countries, x𝑖  the country-mean of that variable, and 
𝜖𝑖𝑡  is the error on level 1 and 𝜖𝑖𝑡  its mean. By subtracting the country-means, this approach 
models only the variation within the countries during the study period, and 𝛽𝑊 thus represents 
the ‘within’ coefficient estimate for the variables of interest.259 This is a conservative strategy 
that minimizes the risk of bias from unobserved confounding between countries, but it excludes 
time-invariant variables from the estimation, as well as all the variation that exists between the 
countries in the dataset.259,260 To use both within- and between-variation I used a second 
modelling strategy, a two-level hierarchical linear mixed model which allows for both intercepts 
and slopes to vary across groups.261,262 I specified the standard errors to account for 
autocorrelation and heteroscedasticity and used the following equation:  
𝑦𝑖𝑡 =  𝛼𝑡[𝑖] +  𝛽𝑡[𝑖]𝑥𝑖 + 𝜀𝑖 
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where 𝛼𝑡[𝑖] is the varying intercept of the value of t assigned to the country 𝑖, 𝛽𝑡[𝑖] is the varying 
slope (or coefficient) of covariate 𝑥 for country 𝑖, and 𝜀𝑖  is the country-specific error term.  
In the multivariable analyses, the first model included only UPF sales; to account for the 
possibility of confounding by unprocessed foods, physical inactivity, or income, model two 
included these variables as covariates; model three additionally adjusted for alcohol 
consumption (not in children and adolescent populations) and total energy intake; and model 
four additionally adjusted for the proportion of the population living in urban areas. As a known 
risk factor of type 2 diabetes mellitus, I additionally included smoking in model three. To 
construct the multiverse, associations were estimated for combinations of each of the 
outcomes, sexes, populations, exposure averages, models, and estimation strategies, yielding 
288 and 64 combinations in total in the case of adiposity and diabetes, respectively. The 
summary of all combinations of the model dimensions are shown in Table 3.3.  
As discussed in the introductory chapter, I recognize that the statistical practice to dichotomize 
statistical findings into ‘not significant’ and ‘significant’ at P-value of 0.05 is arbitrary.166 
Proposed solutions range from completely abandoning statistical significance164,263 to redefining 
it at P=0.005.148,164–166,185,263 Here, I follow Greenland et al.166 and interpret estimated P-values 
as a continuous measure of the compatibility between the observed data and what would be 
predicted or expected if the entire statistical model and all its assumptions (such as the null 
hypothesis) that were used to compute the P-value were correct, ranging from no compatibility 
(P=0) to complete compatibility (P=1). With this approach, the P-value can be viewed as 
measuring the fit of the model to the data, but a low P-value does not indicate which of the 
model assumptions is incorrect. I report P-values down to 0.0001 and P-values smaller than 
0.0001 as 0.0000. The analysis protocol, Stata code, and data (except data from Euromonitor, 
which requires a paid subscription) are available at https://github.com/kai-schulze/upf_panel. 






























M1: Ultra-processed foods 
M2: M1 + unprocessed foods, insufficient physical activity, GDP 
M3: M2 + Total energy intake, alcohol consumption (for adults) 




1. Fixed effects regression with SE adjusted for 
heteroscedasticity, autocorrelation, and cross-sectional 
dependence 
2. Two-level hierarchical linear mixed model with varying 
intercepts and coefficient with SE adjusted for autocorrelation 
and heteroscedasticity  
2 
 Total number of estimates (product) 288 
 
Diabetes 
Outcome Diabetes 1 














M1: Ultra-processed foods 
M2: M1 + unprocessed foods, insufficient physical activity, GDP 
M3: M2 + Total energy intake, alcohol consumption, smoking  




1. Fixed effects regression with SE adjusted for 
heteroscedasticity, autocorrelation, and cross-sectional 
dependence 
2. Two-level hierarchical linear mixed model with varying 
intercepts and coefficient with SE adjusted for autocorrelation 
and heteroscedasticity  
2 
 Total number of estimates (product): 64 
Table 3.3 Multiverse model dimensions for analyses of adiposity and diabetes 
  
 
Chapter 3: Ultra-processed foods and adiposity and diabetes mellitus: A panel analysis of 76 countries 
77 
3.4 Results  
I included data from 76 countries over 16 years, giving 1216 observations in total and 
representing a population of 5.9 billion individuals or 79% of the global population in 2016. Table 
3.4 shows descriptive statistics for all countries in years 2001 and 2016. The prevalence of 
adiposity and diabetes outcomes increased considerably during the study period, for both sexes, 
as well as for adults and children. Unprocessed food sales, urban population, GDP per capita, 
and total available energy grew during the study period, whereas per capita alcohol 
consumption changed little.  
 2001 2016  
 
Median (IQR) Median (IQR) 
p-
value* 
Population (n=76 countries) 5.2 billion 5.9 billion  
BMI (adult female) [kgm-1] 25.7 (25.0-26.3) 26.7 (25.3-27.4) <0.001 
BMI (adult male) [kgm-1] 25.8 (24.5-26.4) 26.8 (25.8-27.5) <0.001 
BMI (female) [kgm-1] 19.2 (18.7-19.9) 19.6 (19.1-20.2) <0.001 
BMI (boys) [kgm-1] 19.1 (18.6-19.6) 19.8 (19.4-20.2)   0.008 
Overweight prevalence (females) [%] 30.0 (28.5-31.3) 30.4 (29.3-31.3)   0.20 
Overweight prevalence (males) [%] 38.3 (34.1-42.2) 40.6 (37.8-42.5)   0.061 
Overweight prevalence (girls) [%] 19.4 (13.0-24.7) 23.9 (19.2-30.6) <0.001 
Overweight prevalence (boys) [%] 18.9 (15.8-25.9) 29.6 (24.1-33.2) <0.001 
Obesity prevalence (females) [%] 19.0 (15.6-23.7) 25.2 (20.6-29.7) <0.001 
Obesity prevalence (males) [%] 15.3 (10.4-17.3) 22.1 (17.1-25.0) <0.001 
Obesity prevalence (girls) [%] 4.0 (2.6-6.0) 7.3 (4.8-10.3) <0.001 
Obesity prevalence (boys) [%] 5.6 (4.2-8.6) 10.8 (8.6-14.0) <0.001 
Diabetes prevalence (female) [%] 6.7 (6.1-7.6) 7.1 (5.9-10.4) <0.001 
Diabetes prevalence (male) [%] 6.5 (5.6-8.0) 8.4 (7.4-10.0)   0.037 
Ultra-Processed Foods [g per 
capita/d] 
405 (249-598) 458 (323-632)   0.061 
Unprocessed Foods [g per capita/d] 731 (557-852) 821 (639-993) <0.001 
Urban Population [%] 66 (55-78) 70 (58-82)   0.10 
Alcohol consumption [litres per 
capita] 
9.1 (6.0-12.2) 9.3 (6.7-11.6)   0.87 
Total Energy Supply [100 kcal/d] 3012.1 (2738.0-
3327.4) 
3158.1 (2911.7-3417.8)   0.02 





Table 3.4 Descriptive statistics at 2001 and 2016 




Globally, absolute sales of UPFs in 2016 ranged from 32 g per capita per day in India to 899 g per 
capita per day in the United States (Figure 3.1, top panel; Table 3.4). Change in the sales of UPFs 
between the years 2001 and 2016 was different for countries at different levels of development 
(Figure 3.1, bottom panel). While sales decreased slightly from 572 to 558 grams per day on 
average in HICs, sales in LMICs increased on average by almost 30% from 261 to 335 grams per 
day. Countries with increases of over 50% were China (299%), India (267%), Indonesia (216%), 
Pakistan (213%), Peru (181%), Thailand (172%), Nigeria (170%), and Chile (150%). Data for each 
country are provided in Appendix Table 4.  
 
 
Figure 3.1 Levels of ultra-processed food sales 
In g per capita per day in 2016 (top panel) and changes in ultra-processed food sales from 2001 to 2016 
(bottom panel, in %, 2001=100%). 
 
I plotted changes in UPF sales against changes in adiposity and diabetes outcomes, for women, 
men, girls, and boys, and for all countries combined and for LMICs and HICs separately. Figures 
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3.2 and 3.3 illustrate results for BMI, obesity, and diabetes. The associations between changes 
in UPF sales and changes in BMI were consistently positive, regardless of sex, age, or country 
income level. Associations between changes in UPF sales and changes in overweight or obesity 
were positive when all countries were considered but were flatter in the HICs subsample. Some 
countries had consistently large positive associations between changes in UPF sales and all 
adiposity outcomes, notably China, India, Nigeria, Pakistan, South Africa, and Thailand. Bivariate 
associations between UPF and diabetes prevalence were positive in the whole sample but were 
more consistent in males when LMICs and HICs were considered separately. 


































 Change in Ultra-processed Food Sales (in %) 
Figure 3.2 Bivariate association between changes in ultra-processed food sales and BMI (top row) and obesity prevalence (bottom row)  
Changes between 2001 and 2016, in %, 2001 = 100. Quadratic predictions from linear regressions between the two change variables as solid lines.   
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 Change in Ultra-processed Food Sales (in %) 
Figure 3.3 Bivariate association between changes in ultra-processed food sales and obesity prevalence (top row) and diabetes prevalence (bottom row) 
Changes between 2001 and 2016, in %, 2001 = 100. Quadratic predictions from linear regressions between the two change variables as solid lines. *LMICs = Low- and 
middle-income countries; ꝉHICs= High-income countries.
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In the multiverse analysis of adiposity, 279 of 288 coefficient estimates of the association 
between UPFs and adiposity were positive (Figure 3.4). The magnitude of associations was 
generally larger between UPFs and BMI than for overweight and obesity and increased with the 
length of rolling average of UPF sales. 176 (61.1%) of P-values were below 0.005 (median P-value 
0.0013).  
 
Figure 3.4 Associations between UPFs and adiposity for 76 countries between 2001 and 2016 
Left panel: coefficients denote the change in the outcome variables for a one SD increase in UPFs. Right 
panel: p-values for the UPF coefficient estimations. UPF1-3: one-year, two-year, and three-year rolling 
averages of UPFs. M1: UPFs (unadjusted); M2: M1 + unprocessed foods, insufficient physical activity, 
GDP per capita (PPP); M3: M2 + total available energy, alcohol consumption; M4: M3 + urbanization.  
 
Coefficients were larger for children and adolescent populations, and the estimated associations 
of the multilevel-models were generally higher than those of the fixed-effects regressions. No 
clear pattern was observed between the sexes in adult populations, but the associations 
between UPFs and adiposity were stronger for boys than for girls. Analysing countries from 
LMICs and HICs separately yielded clear differences in the magnitude and P-values of the 
estimated associations (Figure 3.5). In LMICs, the coefficients of the association between UPFs 
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and adiposity were large, mostly positive, and with low P-values (78.8% of P-values <0.005; 
median 0.0001).  
Figure 3.5: Associations between UPFs and adiposity between 2001 and 2016, for LMICs (top 
panels) and HICs (bottom panels)  
Left panels: coefficients denote the change in the outcome variables for a one SD increase in UPFs. Right 
panel: p-values for the UPF coefficient estimations. UPF1-3: one-year, two-year, and three-year rolling 
averages of UPFs. M1: UPFs (unadjusted); M2: M1 + unprocessed foods, insufficient physical activity, GDP 




In HICs, this pattern was inverted; coefficients were small and sometimes negative while P-
values were large (19.4% of P-values <0.005; median 0.0827).  
In the multiverse analysis of diabetes, all coefficient estimates of the association between UPFs 
and diabetes prevalence were positive (Figure 3.6). The associations were generally larger for 
men, and the successive addition of confounding factors reduced the magnitude of the 
association. 75.0% of the P-values were below 0.005 (median 0.0001). When I analysed LMICs 
and HICs separately, the pattern was broadly similar to that for adiposity. The magnitude of the 
coefficient estimates was higher in LMICs, and 62.5% of the P-values were below 0.005 (median 
0.0001). However, the P-values in the multi-level models 3 and 4 were higher compared to those 
in the fixed-effects models. In HICs, some coefficients were negative, and 1.6% of the P-values 
were below 0.005, and the median P-value was 0.4402.  
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Figure 3.6 Associations between UPFs and diabetes between 2001 and 2016, 
for all countries (top panels), LMICs (middle panels), and HICs (bottom 
panels)  
Left panels: coefficients denote the change in the outcome variables for a one SD 
increase in UPFs. Right panel: p-values for the UPF coefficient estimations. UPF1-4: 
one year- to four year rolling averages of UPFs. M1: UPFs (unadjusted); M2: M1 + 
unprocessed foods, insufficient physical activity, GDP per capita (PPP); M3: M2 + total 





In this study, I compiled a database of annual country-level panel data of UPF sales and adiposity 
and diabetes outcomes for 76 countries between the years 2001 and 2016. The results show 
that sales of UPFs varied greatly between countries and have increased substantially in LMICs 
during the study period, while sales of UPFs stagnated in many HICs. Unadjusted bivariate 
associations were particularly strong in Chile, China, India, Indonesia, Pakistan, South Africa, and 
Thailand. Adiposity was positively associated with UPF sales across almost all combinations in 
the multiverse analyses, including important socioeconomic and nutritional factors such as 
income, total energy intake, sales of unprocessed foods, physical activity, and urbanization, with 
very low P-values indicating strong evidence for violations of the model assumptions. In HICs, 
both the magnitude and the sign of the associations varied, and P-values were often large. 
Between the sexes, associations were larger overall for boys than for girls, but no clear pattern 
was observed in adult populations. These patterns of results were broadly replicated for 
diabetes, although the findings were less consistent for LMICs compared to adiposity.  
3.5.1 Comparison with other studies and interpretation 
One previous country-level panel study used similar data reported a positive association 
between soft drinks sales and adiposity and diabetes outcomes.264 Several other studies have 
shown that the sales of packaged and some processed foods have increased in LMICs from Asia 
and Latin America and have plateaued in HICs. 135,137,249,250,265–267 However, I am not aware of 
previous studies that systematically classified all available food groups according to their degree 
of food processing and performed multivariable analyses on associations with diabetes and 
adiposity outcomes on a large sample of countries in both adult and children and adolescent 
population or reported such analyses for HICs and LMICs separately. Also, for each variable, I 
aimed to select the best data available from leading sources that had been published in peer-
reviewed journals, such as, for example, NCD-RisC, Global Burden of Disease Studies, or the 
WHO. Using the multiverse-analysis approach, I was able to demonstrate that the observed 
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patterns did not result from specific combinations of outcomes, covariates, populations, or 
estimation strategies, and were robust in multiple equivalent analyses.  
Several hypotheses that were explained in chapters 1 and 2 shall be briefly repeated here to 
explain the findings. In studies from different countries, UPFs have been found to contain higher 
levels of sugar, sodium, trans fats (from complete or partially hydrogenated oils), energy, and 
less fibre and various micronutrients.96–98,110,111,134,268–270 UPFs have also been found to be less 
satiating and have a higher glycaemic load than minimally or unprocessed foods.104 High intakes 
of sugar and unhealthy fats, low intakes of dietary fibre, and high intake of foods with a high 
glycaemic index negatively affect the development of insulin resistance and type two diabetes 
mellitus, which accounts for approximately 90-95% of all diabetes mellitus cases.105–109 Obesity 
is a disorder of the energy homeostasis system which is influenced by diet through multiple 
pathways, including brain rewards, satiety, glucose-insulin responses, and energy intake and 
expenditure.3,90,91 Studies have shown that diets high in refined carbohydrates and fats lead to 
rapid and pronounced weight gain.93,271 Since UPFs are often characterized by a combination of 
high levels of refined carbohydrates and fats, are often highly energy-dense and usually contain 
flavours and food additives that affect reward and satiety systems along the gut-brain axis, a 
causal link with obesity is plausible.3,91 Accordingly, the results that UPFs are associated with 
adiposity are consistent with biological mechanisms and evidence from individual-level 
studies.94,132  
Although individual-level evidence of an association between UPFs and adiposity is based on 
studies from HICs94,141, I did not observe an association in HICs at the population-level. This result 
is likely to be related to differences in the variation of the exposure between these two study 
types. While there is much variation in UPF consumption between participants in cohort studies, 
this is not the case when sales of UPFs are measured on the aggregate level in HICs. In HICs, the 
main phase of the nutrition transition happened during the 1980s and 1990s, and levels of UPFs 
were already high and relatively evenly distributed in 2001.65,272,273 With greater awareness of 
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nutritional risks, eating culture has shifted in some HICs, and small noticeable trends towards 
better dietary quality have been reported over the study period.274 This was not the case for 
many LMICs, of which some had just entered a nutrition transition in the early 2000s, or were in 
the midst of it, and there was much variation within and between those countries in the 
sample.272,273 Once the analyses were run separately in HICs, there was little variation in the UPF 
sales exposure and hence no ‘signal’ which could have been picked up by the different analyses. 
This does not mean that there is no association in HICs, but that the rapid increases in LMICs in 
both exposures and outcomes over the study period allow associations to be identified more 
clearly in LMICs. UPFs are likely associated with outcomes in HICs as well, as is indicated by 
individual-level evidence, but the combination of data, methods, and time period used here are 
not suitable to capture this association.  
3.5.2 Strengths and limitations  
This is the first study that provides evidence on the associations between UPFs and adiposity 
and diabetes in regions that traditionally lack data, estimates associations separately for LMICs 
and HICs, and uses a multiverse approach to make the data processing and analytical approaches 
transparent. The study also has several limitations. First, its ecological nature means that the 
analysis is based on aggregate-level data that does not allow inferences to be made at an 
individual-level. Second, measurement error and limitations in the data quality could have 
influenced the results. Euromonitor applies the same methodology to collect and measure data 
in all countries; however, systematic differences in data accessibility, coverage, and precision 
might exist between countries at different stages of development. However, it is not certain in 
which direction the results would be biased by this variability. Also, I used sales data on UPFs as 
a proxy for consumption. Per capita food waste tends to be higher in HICs than in LMICs.275 This 
might have attenuated the estimated association in HICs to some extent, but it is unlikely that 
accounting for differences in food waste would have fundamentally changed observed patterns, 
as this would have required substantial food waste of UPFs, which are by definition shelf-stable 
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and have a lower risk of waste than other food groups. Additionally, food waste also would have 
to be differential according to outcomes, which is unlikely. Another limitation was that data on 
insufficient physical activity was only available for the year 2016. However, a recent analyses of 
the trends in insufficient physical activity between 2001 and 2016 (for which the individual 
country data are unpublished) show no changes in overall insufficient physical activity levels 
globally, but a minor increase in HICs, Latin America, and the Caribbean, and a decrease of 
insufficient physical activity levels in East and southeast Asia.243 Using this data would have 
possibly strengthened the observed overall pattern of results.  
Third, residual confounding could have influenced the results. I included the main factors that 
could have potentially confounded the country-level associations between UPFs and adiposity 
and diabetes outcomes. However, violations of the ‘ignorability’ assumption (a lack of overlap 
or lack of balance in covariate structure between more and less exposed countries) are plausible 
and can imply erroneous covariate-adjusted estimates and P-values.228,261  
Given these limitations, I consider the emphasis on any specific point estimate including any 
specific P-value inappropriate for the context of this study. However, I evaluate that none of the 
limitations alone, or a combination thereof, would have substantially altered the patterns I 
observed. The results provide evidence that greater sales (and likely consumption) of UPFs in 
LMICs are consistently associated with increases in obesity and diabetes, and that likely 
associations in HICs are not captured due to a lack of variation in sales of UPF in HICs.   
3.5.3 Implications for research and policy  
Further research is needed to investigate the associations in LMICs in prospective cohort studies. 
Further analysis is also needed to geographically decompose aggregate findings so as to identify 
regional variations in outcomes and UPF exposure within countries, for example rural versus 
urban areas. Adiposity and diabetes are amongst the most pressing global health issues of our 
time, with worrying trends in low-to-middle income countries.276 Actions at the food system 
level to decrease sales of UPFs likely offer promising strategies to reduce population-level 
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adiposity and diabetes. Such interventions would have a wider reach, greater impact, and equity 
if delivered at the population-level, than to individuals at high risk.232 Further details of research 
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4 A PROSPECTIVE COHORT ANALYSIS IN  
EPIC-NORFOLK  
Co-authors: FI, MW, JA, and Marleen Lentjes. 




This is the final chapter that explores associations between UPF intake and cardiometabolic 
health. The first two chapters established that previous nutrition studies viewed from an UPF 
perspective demonstrated associations between dietary patterns characterized by higher 
relative intake of UPFs and T2DM and CVD, and that associations between sales of UPFs and 
diabetes and adiposity at the country-level exist in LMICs. However, given the methodological 
limitations of both chapters and the limited explicit evidence on UPFs and cardiometabolic 
health from prospective cohorts, the research reported in this chapter aimed to estimate the 
associations of higher UPF intakes and risk of adverse cardiometabolic health outcomes and 
assess the dose-response relationships in the prospective EPIC-Norfolk cohort.  
Two high quality epidemiology studies have previously investigated the relationship between 
UPFs and adiposity. In the first randomized controlled trial of ad libitum UPF versus unprocessed 
food consumption, participants in the UPF group consumed on average about 500 calories more 
than participants in the unprocessed group.94 Participants in the UPF group also gained 0.8 kg 
body weight, while participants in the unprocessed food group lost 1.1 kg over a period of two 
weeks. In the Spanish University of Navarra Follow-Up SUN cohort, UPF intake was prospectively 
associated with an increased risk of overweight and obesity (HR: 1.26; 95% CI: 1.10, 1.45). 
Regarding CVD as an outcome, UPF intake was prospectively associated with an increased risk 
of CVD in the French NutriNet-Santé cohort (HR: 1.12; 95% CI: 1.05, 1.20).144 Both studies, 
however, have their shortcomings. First, the SUN cohort consists of a special population 
(university students), while NutriNet-Santé is a web-based cohort with a comparatively short 
follow-up (7.4 years median) for CVD. Furthermore, to my knowledge, no evidence from 
prospective cohorts on the associations between UPFs and T2DM exists, and no study has 
compared different ways of operationalizing UPF intake.    
Chapter 4: A prospective cohort analysis in EPIC-Norfolk 
93 
4.2 Contributions 
KS, JA, and MW designed the study with inputs from FI and Stephen Sharp. Marleen Lentjes 
coordinated the generation of the dataset and provided input into the operationalization of the 
UPF variables and ultra-processed food groups. KS conducted the analyses and drafted the 
manuscript. All authors contributed to the interpretation of the results and critically reviewed 
the chapter. I would also like to express gratitude to the EPIC-Norfolk data team for preparing 
the dataset and making it accessible.   
4.3 Methods 
4.3.1 Study population and setting 
EPIC-Norfolk is an ongoing prospective cohort that is part of the Europe-wide multi-centre 
European Prospective Investigation into Cancer (EPIC) study located in 23 centres in 10 
countries.277 The goal of the full EPIC study was to follow individuals to estimate incidence of 
cancer and cause-specific mortality; however the aim of EPIC-Norfolk further included causes of 
disability and death in middle and later life, as well as investigating psychosocial factors, physical 
activity, and a broader set of aspects of lifestyle.278 30,445 community-dwelling women and men 
were recruited from thirty-five General Practitioners’ surgeries in Norfolk county, United 
Kingdom (39% response rate). After giving informed consent, 25,639 participants (99.6% British) 
aged 39-79 years attended a baseline health examination (HE1) between 1993 and 1997 and, of 
these, 15,786 (61%) attended a second health examination (HE2) between 1997 and 2000.279 At 
both health checks, participants completed a health and lifestyle questionnaire and a semi-
quantitative food frequency questionnaire (FFQ) and trained personnel took anthropometric 
measurements as well as blood samples, which were then processed for various assays at the 
Department of Clinical Biochemistry, University of Cambridge, or stored for later analysis at -80 
°C.  Participants were followed-up by March 2016 for incidence and mortality outcomes. The 




Since the National Health Service is the point of entry for health-care services in the UK, the 
General Practitioners’ registers almost completely matched with the official population statistics 
estimates during the recruitment years. General practice age and sex registers therefore 
operated as a population sampling frame, and except having had a lower percentage of current 
smokers, the EPIC-Norfolk cohort corresponded to the overall UK population regarding many 
characteristics, such age, sex, and anthropometry measurements.279 The study was approved by 
the Norfolk District Health Authority Ethics Committee, conducted according to the Declaration 
of Helsinki, and participants gave informed consent. 
4.3.2 Dietary assessment and degree of processing 
A semi-quantitative 130-items food-frequency questionnaire (FFQ) that asked participants 
about the average intake of food items over the past year was used to assess habitual diet. The 
validity of this FFQ was evaluated and compared against 16-day weighted dietary records, 24-
hour dietary recall and selected biomarkers.278,280 The open-source cross-platform program FETA 
(FFQ EPIC Tool for Analysis) was used to derive macro- and micronutrient content of the FFQ 
data.279 To classify all FFQ items according to their degree of food processing I used the NOVA 
system, a food classification scheme that classifies foods into four groups according to the 
nature, extent, and purpose of industrial food processing, described in Table 1.1.66,70 Two 
authors (KS and ML) independently classified all foods in the EPIC-Norfolk FFQ according to 
NOVA and disagreements were resolved by consensus.  
4.3.3 Outcome ascertainment at baseline and follow-up 
At the two health examinations weight, height, and waist and hip circumference were measured 
(to the nearest 0.1 kg and cm, respectively), while participants wore light clothing and no shoes. 
BMI was calculated by dividing an individuals’ weight by its height in metres squared. Baseline 
diabetes status was determined by self-reported diabetes medication, diabetes medication 
shown at the baseline examination, participants changing their diet in the past twelve months 
due to diabetes; or participants stating compliance to a diabetic diet. Funding for measuring 
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HbA1c was available from 1995 onward, therefore around 50% of all participants’ HbA1c 
measurements were taken at baseline. HbA1c was measured on fresh EDTA blood samples using 
high-performance liquid chromatography (Diamat Automated Glycated Haemoglobin Analyzer; 
Bio-Rad Laboratories Ltd., Hemel Hemstead, U.K.), which was standardized to the Diabetes 
Control and Complications Trial (DCCT) assay. Identical measurements were taken at HE2. 
During follow-up, incident diabetes was identified if: participants reported physician-diagnosed 
diabetes or diabetes medication or presented diabetes medication to the assessment at HE2; a 
clinical diagnosis appeared on medical records, diabetes registers, or death certificates; or they 
had an HbA1c of ≥ 6.5% at HE2.  
Participants admitted to a hospital with a diabetes-related condition were identified by their 
National Health Service number. Hospitals were linked to the East Norfolk Health Authority 
database, which identifies all hospital contacts throughout England and Wales for Norfolk 
residents. Vital status for all EPIC-Norfolk participants was obtained through death certification 
at the Office for National Statistics, and death certification with coding for diabetes was 
identified. Previous validation studies in this cohort using capture–recapture analysis indicated 
that the use of multiple sources of ascertainment information for diabetes detected 99% of 
incident cases when comparing with diagnostic information from a comprehensive review of 
medical records. 
Incident CVD included any first ever case of fatal and non-fatal event as a result of ischaemic 
heart disease, ischaemic stroke, haemorrhagic stroke, heart failure, peripheral vascular disease, 
or other cardiovascular outcomes as specified by the relevant ICD codes (ICD9 401-448 or ICD10 
I10-I79).281 Again, the East Norfolk Health Authority database in conjunction with the National 
Health Service number was utilized to ascertain cause-specific hospital admissions. 
Cardiovascular mortality was determined through death certificates with ICD codes held at the 
UK Office for National Statistics. Cardiovascular incidence and mortality as well as type 2 
diabetes incidence were ascertained until March 31, 2016.  
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4.3.4 Assessment of other covariates 
Participant information on demographic, lifestyle, and health characteristics were evaluated at 
HE1 and HE2 via a self-administered questionnaire. Four levels of physical activity (inactive, 
moderately inactive, moderately active, active) were determined from the validated EPIC short 
physical activity questionnaire that was developed to assess both leisure and work activity.282 
Levels of education (no education, O-level, A-level, higher education degree), social class (non-
skilled, semi-skilled, skilled manual, skilled non-manual, manager, professional), smoking status 
(current, former, or never smoker) and marital status (single, widowed, separated, divorced, 
married) and Townsend deprivation (continuous). Non-fasting blood samples were taken from 
which blood lipids and cholesterols were assayed. 
4.3.5 Participant exclusions and missing values 
To address potentially invalid dietary assessments, I identified improbable energy reporting by 
calculating the basal metabolic rate from the Henry equations and derived the Goldberg cut-offs 
to determine and exclude improbable energy reporting according to the methods suggested by 
Black.283–285 I then excluded all the participants with missing dietary information for which no 
UPF exposure could be derived. After exclusion of participants based on improbable energy 
reporting and missing dietary information, I observed less than 0.8% of missing values of the 
covariates included in the analysis, except for social class (2.1%) and information on further 
education (1.2%). These values were imputed to the modal value (for categorical variables) or 
to the median (for continuous variables). Participants with T2DM and participants with self-
reported cardiovascular diseases at baseline were excluded for the analyses of T2DM and CVD, 
respectively.  
4.3.6 Ultra-processed food variables, energy adjustment, and repeated 
measurements 
In previous prospective cohort analyses UPF consumption has been expressed as total weight or 
proportion of total food weight.96,98,140,141 This has been justified based on the assumption that 
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a measure of UPF consumption based on total or proportion of energy would not take into 
account the properties of UPFs that do not contribute any calorific value such as added factors 
that result from the processing of foods (i.e. additives, alterations, contaminants, etc.).98,141 This 
assumption has so far remained theoretical as no direct comparisons of associations between 
UPF consumption and health outcomes between weight- and energy-measures of UPFs have 
been performed. However, the decision to use certain ways to define the exposure can affect 
the results of statistical analyses in fundamental ways.158–161 Since I could not justify one specific 
way of measuring or operationalizing UPFs, I combined the UPF weight and energy variables 
with common nutritional epidemiological approaches to define exposures and adjust for total 
energy intake, in order to reduce confounding by total dietary intake and enable an assessment 
of dietary quality independent of dietary quantity.286–288 The approaches are based on 
suggestions for adjustments for total energy by Willett et al. (1997).  
Table 4.1 Summary of approaches to measure UPF exposures, adjust for total energy intake, 
and model exposure disease relations 
 
Five ways of operationalizing the UPF exposure were created: first, absolute weight of UPFs 
consumed per capita per day in grams (adjusted for total energy and total weight by the residual 





Relation expressed Residual method  
 Weight 
(absolute) 
Absolute weight (g 
per day) 
Disease risk = UPF + total 
energy + covariates 
Yes (weight and energy) 
 




Proportion of UPF 
intake as weight (in 
% of total food 
weight per day) 
Disease risk = UPF + total 
energy + covariates 
Yes (weight and energy) 
 
      
 Energy 
(absolute) 
Absolute energy (in 
kcal per day) 
Disease risk = UPF + total 
energy + covariates 
Yes (energy) 
 




Proportion of UPF 
intake as energy (in 
% of total energy 
from foods per day) 
Disease risk = UPF + total 
energy + covariates 
No 
 




Absolute energy (in 
kcal per day) 
Disease risk = UPF + 
energy from non-UPF 
sources + covariates 
No 
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total energy and total weight by residual method); third, absolute intake of energy consumed 
from UPFs per capita per day in kcal (adjusted for total energy by residual method); forth, 
absolute intake of energy consumed from UPFs per capita per day in kcal (not adjusted for total 
energy as required for energy-partition models); and proportion of energy consumed from UPFs 
of total energy intake in per cent (not adjusted for total energy, as required for energy-density 
models). The approaches to model the UPF exposure and adjustments for total energy intake 
are summarized below in table 4.1.  
In the longitudinal analyses of T2DM and CVD, repeated exposure and covariate information 
were included through the cumulative average method for the participants for which the 
incidence of disease occurred after the second health examination.289,290 In other words, if the 
date of the disease incidence was after the second health examination, an average of the two 
measurements at HE 1 and HE 2 was calculated for the exposure and covariate variables to be 
used in the analyses. If the date of the disease incidence was before the second health 
examination, only exposure and covariate values from the first health examination were used.  
To understand which food groups contribute most to UPF intake and how those potentially differ 
for the weight and energy measures, all FFQ food items that were characterized as ultra-
processed according to NOVA were aggregated into eight ultra-processed food groups (ultra-
processed: drinks; starchy foods and cereals; confectionary, sweets, and sugary products; fats; 
fast foods and savoury snacks; milk and dairy; meat, fish, and eggs).  
4.3.7 Statistical analysis 
To evaluate the association between consumption of UPFs and incidence of T2DM or any CVD 
event I used Cox proportional hazard models with the Efron approximation method to handle 
tied events (events with exactly the same survival time) that can potentially cause minor issues 
in Cox-regressions if not accounted for.291,292 The underlying time variable was age from the first 
available FFQ to age at diagnosis of T2DM, CVD (or death for CVD-mortality), or the date of 
administrative censoring, whichever occurred first. Each of the five approaches to express UPF 
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exposure were modelled continuously increasing from the 10th to 90th percentile and 
categorically as quintiles with approximately equal numbers of participants in each group. In the 
analyses of quintiles, the hazard ratios were modelled with the lowest quintile as the reference 
category. The proportional hazard assumption was confirmed by examining Schoenfeld 
residuals. I assessed the risk of being obese at HE1 and HE2 cross-sectionally by estimating 
logistic regression models with robust Huber and White standard errors. 
I estimated five models that were incrementally adjusted to account for known or potential risk 
and confounding factors. Model one was minimally adjusted for sex and age (as the underlying 
timescale in the analyses of T2DM and CVD). Model two included main socio-economic and 
health-related confounders: physical activity, marital status, smoking status, alcohol intake (g/d, 
continuous), educational level, social class, Townsend area deprivation index, and BMI. In the 
analyses of T2DM, model two was additionally adjusted for family history of diabetes. In the 
analyses of adiposity, models were not adjusted for BMI. To assess associations independent of 
the potential influences of the nutritional quality of the diets and individual’s total energy 
intakes, I adjusted for unprocessed food consumption (g/d, continuous) and total energy intake 
(kcal/d, continuous) in model three.  
Based on known nutritional risk factors,3,293–296 I added nutritional confounders to models four 
and five for each of the three outcomes. In the analyses of CVD, model four included sodium 
intake (mg/d, continuous) and saturated fat intake (g/d, continuous), and model five additionally 
adjusted for fibre intake (non-starch polysaccharides, g/d, continuous). In the analyses of T2DM, 
model four adjusted for sugar intake (g/d, continuous) and model five additionally for fibre 
intake. In the analyses of adiposity, model four adjusted for overall carbohydrate intake (g/d, 
continuous) and model five additionally for overall fat intake (g/d, continuous).  
The shapes of the associations were modelled by using restricted cubic splines with four knots 
at the 5th, 35th, 65th, and 95th percentiles UPF exposure, as recommended by Harrell.180 The 
hazard ratios and confidence intervals in those analyses were estimated against the 10th 
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percentile of intake, and in each case reported for all UPF intake values between the 1st and 99th 
percentile.180  
As secondary analyses, I estimated the associations between each of the eight UPF groups and 
risk of T2DM and CVD as well as odds ratio of adiposity.  
I conducted four sensitivity analyses by (1) excluding incident cases during the first two years of 
follow-up, (2) estimating associations based on a complete case analysis, (3) excluding 
participants with improbable energy reporting based on a simpler exclusion rule (<800 kcal or 
>4200 kcal per day in men and <500 or >3500 kcal per day in women)297, and (4) combined 
unprocessed foods with processed culinary ingredients (NOVA 2) for use as a covariate, as those 
two groups are frequently consumed together.  
In line with the previous chapters, I recognize that the choice of any particular threshold to 
determine statistical significance is arbitrary, and that P-values and 95% confidence intervals of 
hypothesis tests often do not adequately reflect the strength of the evidence against null 
hypotheses.148,164,165,185 However, as is common in studies of nutritional epidemiology, provide 
tables with 95% confidence intervals for all main analyses. For the secondary analyses, P-values 
are presented as a continuous measure of the compatibility of the model with the data and I 
report P-values until 0.0001 and P-values smaller than 0.0001 as 0.0000.165,185 All analyses were 
performed in Stata, version 15.1 (StataCorp LLC, College Station, Texas, USA). The analysis 
protocol and Stata code are available at https://github.com/kai-schulze/upf_epic.  
4.4 Results 
4.4.1 Participant selection, cohort characteristics, and UPF food groups  
After exclusion of participants with no dietary information (n=891) and improbable energy-
intake based on Henry and Goldberg equations (n=7,190), a total of 17,558 participants were 
generally eligible for analysis, with a median follow-up of 19.45 years (IQR 17.63-20.89; mean 
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17.85). Of 17,204 participants eligible for the analysis of T2DM, 1,262 developed the disease 
over 302,184 person-years (17.57 years of follow-up on average).  
A total of 8,333 participants developed primary incident CVD (non-fatal or fatal) over 242,224 
person-years (15.05 years of follow-up on average). Figure 4.1 shows the process for selecting 
and excluding participants and creating three datasets for the analysis of the three conditions.  
Figure 4.2 shows the relative contribution of the eight aggregated ultra-processed food groups 
to the overall UPF intake as energy and weight. When UPF intake was expressed as energy, the 
three food groups ultra-processed confectionary, sweets, and sugary products; breads, starchy 
foods, and cereals; and fats were the three largest contributors to UPF intake with 27, 24, and 
22 percent of total UPF energy intake. When UPFs were measured as weight, ultra-processed 
breads, starchy foods, and cereals; drinks and SSBs; and confectionary, sweets, and sugary 
products were the three main contributing groups with 22, 19, and 17 percent of total UPF 
intake measured as weight. The main difference between weight and energy measures were the 
almost four-fold difference of UPF drinks (5 vs. 19%), an over two-fold difference of UPF fats (9 
vs. 22%), a higher share of confectionary, sweets, and sugar products in the UPF energy measure 
(17 vs. 27%), and a higher share of UPF fruits and vegetables when UPF is expressed as weight 
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Figure 4.2 Relative contribution of aggregated ultra-processed food groups to UPF weight and 
energy variables 
All food items in the aggregated groups are ultra-processed according to NOVA 4. 
Table 4.2 shows the main baseline characteristics of participants according to the lowest and 
highest UPF intake quintiles of the four UPF approaches to measure UPF intake.0Fb Participants at 
baseline had a mean age of 59.7 years, were 57.9% female, had an average BMI of 26, and about 
60% of the sample were inactive or moderately inactive. Across the four UPF variables, 
individuals in the fifth quintile (Q5) were slightly younger and were much less likely to be female. 
For example, while in the first quintile (Q1) of UPF intake measured as weight 80.3% of 
individuals were female, only 32.9% were female in Q5. Participants in Q5 of the UPF variables 
had less formal education and slightly below average levels of higher education. High consumers 
of UPFs worked more in skilled manual jobs and were more active in comparison to the sample 
average. They smoked less than those consuming few UPFs, and the difference was particularly 
strong when UPF intake was expressed as weight or proportion of weight.  
 
 
b Note: I present participant characteristics using the four unadjusted UPF variables weight, proportion of 
weight, energy, and proportion of energy. In statistical analyses, however, I used those four variables 
residually adjusted, and additionally energy unadjusted in the energy partition models. Hence the 
difference between five approaches in the statistical analyses and the four variables in the descriptive.  
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Table 4.2  Baseline characteristics of study population  
For quintiles one and five of UPF consumption variables, EPIC-Norfolk cohort (n=17558), United Kingdom, 1993-2016. Values are numbers (percentages / SD). 
    
    Quintiles 1 and 5 of ultra-processed food consumption variables 
 
      
All 
participants 
Weight Proportion of Weight Energy Proportion of Energy 
   Q1 Q5 Q1 Q5 Q1 Q5 Q1 Q5  
 Age (years) 59.7 (9.4) 60.6 (9.3) 58.2 (9.3) 60.3 (9.2) 58.8 (9.6) 60.3 (9.3) 58.5 (9.4) 60.2 (9.3) 59.1 (9.5)  
 Sex           
 




















 Social class           






















 skilled non-manual 2,959 (16.9%) 657 (18.7%) 550 (15.7%) 624 (17.8%) 570 (16.2%) 619 (17.6%) 532 (15.2%) 559 (15.9%) 583 (16.6%)  
 skilled manual 3,934 (22.4%) 674 (19.2%) 842 (24.0%) 697 (19.8%) 850 (24.2%) 668 (19.0%) 924 (26.3%) 675 (19.2%) 899 (25.6%)  
 semi-skilled 2,245 (12.8%) 435 (12.4%) 474 (13.5%) 401 (11.4%) 496 (14.1%) 404 (11.5%) 520 (14.8%) 374 (10.6%) 545 (15.5%)  
 non-skilled 583 (3.3%) 113 (3.2%) 132 (3.8%) 108 (3.1%) 150 (4.3%) 98 (2.8%) 137 (3.9%) 103 (2.9%) 171 (4.9%)  
 Marital Status           
 Single, Widowed, 
  Separated, Divorced 























 Education           
 




















 School until age 16 1,848 (10.5%) 381 (10.8%) 384 (10.9%) 367 (10.4%) 391 (11.1%) 385 (11.0%) 335 (9.5%) 362 (10.3%) 342 (9.7%)  
 





















   degree or above 
2,232 (12.7%) 450 (12.8%) 412 (11.7%) 464 (13.2%) 378 (10.8%) 479 (13.6%) 399 (11.4%) 517 (14.7%) 356 (10.1%) 
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Table 4.2 (continued) Baseline characteristics of study population  





            
  Quintiles 1 and 5 of ultra-processed food consumption variables  





Q1 Q5 Q1 Q5 Q1 Q5 Q1 Q5 
 











































 Moderately active 4,053 (23.1%) 766 (21.8%) 821 (23.4%) 791 (22.5%) 797 (22.7%) 730 (20.8%) 855 (24.4%) 809 (23.0%) 812 (23.1%)  
 Active 2,969 (16.9%) 402 (11.4%) 787 (22.4%) 499 (14.2%) 665 (18.9%) 397 (11.3%) 864 (24.6%) 563 (16.0%) 620 (17.7%)  
 BMI 26.0 (3.7) 25.2 (3.5) 27.1 (4.0) 25.5 (3.5) 26.7 (4.1) 25.4 (3.5) 26.5 (3.7) 25.6 (3.6) 26.3 (3.9)  
 Smoking status           
    Current Smoker 1,943 (11.1%) 497 (14.2%) 351 (10.0%) 510 (14.5%) 348 (9.9%) 453 (12.9%) 424 (12.1%) 463 (13.2%) 453 (12.9%)  
 









































 Family history of 
Diabetes 
          
    Yes 2,257 (12.9%) 435 (12.4%) 482 (13.7%) 429 (12.2%) 485 (13.8%) 459 (13.1%) 463 (13.2%) 443 (12.6%) 469 (13.4%)  
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Table 4.3 UPF and nutrient intakes of study population  




    Quintiles 1 and 5 of ultra-processed food consumption variables 
 
      
All 
participants 
Weight Proportion of Weight Energy Proportion of Energy 
   Q1 Q5 Q1 Q5 Q1 Q5 Q1 Q5  
 UPF intake           
 Weight (g/day)    426.7 (193.8) 227.3 (42.5) 715.7 (213.0) 247.0 (65.0) 674.0 (242.5) 278.3 (130.3) 613.0 (209.6) 293.3 (130.6) 570.8 (222.9)  
 Proportion of weight (%) 14.4 (5.9) 8.6 (2.3) 22.0 (6.6) 7.9 (1.5) 23.3 (5.7) 10.0 (4.5) 19.2 (6.2) 9.6 (3.8) 19.7 (6.6)  
 Energy (kcal/d)  922.9 (342.9) 578.5 (150.8) 1276.3 (386.5) 613.2 (184.7) 1205.4 (392.4) 512.3 (93.6) 1449.4 (248.8) 562.2 (154.5) 1329.8 (330.7)  
 Proportion of energy 41.2 (9.8) 31.7 (7.7) 48.6 (9.0) 30.9 (7.0) 49.7 (8.9) 29.4 (6.1) 52.1 (7.0) 27.6 (4.4) 55.0 (4.8)  
 Total energy intake           
 Kcal/d 2194.1 (483.7) 1826.3 (309.8) 2591.5 (548.0) 1973.3 (398.0) 2383.0 (545.4) 1759.8 (284.0) 2786.2 (430.3) 2021.5 (431.2) 2394.4 (525.7)  
 Nutrients           
 Carbohydrates (g/day) 276.7 (69.0) 220.8 (43.6) 335.7 (78.0) 239.0 (55.3) 309.1 (78.8) 215.5 (42.8) 359.2 (63.6) 242.8 (58.8) 314.6 (75.9)  
 Sugars (g/day) 144.4 (45.8) 116.9 (32.7) 177.5 (53.7) 128.3 (39.1) 161.8 (53.7) 116.3 (33.1) 186.7 (52.1) 131.2 (39.9) 162.3 (56.6)  
 Fats (g/day) 82.9 (25.8) 68.9 (19.1) 97.4 (30.3) 72.7 (21.7) 90.9 (28.7) 62.7 (17.6) 110.0 (25.6) 74.4 (24.7) 92.7 (27.1)  
 Saturated fats (g/day) 31.9 (11.7) 27.7 (9.9) 36.6 (12.9) 29.0 (10.9) 34.3 (12.2) 25.1 (9.6) 41.6 (11.7) 30.4 (12.6) 34.2 (11.1)  
 Alcohol (g/day) 8.8 (13.3) 9.6 (14.9) 9.4 (13.7) 12.6 (18.0) 7.3 (10.9) 9.9 (14.8) 8.5 (12.7) 12.8 (17.7) 6.0 (9.5)  
 Sodium (mg/day) 3056.2 (790.1) 2400.7 (476.8) 3717.6 (913.5) 2599.9 (612.2) 3404.0 (899.5) 2418.9 (514.7) 3816.3 (819.4) 2700.6 (705.8) 3365.7 (843.2)  
 Fibre (g/day) 19.7 (6.2) 17.1 (5.4) 22.3 (6.9) 18.9 (6.3) 19.9 (6.3) 18.1 (6.0) 21.7 (6.4) 19.7 (6.9) 19.2 (5.9)  
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At baseline, the mean intake of UPFs expressed as weight was 426.7 grams per day and the mean 
proportion of UPFs of total food weight consumed was 14.4% (Table 4.3). On average, 922.9 
kcals per day were consumed when UPFs were measured as energy, and this amounted to an 
average of 42.1% of total energy consumed. Comparing UPF intake between individuals with the 
highest and lowest consumption revealed important findings. First, average UPF intakes 
between Q1 and Q5 roughly increased between two- to threefold. This was the case when UPF 
intake was measured as absolute weight, proportion of weight, and absolute energy; the 
increase was slightly lower on average when UPF intake was expressed as the proportion of 
energy (roughly between a 50 to 100% increase). Secondly, a higher proportion or relative intake 
of UPFs in the diet also implied a higher absolute consumption of UPFs in the overall diet. For 
example, the average consumption of UPFs measured as absolute weight was on average 247 
g/day for individuals with the lowest proportion of weight of UPF, compared to 674 g/day for 
those in Q5 of the proportion of weight from UPFs. Thirdly, the changes between in UPF intake 
between Q1 and Q5 were more pronounced when UPF intake was measured as weight – 
regarding the weight measures, the average increase for all eight possible comparisons between 
Q1 and Q5 was 144%, while the average increase for all eight comparisons of the energy 
measures was 103% (calculations not shown). The total energy intake was higher for those in 
the Q5 of UPF consumption, but the increase was less strong for the two variables measuring 
the proportion of UPF intake. 
Regarding nutrient intakes, the carbohydrate and sugar intake increased relatively more than 
the fat and saturated fat intake between Q1 and Q5 for all UPF measures, while alcohol 
consumption was lower in Q5 of UPF intake, except when measured as weight. Finally, sodium 
intake was much higher for those in the fifth quintiles of UPF intake, while fibre consumption 




4.4.2 Associations between ultra-processed food intake and adiposity, type 2 
diabetes mellitus, and cardiovascular diseases  
4.4.2.1 Ultra-processed food intake and incident type 2 diabetes mellitus 
Table 4.4 displays the estimated associations between UPF intake and risk of T2DM. The number 
of incident type 2 diabetes cases increased with increasing quintiles of UPF intake expressed as 
weight or proportion of weight (from 209 to 334 and 200 to 329, quintiles one to five). This was 
also the case in the three models in which participants were classified according to quintiles of 
energy from UPF, although the difference of incident cases between the first and the second 
quintile was much more pronounced compared to the weight-based measures, and the trend 
appeared less linear than in the case of the weight measures.  
In the Cox-models, higher intake of UPFs expressed as weight was associated with a higher risk 
of type T2DM, after multivariable adjustment for covariates. For a continuous increase from the 
10th to the 90th percentile of UPF intake the HRs ranged from 1.63 (95% CI: 1.47 to 1.81, UPF 
weight as proportion, unadjusted model 1) to 1.28 (95% CI: 1.15 to 1.42; UPF as absolute weight; 
model 5). When risks were estimated for being in the highest vs. lowest quintile of UPF intake, 
HRs ranged from 1.90 (95% CI: 1.59 to 2.25; UPF as absolute weight; unadjusted model 1) to 
1.49 (95% CI: 1.23 to 1.81; UPF weight as proportion; model 5). The confidence intervals 
consistently excluded 1.00, and the HRs slightly increased once sugar and fibre consumption 
were adjusted for in model 4. Once waist circumference and BMI were included (model 5), HRs 
decreased substantially. Overall, the estimated risk of T2DM of the UPF approaches expressed 
as energy were less pronounced and had more uncertainty compared to UPFs expressed as 
weight. The HRs for the continuous case ranged from 1.47 (95% CI: 1.23 to 1.77; UPF energy-
partition; model 4) to 1.08 (95% CI: 0.93 to 1.25; UPF as absolute energy; model 5). HRs for 
individuals in the fifth quintile relative to those in the first quintile varied between 1.49 (95% CI 
1.25 to 1.79; UPF as proportion of energy; model 1) to 1.04 (95% CI: 0.83 to 1.31; UPF energy-
partition; model 5). Here, the confidence intervals did not always exclude 1.00.  
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Table 4.4 Associations between ultra-
processed food intake and risk of type 2 
diabetes mellitus, from multivariable 
Cox proportional hazard models, EPIC-
Norfolk cohort, United Kingdom, 1993-
2016 (n=17,204) 
 ¥ Continuous HR: Hazard ratio for an 
increase in consumption from the 10th to 90th 
percentile for each of the ultra-processed 
foods variables. 
* Ultra-processed food exposure variables 1-
3 (absolute weight, proportion of weight, 
and absolute energy) were adjusted with the 
residual method. Model 1: adjusted for age 
(as timescale) and sex; Model 2: model 1 + 
physical activity, social class, education, 
smoking status, marital status, Townsend 
deprivation index, alcohol consumption, 
height, family history of diabetes. Model 3: 
model 2 + unprocessed food intake, and total 
energy intake; Model 4: model 3 + sugar and 
fibre consumption; Model 5: Model 4 + waist 
circumference and BMI.  
ƚ Variables in the energy-partition and 
proportion of energy (or density) models 
were not adjusted via residual method. 
Models 1-5 of the energy-partition approach 
were like the above except that instead of 
total energy intake a variable with the energy 
from non-UPF sources was included, derived 
by subtracting the energy from UPFs from 




     Quintiles 
         Continuous ¥ 1           2 vs. 1 3 vs. 1 4 vs. 1 5 vs. 1  
    HR (95% CI) HR HR (95% CI)    HR (95% CI)    HR (95% CI)    HR (95% CI)  
 Weight (absolute)*            
 Cases/non-cases     1,262/15,942 209/3,236 219/3,209    244/3,171    256/3,064    334/3,064  
 Model 1 1.51 (1.38 to 1.64) 1 1.08 (0.89 to 1.30) 1.20 (0.99 to 1.44) 1.30 (1.08 to 1.56) 1.90 (1.59 to 2.25)  
 Model 2 1.50 (1.37 to 1.63) 1 1.08 (0.89 to 1.31) 1.22 (1.01 to 1.47) 1.31 (1.09 to 1.57) 1.87 (1.57 to 2.23)  
 Model 3 1.50 (1.36 to 1.65) 1 1.07 (0.89 to 1.30) 1.20 (1.00 to 1.45) 1.28 (1.06 to 1.54) 1.82 (1.51 to 2.18)  
 Model 4 1.55 (1.41 to 1.72) 1 1.08 (0.89 to 1.30) 1.23 (1.02 to 1.48) 1.31 (1.09 to 1.58) 1.90 (1.58 to 2.29)  
 Model 5 1.28 (1.15 to 1.42) 1 1.06 (0.87 to 1.28) 1.18 (0.98 to 1.43) 1.22 (1.01 to 1.47) 1.53 (1.27 to 1.84)  
 Weight (proportion)*            
 Cases/non-cases     1,262/15,942 200/3,258 221/3,221    229/3,218    283/3,158    329/3,087  
 Model 1 1.63 (1.47 to 1.81) 1 1.10 (0.91 to 1.33) 1.15 (0.95 to 1.39) 1.45 (1.21 to 1.74) 1.85 (1.56 to 2.21)  
 Model 2 1.59 (1.43 to 1.76) 1 1.11 (0.91 to 1.34) 1.13 (0.93 to 1.36) 1.47 (1.22 to 1.77) 1.75 (1.47 to 2.10)  
 Model 3 1.61 (1.42 to 1.83) 1 1.10 (0.91 to 1.34) 1.11 (0.92 to 1.35) 1.45 (1.20 to 1.74) 1.69 (1.40 to 2.05)  
 Model 4 1.64 (1.44 to 1.87) 1 1.09 (0.90 to 1.32) 1.11 (0.92 to 1.35) 1.45 (1.20 to 1.74) 1.71 (1.41 to 2.07)  
 Model 5 1.41 (1.24 to 1.61) 1 1.09 (0.90 to 1.33) 1.09 (0.90 to 1.32) 1.40 (1.16 to 1.68) 1.49 (1.23 to 1.81)  
 Energy (absolute)*            
 Cases/non-cases     1,262/15,942 205/3,242 259/3,188    250/3,177    264/3,177    284/3,158  
 Model 1 1.30 (1.13 to 1.50) 1 1.26 (1.05 to 1.51) 1.23 (1.02 to 1.48) 1.28 (1.06 to 1.53) 1.43 (1.19 to 1.71)  
 Model 2 1.17 (1.01 to 1.35) 1 1.23 (1.02 to 1.47) 1.18 (0.98 to 1.43) 1.20 (1.00 to 1.44) 1.27 (1.05 to 1.52)  
 Model 3 1.15 (1.00 to 1.34) 1 1.21 (1.01 to 1.46) 1.16 (0.96 to 1.40) 1.18 (0.98 to 1.41) 1.24 (1.03 to 1.50)  
 Model 4 1.14 (0.98 to 1.32) 1 1.21 (1.01 to 1.46) 1.16 (0.96 to 1.39) 1.17 (0.97 to 1.41) 1.23 (1.02 to 1.48)  
 Model 5 1.08 (0.93 to 1.25) 1 1.20 (0.99 to 1.44) 1.14 (0.95 to 1.38) 1.18 (0.98 to 1.42) 1.15 (0.95 to 1.39)  
 Energy (proportion)ƚ            
 Cases/non-cases     1,262/15,942 198/3,250 247/3,185    256/3,176    269/3,176    292/3,153  
 Model 1 1.41 (1.22 to 1.63) 1 1.25 (1.04 to 1.51) 1.27 (1.05 to 1.52) 1.35 (1.12 to 1.62) 1.49 (1.25 to 1.79)  
 Model 2 1.30 (1.12 to 1.50) 1 1.27 (1.05 to 1.53) 1.23 (1.02 to 1.49) 1.32 (1.09 to 1.59) 1.37 (1.13 to 1.64)  
 Model 3 1.25 (1.07 to 1.46) 1 1.26 (1.04 to 1.52) 1.21 (1.00 to 1.46) 1.28 (1.06 to 1.55) 1.30 (1.07 to 1.58)  
 Model 4 1.26 (1.08 to 1.48) 1 1.26 (1.04 to 1.52) 1.21 (1.00 to 1.46) 1.28 (1.06 to 1.55) 1.32 (1.08 to 1.60)  
 Model 5 1.16 (0.99 to 1.36) 1 1.18 (0.98 to 1.43) 1.15 (0.95 to 1.39) 1.21 (1.00 to 1.47) 1.18 (0.97 to 1.44)  
 Energy (partition)ƚ            
 Cases/non-cases    1,262/15,942 207/3,234 251/3,180    239/3,191    290/3,153    275/3,184  
 Model 1 1.31 (1.14 to 1.51) 1 1.20 (1.00 to 1.44) 1.11 (0.92 to 1.33) 1.34 (1.12 to 1.61) 1.32 (1.09 to 1.60)  
 Model 2 1.27 (1.10 to 1.47) 1 1.20 (1.00 to 1.45) 1.10 (0.91 to 1.33) 1.32 (1.10 to 1.59) 1.29 (1.06 to 1.57)  
 Model 3 1.27 (1.10 to 1.47) 1 1.20 (1.00 to 1.45) 1.10 (0.91 to 1.33) 1.32 (1.10 to 1.59) 1.29 (1.06 to 1.57)  
 Model 4 1.47 (1.23 to 1.77) 1 1.23 (1.02 to 1.48) 1.14 (0.94 to 1.39) 1.40 (1.15 to 1.70) 1.43 (1.15 to 1.79)  
 Model 5 1.11 (0.92 to 1.33) 1 1.09 (0.90 to 1.31) 0.94 (0.78 to 1.14) 1.09 (0.90 to 1.33) 1.04 (0.83 to 1.31)  
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Figure 4.3 Associations between ultra-processed food intake and risk of type 2 diabetes mellitus, from multivariable Cox proportional hazard models, modelled 
with restricted cubic splines, EPIC-Norfolk cohort, United Kingdom, 1993-2016 (n=17,204) 
UPF intake as absolute weight (left column, top), proportion of weight (left column, bottom), and absolute energy (middle column, top) were adjusted with the residual method. 
UPF intake as proportion of energy (middle column, bottom) and energy-partition (right column) were not adjusted via residual method. All estimates were adjusted for age (as 
timescale) and sex, physical activity, social class, education, smoking status, marital status, Townsend deprivation index, alcohol consumption, height, family history of diabetes, 
unprocessed food intake, and total energy intake. The energy-partition approach was like the above except that instead of total energy intake a variable with the energy from 
non-UPF sources was included, derived by subtracting the energy from UPFs from total energy consumed for each participant. 
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All estimates of the energy models that included BMI and waist circumference (model 5) did 
include 1.00, as well as four other estimates (model 3 and 4, see Table 4.4). Similar to the UPF 
weight measure, the HRs increased once sugar and fibre consumption were adjusted for in 
model 4 and decreased once waist circumference and BMI were included in model 5.  The results 
of the estimated shapes of the associations between UPF and T2DM, shown graphically in Figure 
4.3, reflect these findings. The difference in the range of HRs between the weight and the energy 
models is visible, as well as the overall general trend of a continuously increased risk with higher 
UPF intake. In the weight measures, up to approximately 250g of UPFs per day, or about 10% 
share of UPF intake of overall intake, no change of risk is visible; the slopes then increase while 
the confidence intervals widen slightly at higher levels of UPF consumption. The shapes for the 
UPF energy approaches also show positive trends, but, as above, with generally lower values of 
relative risks and wider confidence intervals than in the estimates of the UPF weight measures. 
Also, the lower confidence interval is either below or remains close to 1.00 for the energy-




Table 4.5 Associations between ultra-
processed food intake and risk of 
cardiovascular diseases, from 
multivariable Cox proportional hazard 
models, EPIC-Norfolk cohort, United 
Kingdom, 1993-2016 (n=16,095) 
 ¥ Continuous HR: Hazard ratio for an 
increase in consumption from the 10th to 
90th percentile for each of the ultra-
processed foods variables. 
* Ultra-processed food exposure variables 1-
3 (absolute weight, proportion of weight, 
and absolute energy) were adjusted with the 
residual method. Model 1: adjusted for age 
(as timescale) and sex; Model 2: model 1 + 
physical activity, social class, education, 
smoking status, marital status, Townsend 
deprivation index, alcohol consumption, 
height, family history of diabetes. Model 3: 
model 2 + consumption of unprocessed food 
consumption and total energy intake; Model 
4: model 3 + salt and saturated fat intake; 
Model 5: Model 4 + waist circumference and 
BMI. 
ƚ Variables in the energy-partition and 
proportion of energy (or density) models 
were not adjusted via residual method. 
Models 1-5 of the energy-partition approach 
were like the above except that instead of 
total energy intake a variable with the 
energy from non-UPF sources was included, 
derived by subtracting the energy from UPFs 
from total energy consumed for each 
participant. 
 
     Quintiles 
         Continuous ¥ 1           2 vs. 1 3 vs. 1 4 vs. 1 5 vs. 1  
    HR (95% CI) HR HR (95% CI)    HR (95% CI)    HR (95% CI)    HR (95% CI)  
 Weight (absolute)*            
 Cases/non-cases     8,333/7,762 1,688/1,556 1,601/1,633    1,693/1,547    1,659/1,542    1,692/1,484  
 Model 1 1.15 (1.10 to 1.20) 1 0.96 (0.89 to 1.03) 1.04 (0.98 to 1.12) 1.08 (1.01 to 1.15) 1.20 (1.12 to 1.29)  
 Model 2 1.14 (1.10 to 1.19) 1 0.96 (0.89 to 1.03) 1.05 (0.98 to 1.12) 1.07 (1.01 to 1.16) 1.20 (1.12 to 1.28)  
 Model 3 1.13 (1.08 to 1.18) 1 0.95 (0.89 to 1.02) 1.04 (0.97 to 1.11) 1.07 (1.00 to 1.15) 1.17 (1.09 to 1.26)  
 Model 4 1.11 (1.06 to 1.17) 1 0.95 (0.88 to 1.01) 1.02 (0.95 to 1.10) 1.05 (0.98 to 1.13) 1.15 (1.06 to 1.24)  
 Model 5 1.07 (1.02 to 1.12) 1 0.94 (0.88 to 1.01) 1.01 (0.95 to 1.09) 1.03 (0.96 to 1.11) 1.09 (1.01 to 1.18)  
 Weight (proportion)*            
 Cases/non-cases     8,333/7,762 1,661/1,593 1,595/1,638    1,664/1,549    1,677/1,537    1,736/1,445  
 Model 1 1.18 (1.13 to 1.24) 1 0.94 (0.88 to 1.01) 1.04 (0.97 to 1.11) 1.05 (0.98 to 1.13) 1.23 (1.15 to 1.32)  
 Model 2 1.16 (1.11 to 1.22) 1 0.94 (0.87 to 1.00) 1.03 (0.96 to 1.10) 1.05 (0.98 to 1.12) 1.20 (1.13 to 1.29)  
 Model 3 1.14 (1.08 to 1.21) 1 0.93 (0.87 to 1.00) 1.02 (0.96 to 1.10) 1.04 (0.97 to 1.11) 1.18 (1.10 to 1.27)  
 Model 4 1.13 (1.07 to 1.19) 1 0.93 (0.87 to 1.00) 1.01 (0.95 to 1.09) 1.02 (0.95 to 1.10) 1.16 (1.08 to 1.25)  
 Model 5 1.10 (1.05 to 1.17) 1 0.93 (0.87 to 1.00) 1.02 (0.95 to 1.09) 1.02 (0.95 to 1.10) 1.14 (1.06 to 1.23)  
 Energy (absolute)*            
 Cases/non-cases     8,333/7,762 1,586/1,654 1,673/1,573    1,681/1,534    1,717/1,495    1,676/1,506  
 Model 1 1.15 (1.09 to 1.22) 1 1.07 (1.00 to 1.15) 1.11 (1.03 to 1.19) 1.14 (1.07 to 1.22) 1.17 (1.09 to 1.25)  
 Model 2 1.11 (1.05 to 1.17) 1 1.07 (1.00 to 1.14) 1.09 (1.01 to 1.17) 1.12 (1.05 to 1.20) 1.12 (1.04 to 1.20)  
 Model 3 1.10 (1.04 to 1.17) 1 1.06 (0.99 to 1.14) 1.08 (1.01 to 1.16) 1.11 (1.04 to 1.19) 1.11 (1.04 to 1.20)  
 Model 4 1.08 (1.02 to 1.15) 1 1.06 (0.99 to 1.13) 1.07 (0.99 to 1.14) 1.10 (1.02 to 1.18) 1.09 (1.02 to 1.18)  
 Model 5 1.08 (1.02 to 1.15) 1 1.05 (0.98 to 1.13) 1.07 (1.00 to 1.14) 1.10 (1.03 to 1.18) 1.09 (1.01 to 1.17)  
 Energy (proportion)ƚ            
 Cases/non-cases     8,333/7,762 1,595/1,654 1,619/1,603    1,747/1,491    1,685/1,529    1,687/1,485  
 Model 1 1.18 (1.12 to 1.25) 1 1.05 (0.98 to 1.13) 1.14 (1.06 to 1.21) 1.13 (1.06 to 1.21) 1.18 (1.10 to 1.27)  
 Model 2 1.16 (1.09 to 1.23) 1 1.06 (0.99 to 1.14) 1.14 (1.06 to 1.21) 1.13 (1.05 to 1.21) 1.15 (1.08 to 1.24)  
 Model 3 1.14 (1.07 to 1.21) 1 1.06 (0.98 to 1.13) 1.12 (1.05 to 1.20) 1.11 (1.04 to 1.20) 1.13 (1.05 to 1.22)  
 Model 4 1.11 (1.04 to 1.18) 1 1.05 (0.97 to 1.12) 1.10 (1.03 to 1.17) 1.09 (1.01 to 1.17) 1.10 (1.02 to 1.18)  
 Model 5 1.10 (1.03 to 1.17) 1 1.05 (0.98 to 1.12) 1.10 (1.02 to 1.27) 1.09 (1.02 to 1.17) 1.09 (1.01 to 1.18)  
 Energy (partition)ƚ            
 Cases/non-cases     8,333/7,762 1,580/1,654 1,645/1,570    1,703/1,519    1,708/1,512    1,697/1,507  
 Model 1 1.19 (1.12 to 1.26) 1 1.07 (1.00 to 1.14) 1.09 (1.02 to 1.17) 1.12 (1.04 to 1.20) 1.22 (1.14 to 1.32)  
 Model 2 1.18 (1.11 to 1.25) 1 1.08 (1.00 to 1.15) 1.09 (1.02 to 1.17) 1.13 (1.05 to 1.21) 1.22 (1.13 to 1.31)  
 Model 3 1.18 (1.12 to 1.25) 1 1.08 (1.00 to 1.15) 1.09 (1.02 to 1.17) 1.13 (1.05 to 1.21) 1.22 (1.13 to 1.31)  
 Model 4 1.17 (1.10 to 1.24) 1 1.07 (1.00 to 1.12) 1.08 (1.01 to 1.16) 1.11 (1.04 to 1.19) 1.20 (1.11 to 1.29)  
 Model 5 1.10 (1.04 to 1.17) 1 1.04 (0.97 to 1.12) 1.05 (0.98 to 1.13) 1.06 (0.99 to 1.14) 1.12 (1.04 to 1.21)  
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Figure 4.4 Associations between ultra-processed food intake and risk of cardiovascular diseases, from multivariable Cox proportional hazard models, modelled 
with restricted cubic splines, EPIC-Norfolk cohort, United Kingdom, 1993-2016 (n=16,095) 
UPF intake as absolute weight (left column, top), proportion of weight (left column, bottom), and absolute energy (middle column, top) were adjusted with the residual method. 
UPF intake as proportion of energy (middle column, bottom) and energy-partition (right column) were not adjusted via residual method. All estimates were adjusted for age (as 
timescale) and sex, physical activity, social class, education, smoking status, marital status, Townsend deprivation index, alcohol consumption, height, family history of diabetes, 
unprocessed food intake, and total energy intake. The energy-partition approach was like the above except that instead of total energy intake a variable with the energy from 
non-UPF sources was included, derived by subtracting the energy from UPFs from total energy consumed for each participant. 
 
114 
4.4.2.2 Ultra-processed food intake and incident cardiovascular diseases 
Table 4.5 and Figure 4.4 present the estimated associations between UPF intake and risk of any 
incident cardiovascular disease event. The number of incident CVD cases first decreased 
between the first and the second quintile of UPF intake expressed as absolute weight or 
proportion of weight, and then increased continuously between quintiles three to five. When 
UPF intake was expressed as energy, this was not the case – here incident cases increased 
between the first and second quintile but then remained at an approximately similar level.   
In the Cox-models, higher intake of UPFs was associated with an increased risk of CVD across 
both weight and energy measures. The HRs were smaller than in the case of T2DM, but more 
consistent across all five approaches to expressing and modelling UPF intake. HRs for an increase 
UPF intake from the 10th to the 90th percentile ranged from 1.19 (95% CI: 1.12 to 1.26; UPF 
energy-partition; model 1) to, 1.07 ([i.e.] 95% CI: 1.02 to 1.12; UPF as absolute weight; model 5). 
In all continuous cases, the confidence intervals excluded 1.00. HRs for being in the highest vs. 
lowest quintile of UPF intake ranged from 1.23 (95% CI: 1.15 to 1.33; UPF as proportion of 
weight; model 1) to 1.09 ([i.e.] 95% CI: 1.01 to 1.18; UPF as proportion of energy, model 5). In 
none of the continuous or the Q5 vs. Q1 estimates was 1.00 included in the confidence intervals. 
However, the lower confidence intervals were often close to 1.00, mostly for models 4 and 5, 
and especially in the energy models (absolute and as a proportion). In comparison with T2DM, 
the inclusion of salt and saturated fats did not affect risk estimates as much as sugar and fibre, 
and the inclusion of waist circumference resulted in decreased HRs, but not as much as it did in 
the case of T2DM.   
Estimating the risks across the ranges of UPF intakes indicated a different functional relationship 
between UPF energy and weight approaches that was not as clearly visible in the previous results 
(Figure 4.4). In the weight measures, estimated risks followed some sort of sigmoid curve (first 
a small decrease in risk, followed by an increase, and flattening of the curve towards the higher 
intakes). In the energy measures, the shapes appeared positively linear. 
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4.4.2.3 Ultra-processed food intake and adiposity  
Table 4.6 Associations between ultra-processed food intake and adiposity, from multivariable 
logistic regression models, EPIC-Norfolk cohort, United Kingdom, 1993-2016 (n=17,558) 
 ¥ Continuous OR: Odds ratio for an increase in consumption from the 10th to 90th percentile for each of 
the ultra-processed foods variables. 
* Ultra-processed food exposure variables 1-3 (absolute weight, proportion of weight, and absolute 
energy) were adjusted with the residual method. Model 1: adjusted for age (as timescale) and sex; Model 
2: model 1 + physical activity, social class, education, smoking status, marital status, Townsend deprivation 
index, alcohol consumption, height. Model 3: model 2 + unprocessed food intake, and total energy intake; 
Model 4: model 3 + sugar intake.  
ƚ Variables in the energy-partition and proportion of energy (or density) models were not adjusted via 
residual method. Models 1-4 of the energy-partition approach were like the above except that instead of 
total energy intake a variable with the energy from non-UPF sources was included, derived by subtracting 








       
  
Health Check 1 Health Check 2  
         Continuous ¥      Q5 vs. Q1    Continuous ¥       Q5 vs. Q1  
  
  OR (95% CI) OR (95% CI) OR (95% CI) 





Weight (absolute)*        
 
 Model 1 1.79 (1.66 to 1.93) 2.50 (2.16 to 2.89) 1.68 (1.51 to 1.87) 2.20 (1.81 to 2.68)  
 Model 2 1.71 (1.58 to 1.85) 2.33 (2.01 to 2.70) 1.64 (1.47 to 1.83) 2.08 (1.70 to 2.54)  
 Model 3 1.66 (1.52 to 1.83) 2.13 (1.82 to 2.49) 1.60 (1.41 to 1.81) 1.91 (1.54 to 2.36)  
 Model 4 1.71 (1.57 to 1.87) 2.20 (1.88 to 2.57) 1.63 (1.43 to 1.85) 1.95 (1.57 to 2.41)  
 
Weight (proportion)*        
 
 Model 1 1.74 (1.60 to 1.90) 2.03 (1.76 to 2.34) 1.57 (1.40 to 1.76) 1.92 (1.58 to 2.34)  
 Model 2 1.61 (1.47 to 1.76) 1.82 (1.57 to 2.10) 1.49 (1.32 to 1.69) 1.77 (1.44 to 2.17)  
 Model 3 1.46 (1.31 to 1.62) 1.60 (1.37 to 1.87) 1.36 (1.17 to 1.58) 1.54 (1.24 to 1.92)  
 Model 4 1.49 (1.34 to 1.66) 1.62 (1.39 to 1.90) 1.37 (1.18 to 1.59) 1.55 (1.24 to 1.93)  
 
Energy (absolute)*        
 
 Model 1 1.35 (1.20 to 1.51) 1.37 (1.19 to 1.58) 1.25 (1.07 to 1.45) 1.34 (1.10 to 1.64)  
 Model 2 1.16 (1.03 to 1.30) 1.16 (1.00 to 1.34) 1.08 (0.92 to 1.27) 1.16 (0.95 to 1.43)  
 Model 3 1.13 (1.00 to 1.28) 1.12 (0.97 to 1.31) 1.05 (0.89 to 1.24) 1.13 (0.91 to 1.39)  
 Model 4 1.14 (1.01 to 1.29) 1.13 (0.97 to 1.32) 1.05 (0.89 to 1.24) 1.13 (0.92 to 1.39)  
 
Energy (proportion)ƚ        
 
 Model 1 1.60 (1.42 to 1.80) 1.57 (1.36 to 1.82) 1.36 (1.16 to 1.60) 1.41 (1.16 to 1.71)  
 Model 2 1.54 (1.36 to 1.74) 1.49 (1.28 to 1.73) 1.26 (1.07 to 1.49) 1.28 (1.04 to 1.57)  
 Model 3 1.30 (1.14 to 1.48) 1.23 (1.05 to 1.44) 1.19 (0.99 to 1.43) 1.19 (0.96 to 1.49)  
 Model 4 1.32 (1.16 to 1.51) 1.25 (1.06 to 1.47) 1.20 (1.00 to 1.44) 1.20 (0.97 to 1.50)  
 
Energy (partition)ƚ        
 
 Model 1 1.99 (1.78 to 2.22) 2.17 (1.86 to 2.53) 1.37 (1.18 to 1.59) 1.60 (1.31 to 1.97)  
 Model 2 2.20 (1.96 to 2.47) 2.45 (2.09 to 2.86) 1.46 (1.24 to 1.71) 1.63 (1.32 to 2.02)  
 Model 3 2.20 (1.96 to 2.46) 2.44 (2.09 to 2.85) 1.41 (1.19 to 1.67) 1.57 (1.26 to 1.95)  
 Model 4 2.49 (2.15 to 2.88) 2.51 (2.10 to 3.00) 1.55 (1.25 to 1.93) 1.63 (1.26 to 2.11)  
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Table 4.6 and Figure 4.5 present the associations between UPF intake and adiposity. In cross-
sectional logistic models, odds ratios (ORs) for an increase in UPF intake from the 10th to the 90th 
percentile ranged from 2.49 (95% CI: 2.15 to 2.88; UPF energy-partition; HE1; model 4) to 1.08 
(95% CI: 0.89 to 1.24; UPF as absolute energy; HE2; model 3). When individuals of the fifth 
quintile were compared to the first quintile of UPF intakes, ORs ranged from 2.51 (95% CI: 2.10 
to 3.00; UPF energy-partition; HE1; model 4) to 1.12 (95% CI: 0.97 to 1.31; UPF as absolute 
energy; HE1; model 3). Overall, estimates at the second health examination were slightly lower 
than at the first. The lower CIs of the approaches using absolute energy from UPFs and 
proportion of energy from UPFs included 1.00 or were very close to including 1.00 when the 
models were adjusted for confounders. This was not the case for the two weight approaches 
and the energy-partition models, the latter of which had the highest estimates of all five 
approaches.  
Estimating the risks across the ranges of UPF intakes non-linearly indicated similar positive 
functional relationships between UPF energy and weight approaches (Figure 4.5). Reflecting the 
results from Table 4.6, the weight approaches as well as the energy-partition approach showed 
positive associations, large estimates, and narrow CIs. While UPF as absolute energy at both 
health examinations and UPF expressed as proportion of total energy consumed at HE2 indicate 
no clear association, UPF expressed as proportion of total energy consumed at HE1 shows a 
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                      Weight (absolute)             Weight (proportion)                  Energy (absolute)                 Energy (proportion)    Energy (partition) 
Figure 4.5 Associations between ultra-processed food intake and obesity, from multivariable logistic models, modelled with restricted cubic splines, EPIC-Norfolk 
cohort, United Kingdom, 1993-2016 (n=17,588) 
Associations were estimated at the first health examination (top row) and second health examination (bottom row). UPF intake as absolute weight (first column), 
proportion of weight (second column), and absolute energy (third column) were adjusted with the residual method. UPF intake as proportion of energy (forth column) 
and energy-partition (fifth column) were not adjusted via residual method. Estimates were adjusted for age (as timescale) and sex, physical activity, social class, 
education, smoking status, marital status, Townsend deprivation index, alcohol consumption, height, unprocessed food intake, total energy intake, and sugar intake. 
The energy-partition approach was like the above except that instead of total energy intake a variable with the energy from non-UPF sources was included, derived 







               T2DM                                  CVD                     Adiposity 
Figure 4.6 Associations between ultra-processed food groups intake and obesity, from multivariable logistic models, modelled with restricted cubic splines, EPIC-
Norfolk cohort, United Kingdom, 1993-2016 (n=17,588) 
Associations between eight ultra-processed food groups and T2DM, CVD, and adiposity were estimated in multivariable Cox-regressions (T2DM and CVD) and logistic 
regressions (adiposity). For each outcome, the models were identical to those used in the analyses above. HRs and ORs were estimated for an increase in consumption 
of each ultra-processed food group from the 10th to 90th percentile. The cells in the upper half represent the estimated HRs or ORs; the darker the colour, the higher 
the estimate of association. The cells in the bottom half represent the P-value of the point estimates; the darker the colour, the smaller the P-value.  
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4.4.2.4 Ultra-processed food groups and cardiometabolic health 
UPF intake was decomposed into eight ultra-processed food groups to estimate associations of 
individual food groups with T2DM and CVD risk, as well as adiposity (Figure 4.6). Intake from 
each ultra-processed food group was expressed as weight and energy (both absolute), in 
changes from the 10th to the 90th intake percentiles. In the analyses of T2DM and CVD risk, a 
similar pattern emerged. The three ultra-processed food groups meat, fish, and eggs; fast foods; 
and drinks and SSBs were consistently associated with increased risk of T2DM and CVD. For 
example, the HR for an increased intake of fast foods from the 10th to 90th percentile was 1.18 
(P-value < 0.0001; fast food as weight or energy; model 5). The HRs of the estimated T2DM risk 
were larger than those of CVD risk, and regarding T2DM, confectionary, chocolates, and sweets 
were only associated when they were expressed as weight, while they were not associated 
regarding CVD. Ultra-processed fruits and vegetables; milk and dairy; fats; and breads and 
cereals were not associated with an increased risk of disease for neither of the two diseases. 
In the analyses with adiposity as an outcome, the pattern was different. Ultra-processed drinks 
and SSBs were strongly positively associated, as were ultra-processed milk and dairy foods, while 
meat, fish, and eggs, were associated only in the weight measures. Surprisingly, fast foods were 
negatively associated here – an increased consumption of fast foods from the 10th to the 90th 
percentile was associated with an OR of 0.34 (P-value < 0.0001; fast food as weight or energy; 
model 4). Breads and cereals were also negatively associated with adiposity, although only 
marginally, and meat, fish, and eggs were positively associated with adiposity, but only when 
expressed as weight.  
4.4.2.5 Sensitivity analyses 
Excluding incident T2DM and CVD during the first years of follow-up and estimating associations 
based on complete cases did not change the estimated associations and their functional forms. 
Excluding participants with improbable energy reporting based on a simpler exclusion rule (<800 
kcal or >4200 kcal per day in men and <500 or >3500 kcal per day in women) and combining 
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unprocessed foods with processed culinary ingredients for use as a covariate instead of only 
NOVA also did not change the results across the three analyses.   
4.5 Discussion  
4.5.1 Summary of main findings 
In this prospective cohort study, two main ways to measure UPF intake according to NOVA were 
used – UPF intake as absolute weight and energy. When the two variables were disaggregated 
into eight ultra-processed food groups, the three groups ultra-processed confectionary, sweets, 
and sugary products; breads, starchy foods, and cereals; and fats contributed most to energy 
intake from UPFs. When UPF intake was measured as weight, ultra-processed drinks and SSBs 
instead of fats were among the top three food groups. Higher intake of UPFs was associated 
with an increased risk of T2DM in four of the five approaches to measure UPFs and adjust for 
total energy intake, and the risks were more pronounced when UPF intake was measured as 
weight compared to energy. Furthermore, the addition of BMI and waist circumference reduced 
the risk estimates substantially. UPF intake was also associated with an increased risk of CVD. 
The estimated HRs were lower than in the case of T2DM but were more consistent across the 
five ways of expressing UPF and adjusting for total energy intake. UPF intake was associated 
with obesity for both weight measures and the energy partition models, but when UPF intake 
was expressed as energy, ORs as well as the CIs decreased once the confounders including total 
energy were adjusted for. Estimating associations between each ultra-processed food group and 
risk of T2DM and CVD showed a similar pattern, with ultra-processed meat, fish, and eggs; drinks 
and SSBs; and fast foods being associated with an increased risk of diseases. The associations 
between the ultra-processed food groups and adiposity were somewhat surprising – while 
drinks, SSBs, milk, and dairy were strongly associated with adiposity, fast foods were associated 
with reduced odds of obesity.  
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4.5.2 Comparison with other studies and interpretation 
Two previous studies have estimated the proportion of energy from ultra-processed foods in 
the United Kingdom based on the National Diet and Nutrition Survey to be 53 and 56.8%, 
respectively.131,298 In this study, the average energy from UPFs was 41%, which is likely due to 
the fact that the dietary assessments at HE1 and HE2 happened in the mid to late 1990s – 20-25 
years ago – when dietary habits and the range of UPFs available was somewhat different. While 
no research on the long term trends of food groups defined as ‘ultra-processed’ is available for 
the UK, previous studies have shown that the consumption of sugary drinks has doubled 
between 1975 and 2007 and ready-meals and convenience meat products have increased by 
480% between 1974 and 2011, while fresh fruits and vegetables, cereals, and milk have 
remained constant over time.299–301 In Sweden (which arguably has experienced a comparable 
transformation of its food system), UPF consumption increased by 134% between 1960 and 
2010, mostly driven by large increases in sodas as well as snack foods such as crisps and 
candies.302 Thus, the somewhat lower overall energy from UPFs in EPIC-Norfolk is in line with 
previous research and is likely to be partially driven by less consumption of UPF drinks, ready-
meals, and convenience products in the 90’s. Outside the UK, the largest share of energy intake 
in many countries come from UPFs – figures from Brazil, Canada, France, Germany, Netherlands, 
Norway, Spain, and Sweden suggest a range of energy intake from 40% to 65% in population 
diets.97,98,170,268,303 These figures demonstrate the important role of UPFs in the U.K., high-
income, but increasingly also low-to-middle-income countries.133  
A few studies have previously suggested that UPFs contribute to increasing risk of adverse 
cardiometabolic health, such as obesity141,142, hypertension140, and dyslipideamia143 – but no 
previous prospective epidemiological study has evaluated the association between the degree 
of food processing specifically and T2DM, which is why the systematic review and meta-analyses 
was performed in chapter 2. In chapter 2, the summary relative risk estimate for the highest 
versus lowest UPF intake or dietary pattern score was 1.46 (95% CI: 1.23 to 1.68). Even though 
the UPF exposure was not identical with the more precise exposure data used here, the 
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estimated HRs in EPIC-Norfolk were roughly comparable when UPF was expressed as weight, 
and lower when UPF was expressed as energy.  
One study from the French Nutrinet-Santé has specifically estimated associations between UPF 
intake according to NOVA and CVD, finding a small but positive association  of 1.12 (HR; 95% CI: 
1.06 to 1.21; model 5) for a 10 percent increase in the proportion of UPF intake expressed as 
weight of total food intake.144 When the highest quarter was compared to the lowest quarter of 
UPF intake, the estimated HR was 1.26 (HR; 95% CI: 1.07 to 1.48; model 5). The HRs in Nutrinet-
Santé were more consistent across the different model specifications; the models adjusted for 
only age and sex were even identical to the fully adjusted models. In EPIC-Norfolk, adjusting for 
nutritional and non-nutritional confounders changed the estimated risks. However, the study in 
Nutrinet-Santé was internally less consistent: while the HR for a continuous increase of 10% was 
1.12, an increase from the highest versus lowest quarter (which would amount to an average 
increase of 75%) of UPF intake was 1.26, less than what would be expected from the continuous 
HR estimates. In the present study, the continuous and the categorical estimates were supposed 
to estimate similar intake differences, and the estimated risks were comparable. Furthermore, 
Srour et al. also applied Black’s method to use the basal metabolic rate and the Goldberg cut-
offs to identify and exclude energy underreporting. 20% of the Nutrinet-Santé cohort were 
excluded. Here, 26% of the sample were excluded based on energy underreporting, and the 
small difference is likely due to the higher validity of the dietary assessment method in the 
Nutrinet-Santé cohort (24h dietary records with measurements every 6 months).  
Several hypotheses could explain the associations between UPF and T2DM and CVD. The 
nutritional hypotheses introduced in the first chapter are also relevant here and will be 
discussed briefly: UPFs have been found to contain higher levels of sugar, sodium, energy, and 
less fibre, nuts, seeds, whole grains, and various micronutrients.96–103 UPFs have also been found 
to be less satiating and have a higher glycaemic load than minimally or unprocessed foods.104 
High intakes of sugar, little dietary fibre, nuts, seeds, grains, and consumption of foods with a 
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high glycaemic index negatively affect the development of insulin resistance and T2DM.105–109 
Ultra-processed drinks and SSBs had the highest estimated HRs in the analyses of food groups, 
followed by fast foods and ultra-processed meats, fish and eggs. The associations between UPFs 
and T2DM can thus be partially explained by ultra-processed food groups with previously 
established disease associations.304–309  
Additionally regarding CVD, diets high in UPFs contained lower levels of fruits and vegetables 
and higher levels of dietary sodium.97,110–112 These characteristics have previously been 
associated with increased risk of CVD.3,113 Also, trans fats from partially hydrogenated oils were 
a still a widely used ingredient during the period during which the data was collected at HE1 and 
HE2 (1990 and 2000). Trans fats have been associated with increased CVD risk, especially total 
CHD and CHD mortality risk.119,120   
The associations between UPF intake and higher risk of CVD and T2DM might be due to the 
lower consumption of un- and minimally processed foods in individuals with higher intakes of 
UPFs.c  This is difficult to disentangle because individuals with higher consumption of UPFs 
consumed relatively less non-UPFs. However, associations remained similar after adjusting for 
the intake of non-UPFs, indicating that less intake of non-UPFs could not be a major source of 
the associations. Furthermore, adjustments for saturated fats, sugar, fibre, sodium, and total 
energy also did not alter the associations substantially, suggesting that the nutritional 
composition of UPFs is not the only factor that explains estimated associations and other 
components of UPFs might contribute to an increased disease risk.  
Thus, a second set of mechanisms that might potentially explain UPF-CVD associations do not 
relate to common nutritional factors but to food additives and newly formed compounds that 
result from the food processing process. In principle, safety regulations determine upper limits 
of artificial food additives to guard consumers from potentially harmful effects of specific 
 
c In EPIC-Norfolk, the correlation between UPFs and un- and minimally processed foods (expressed as 
proportion of weight) was -0.5.  
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compounds, but how multiple substances from multiple consumed foods may add up and 
interact with each other is mostly unknown.144 For some of the additives allowed in the 
European Union, several negative health effects have been suggested in animal and in vitro 
studies. I will list evidence for some of the commonly used food additives here, summaries of 
greater detail can be found elsewhere.144,310–312  
High amounts of sulphur-based compounds (such as sulphites) used in ready-to-eat dressings 
have been shown to negatively impact heart health in rats.313 Monosodium glutamates found in 
sauces, dressings, and other convenience products have been demonstrated to induce oxidative 
stress through lipid peroxidation in mice and thus may harm coronary arteries and increase risk 
of CVD.314 Monosodium glutamate also has the potential to disrupt endocrine hormone 
regulation which might play a role in the pathogenesis of obesity by impairing secretion of 
glucagon-like peptide-1, related satiety responses, and glucose-stimulated insulin release.315 
Emulsifiers commonly used in UPFs can affect low grade inflammation and obesity in mice.316 
Animal and in vitro models of thickening agents such as carrageenan have also shown an 
increased risk of impaired fasting glucose and insulin resistance, as well as distortion of insulin 
signals.317 Furthermore, prolonged exposure to zero-calorie artificial sweeteners in cellular 
models suggest potential adverse effects on heart health, while an RCT with adipose women has 
found that sucralose elevated blood sugar and insulin levels.318,319 However, studies of regular 
consumers of sucralose did not have this effect.320–322  
The high temperatures of food processing techniques produce newly formed contaminants such 
as acrylamide, bisphenol A, polycyclic aromatic hydrocarbons, or glycidyl fatty acid esters from 
palm oils and fats. Acrylamide is found in chips, biscuits, fries, certain preparation based on 
cereals, or breads, and has been found to increase the risk of CVDs in two cohorts in the US.323,324 
Animal studies have shown associations between prenatal exposures of bisphenol A and 
increased body weight and prevalence of obesity, impaired glucose tolerance, and lipid 
metabolism in mice, as well as higher concentrations of plasma triglycerides.325 While the 
carcinogenic properties of glycidyl fatty acid esters have been repeatedly demonstrated, high 
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dosages of one type (2-MCPD) have caused cardiac arrests and other adverse heart events in 
experimental studies of rodents.312  
In summary, a large range of potentially harmful compounds that are produced and added 
during the processing of foods might be related to health. In their study, Srour et al. 
hypothesized that ‘cocktail effects’ of food additives and substances due to food processing may 
explain the estimated associations, because associations between UPF and CVD risk remained 
after adjusting for nutritional and non-nutritional confounders. This interpretation of the 
Nutrinet-Santé study is flawed for two reasons. First, none of the models included in the paper 
estimated the association between UPF intake and CVD while adjusting for un- and minimally 
processed foods as well as other potentially adverse nutritional factors such as sugar and sodium 
intake at the same time. Hence none of the study results represented an attempt to 
simultaneously adjust for all nutritional factors other than the ‘cocktail’ of additives and other 
food related substances. Secondly, even if all confounders would be accounted for, individuals 
that consume little UPFs are substantially different from those consuming a lot of UPFs – they 
smoke less, are more active, have a higher education, and have an overall healthier diet. It is 
questionable that multivariable regression adjustment methods can really account for these 
differences and provide adequate control in a way that allows the type of ceteris paribus 
interpretation as described above. This point will be discussed further in the limitation section 
below, but it is mainly for this reason that the results presented in this chapter also do not allow 
for any inferences regarding potential effects of additives and other compounds, even though I 
have adjusted for a large range of potential nutritional confounders simultaneously and 
associations remained. The estimated associations for CVD could simply be the result of the 
generally poorer nutritional quality of diets that are high in UPFs combined with the effects of 
other health-related characteristics and non-nutritional confounders. In the context of a non-
randomized observational cohort study, it is untestable and, unfortunately, a matter of beliefs 
whether the interaction of food additives and other compounds play a role in the disease 
pathogeneses or not. However, a well-established mechanism regarding food additives is the 
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increased food and excess energy intake due to formulations that are designed to hit a ‘bliss 
point’ or state of satiety, pleasure, and ‘hedonia’ during consumption.326 The influences that 
food additives such as flavour enhancers can have on interactions of neurotransmitter, 
receptors, appetite, satiety, conditioned preferences, as well as the brain reward system have 
been established previously, and it is likely that increased energy intake and a sustained positive 
energy balance is one of the central mechanisms through which food additives in UPFs affect 
cardiometabolic health.327  
Regarding both CVD and T2DM, another potential pathway explaining diet-disease associations 
could be the relationship between diets and the gut microbiome. A large body of research 
supports the hypothesis UPFs and Western diets (that are often characterized by higher relative 
intakes of UPFs, as shown in chapter 2) affect changes in the gut microbiome which are 
associated with obesity and metabolic diseases, possibly through the pathways of gut dysbiosis 
(microbial imbalance or maladaptation) and inflammation.127 
More generally, CVD has a more complex aetiology in which, depending on disease subtype, 
non-nutritional risk factors may play a relatively more important role than in the aetiology of 
T2DM. This could explain why the estimated relative risks between UPFs and CVD were smaller 
and possibly have a slightly different functional form than in the association between UPFs and 
T2DM.  
In line with current research, positive associations between UPF intake and adiposity were found 
in the analyses. In the previously mentioned RCT of ad libitum UPF versus unprocessed food 
consumption, participants in the UPF group consumed on average about 500 calories more than 
participants in the unprocessed group, and this was due to increased fat and carbohydrate but 
not protein intake.94 Participants in the UPF group also gained 0.8 kg body weight over a two-
week period, while participants in the unprocessed group lost 1.1 kg (P < 0.001).  
Physically, all weight gain is the result of a positive energy balance: if an individual consumes 
more than she expends, she gains weight, but if there are no excess calories, there is no weight 
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gain. This would imply, however, that once total energy intake (i.e. the quantity of food) is 
accounted for, no positive association should be observed. In the analysis presented here, this 
was only the case for the UPF-energy and UPF as proportion of energy measures. This might 
indicate that some ways of adjusting for total energy intake perform better than others. For 
example, when the energy-based measure of UPFs was used in conjunction with the residual 
method and total energy consumed as a model covariate, little association between UPFs and 
adiposity remained. This, however, also indicates that the inclusion of confounders (such as total 
energy intake) in multivariable regressions might not always provide adequate control for the 
confounder of interest. It might also mean that associations based on weight-based 
measurements overestimate exposure-disease relationships, because even after adjusting and 
controlling for energy intake, UPF consumption expressed as absolute or proportion of weight 
was strongly associated with increased odds of adiposity. This should not have been the case if 
adjusting for energy intake provides adequate control of the influence of the quantity of the 
foods consumed. Furthermore, the estimated associations between UPF intake and CVD risk 
were broadly similar for the weight and energy measures but varied considerably when 
associations between UPF intake and T2DM and adiposity were estimated. The way exposures 
are expressed might therefore affect estimates of different exposure-disease associations to 
varying degrees, possibly as a result of underlying mechanisms.  
The comparison of the food groups that contribute most to UPF consumption as either weight 
or energy measure might offer a potential explanation of the different associations with risks of 
disease. Participants with the highest consumption of energy from UPF consumed over 50% of 
this energy through ultra-processed breads, starchy foods, cereals, fats, and fruits and 
vegetables. Thus, a large part of the main contributing food groups to energy from UPFs 
according to NOVA in EPIC-Norfolk were therefore foods that do not have an unequivocally 
disadvantageous nutritional profile. In comparison, almost a fifth of the UPFs measured as 
weight were ultra-processed drinks and SSBs alone, and another 17 percent were confectionary, 
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sweets, and sugary products. Thus, the stronger association of UPF intake expressed as weight 
or proportion of weight and T2DM might therefore be explained by different relative shares of 
ultra-processed food groups to the overall composition of the weight and energy measures.308,328 
Additionally, the increase in the consumption of UPFs between the lowest and highest quintiles 
of UPF consumption was on average 40% higher when UPF was measured as weight in 
comparison to UPF measured as energy. These two findings are related – the larger increases of 
UPF intake measured as weight was driven by the higher share of UPF drinks and SSBs, which 
weigh a lot but are not as energy dense as other UPFs (due to the high water content). Thus, 
differences in the contribution of food groups and related larger increases in measured UPF 
intake likely account for the differences in the estimates of the UPF weight and energy measures.  
The findings that fast foods were negatively associated with adiposity is puzzling. One potential 
explanation might be reversed causality, because overweight and obese people could have been 
eating fewer of these foods to avoid further weight gain or to lose weight. During the 1990s, 
when public knowledge and attitudes to food were somewhat different, to lose weight people 
tended to cut out fatty foods, whereas now they are more likely to cut out sugary and 
carbohydrate-rich foods. In EPIC-Norfolk, the correlation between proportion of fast foods as a 
share of overall food intake and BMI was -0.05, implying that individuals with higher BMI and 
higher energy intakes consumed almost the same relative or slightly fewer relative amounts of 
fast foods than people with low BMI and lower energy intakes. Individuals thus consumed more 
energy through ultra-processed food groups other than fast foods, and this higher relative 
amount of other food groups and similar or even less amount of fast foods has potentially led 
to the estimation of the negative association between fast foods and adiposity.  
4.5.3 Strengths and limitations of study 
Strengths of this study include the prospective design with a large sample size and a long follow-
up time of over 17 years which is well suited to assess risks of chronic diseases with long 
pathogeneses. Since outcome ascertainment in EPIC-Norfolk was externally linked to medical 
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records, potential bias from loss to follow-up is minimized. Furthermore, this is the first study to 
assess and compare different ways of expressing UPFs, and the first study to provide a 
comprehensive analysis of the associations between UPF intake and three cardiometabolic 
health outcomes in one cohort study. It is also the first study to explicitly estimate associations 
between UPFs and risk of T2DM.  
This study has also several limitations. First, dietary intakes were measured between over 25 (at 
HE1) to 15 years ago (at HE2). As discussed above, this explains why a little over 40% of overall 
energy was consumed through UPFs, which is 15-20% less intake compared to what has been 
estimated for today.131,298 The overall summary relative risks estimated in EPIC-Norfolk might 
therefore be lower as what would have been observed with average exposure levels of today. 
Furthermore, measurement error from self-reported dietary exposures may have influenced the 
relative risks by regression dilution bias, which attenuates the estimated disease risk 
association.230 However, given that there might have been measurement error in the covariates 
as well, it is unclear in which direction the observed association could have been biased. Also, 
changes in the diet over the study could not be fully accounted for, although some of the error 
was accounted for by using repeated measurements of diet as well as of covariates.  
Residual confounding from unmeasured confounders and imprecise measurements of potential 
confounders could also have influenced the results. I attempted to adjust as well as possible for 
confounders. However, the ‘ignorability’ assumption holds that conditional on the confounding 
covariates, the probability that a participant is exposed to high or low levels of UPFs should be 
equal, or in other words, all confounding variables are controlled for. Even if this was the case, 
differences in the distributions of the confounder covariates between more and less exposed 
participants (or a lack of overlap and lack of balance in technical terms) are plausible and can 
imply erroneous covariate-adjusted estimates and confidence intervals.227–229 Accordingly, a 
review reported that the coefficient estimates from confounder adjusted multivariable logistic 
and Cox-regression were larger than estimates using propensity score methods (to adjust for 
confounders) in over 50% of the cases (50 of 96 studies).329 Differences in the distributions of 
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important confounders such as un- and minimally processed foods, sex, smoking, physical 
activity, or education level between individuals with high and low intakes of UPFs exist in EPIC-
Norfolk. Residual confounding from differences in distributions of those variables might 
therefore explain some of the estimated associations.  
Furthermore, BMI and waist circumference were considered as confounders in the analyses of 
the risk of CVD and T2DM. Yet, recent evidence has suggested BMI as a mediator in the 
association between diet and T2DM and CVD.281,330–332 This might explain the decreases in risk 
estimates once BMI was accounted for in the models 5 of the analyses presented here, which 
might underestimate UPF-disease associations. Additionally, generalisability is limited due to a 
potential healthy cohort bias and the inclusion of mostly Caucasian Europids in the UK in the 
sample.278  
4.5.4 Conclusions and implications for research and policy 
In this prospective cohort study, higher intakes of UPFs were associated with adiposity and 
increased risk of T2DM and CVD. While different approaches to measure UPF intakes and to 
adjust for total energy intake yielded different estimated associations between UPF and 
adiposity and T2DM risk, this was not the case for CVD. The stronger associations between UPF 
intake measured as weight and T2DM were possibly due to higher relative contribution of ultra-
processed drinks and SSBs and larger increases in UPF intake between Q1 and Q5 of UPF intake 
measured as weight (compared to increases when UPF intake was measured as energy). 
Generally, associations between UPF and CVD and T2DM were likely driven by a combination of 
unhealthy nutritional profiles of UPFs, less relative intakes of un- and minimally processed foods, 
and at least to some extent from potential residual confounding from adjusted nutritional and 
non-nutritional confounders. Whether food additives and newly formed substances from food 
processing processes contribute to the CVD pathogeneses is, currently, subject to speculation. 
It is, however, likely that the ingredients used in UPFs to increase consumption therefore lead 
to an overconsumption of food and energy. Although inference from cross-sectional analyses 
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are limited, the estimated associations between UPF and adiposity at both health examinations, 
as well as the decreases of the estimated associations after adjustment for BMI and waist 
circumference in the prospective analyses, point towards a substantial mediating effect of body 
weight on the UPF-disease pathway.  
Despite the limitations, the findings imply that the processing of some but not all ultra-processed 
food groups does affect health adversely through various ways, most likely the overall 
nutritional composition and a production that is designed to hit the ‘bliss point’ to increase 
consumption. However, not all UPFs seem to be created equal. A modified hypothesis on UPFs 
could be that not all UPFs are unhealthy, but most food groups that are associated with 
increased risk of disease are ultra-processed. It is likely that much of the food processing that is 
currently used does something to the foods that make it unhealthy, whether it is the nutritional 
composition, a hyper-palatability through additives, or potential interaction effects of 
compounds resulting from the food processing itself.  
These findings have some implications for future research. The UPF disease association should 
be tested in other large cohorts. To provide further insights, associations between the entire 
UPF group as well as disaggregated ultra-processed food groups and disease should be 
estimated. In this context, it should also be tested whether associations between the entire UPF 
group and diseases remain once some of the major ultra-processed food groups such as ultra-
processed drinks and SSBs or confectionary and sugary products are removed from the 
aggregated UPF group. If this was not the case, it would call an undifferentiated negative 
assessment of all foods ultra-processed further into question.  
Additionally, as the analyses presented here have shown, different ways of measuring UPF 
intake and adjusting for total energy affect the results. Future research efforts should be guided 
towards developing theory and testing of the implications of these data processing choices for 
different diseases by reporting the results for different combinations of measuring UPF intake, 
as well as adjusting for total energy intake. Furthermore, adjusting for confounding in 
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multivariable regression models has limitations and can potentially lead to biased associations. 
In this context, non-randomized observational studies should compare different methods to 
adjust for confounders, such as using Cox-regression in propensity score matched samples and 
samples without propensity score matching.333,334 Reporting the results for different adjustment 
methods can help to make transparent whether residual confounding from adjusted 
confounders exists and whether the findings are similar for different methods. 
Regarding food additives and compounds generated during food processing, it is unlikely that 
further research from cohort studies without brand and product-specific dietary assessment 
methods will provide insights into the question of whether potential interaction or ‘cocktail’ 
effects of these substances exist. Newer cohorts that have exact brand and product information 
may be better suited to assess these associations.  
Yet, regardless of whether these substances or mixtures thereof play a role or not, or whether 
certain ultra-processed food groups are more important than others, in light of previous 
evidence and the findings presented in this chapter, the evidence of an association between 
higher intakes of UPFs and adverse cardiometabolic health is broadening.132,140,143–145 Consumers 
should therefore be informed about these associations. France and Brazil have already 
introduced recommendations to promote the consumption of unprocessed or minimally 
processed foods in their national dietary guidelines.335,336 The field of food science and 
technology could potentially contribute to a product reformulation by developing products that 
may still have ‘bliss point’ and are as enjoyable as UPFs, but with better nutritional profiles, 
fresher and less refined ingredients, more fibre, and less calories. While the evidence on the 
positive impact of diet-related fiscal measures on the consumption of unhealthy (and often 
ultra-processed) foods has accumulated, the effect of fiscal policies on population-level body 
weight and health has been ambiguous.337–340 The combination of food taxes and subsidies 
combined with information may be a good starting point but is likely not enough to have the 
transformative effect that would be needed to halt the global cardiometabolic health crisis. 
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Other, more drastic regulatory and fiscal solutions are potentially needed. Further discussion on 
the implications of the findings for research and policy are provided in the next chapter, the 






5 OVERALL DISCUSSION 
5.1 Introduction  
In this thesis, my overall aims were to investigate the associations between ultra-processed food 
consumption and cardiometabolic health, both at the individual and the population-level, while 
following methodological principles such as incorporating and presenting the multiverse of 
statistical results as well as approaching statistical hypothesis testing in a non-dichotomous way. 
I addressed these aims with three studies: a systematic review and meta-analysis, an ecological, 
cross-country comparison, and a prospective cohort analysis. Each chapter includes an 
interpretation of the results, a contextualisation within the existing literature, a section outlining 
the strengths and limitations of the study and a discussion of the implications for policy and 
future research.  
In chapter two (systematic review) I discussed the reasons for the limited comparability of the 
exposure across the studies included in the meta-analysis, the risk of confounding from 
unobserved and observed variables, as well as measurement errors in exposures and covariates. 
In chapter three (ecological study), I discussed the challenges of undertaking studies at the 
population-level, the limitations of comparability of food system data across different countries, 
and the difficulties in estimating associations when little or no variability in the data exists, even 
though a ‘true’ association is likely. In chapter four (cohort study), I discussed the influence that 
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different ways of operationalizing UPF exposure had on statistical results in the prospective 
cohort analysis and the residual confounding that can stem from imbalances in the covariate 
structure. In this chapter I summarize the main findings of these three epidemiological analyses, 
discuss the overall methodological strengths and weaknesses of the methods used, and give an 
overview of the implications for public health policy, alongside recommendations for future 
research.   
5.2 Summary of findings 
The research presented in this dissertation reveals consistent associations between UPFs and 
adverse cardiometabolic health. My analyses are the first to review previous dietary patterns 
studies from a food processing perspective and meta-analyse associations between diets and 
dietary patterns high in UPFs and risk of T2DM and CVD. Individual-level data is not always 
available in countries with less resources and analyses of country-level data can identify global 
trends and associations. By systematically investigating country-level associations between UPF 
sales and adiposity and diabetes in both LMICs and HICs over a prolonged period, chapter 3 adds 
insights about the global nature of UPFs and their associations with the cardiometabolic health 
of populations. The research in chapter 4 advances provides insights regarding an important 
aspect of nutritional epidemiological research through comparing different ways of 
operationalizing measurement of UPFs in a prospective cohort study. This work is the first to 
establish an association between a higher share of UPFs in diets (as defined by NOVA) and risk 
of T2DM, in a prospective cohort study.  
The results of the systematic review and meta-analyses contribute to research on UPFs, and 
nutrition in general, by providing the first systematic analysis of published nutrition and dietary 
pattern studies from the perspective of UPFs according to the NOVA classification. By including 
studies that have previously not been considered in the assessment of the relevance of UPFs for 
health outcomes, this research makes a significant contribution to the field by showing that the 
evidence-base on UPFs and cardiometabolic health risk is not limited to studies of the NOVA 
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classification. In my study, I uniquely defined UPF consumption more broadly, identifying studies 
in which UPF consumption had been assessed in a range of ways under several different names, 
and combining those that were characterized by a higher relative intake of UPFs into one 
summary estimate. 
The result that higher sales of UPF are associated with an increased risk of adiposity and DM at 
the country-level was demonstrated in the panel analysis in chapter 3, using data from 76 
countries across all five continents. The panel analysis revealed that a strong and consistent 
association exists between the sales of UPFs at the food system level and adiposity and diabetes 
prevalence in LMICs for children, adolescent, and adult populations, as well as for both sexes 
separately. This finding adds value to the literature as no previous study had conclusively 
investigated these associations in countries for which a lack of data existed and had estimated 
associations for LMICs and HICs separately. However, the analysis did not establish an 
association between UPF and adiposity in HICs, which was surprising, given that the previous 
studies indicating an association at the individual level were mostly from HICs. This result must 
be interpreted cautiously. It seems likely that the lack of variability in UPF data from HICs during 
the study period were a key reason for the lack of estimated associations in HICs. Given the 
biological plausibility, previous evidence on the nutrition transition in LMICs, and the impact that 
food system transformations have on the health of those populations, as well as convincing 
evidence from an RCT and prospective cohort studies, it is very possible that the estimated 
associations in LMIC represent true associations but proving causality will require further 
prospective studies of individuals in LMICs. Because of the many combinations of data 
processing, analytical methods and the resulting variability of point estimates and P-values, 
emphasizing any particular set of point estimates would not have made sense in this case. 
However, the consistency of findings indicates that the expansion of global adiposity and 
diabetes since 2000 can partially be attributed to the increased sales of UPFs. 
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The associations that were found in the meta-analysis and the panel study were replicated in 
prospective analyses of detailed data from over 17,000 individuals in the EPIC-Norfolk cohort. 
This study added to the literature showing that the way exposures are measured or 
operationalized can fundamentally influence results.161,163 Previous UPF studies have only 
expressed UPFs as weight or the proportion of food weight, with the justification that energy 
measures would not capture the non-calorific components of UPFs with potentially adverse 
effects on health. As outlined in chapter four, this argument is somewhat misguided given that 
many of the components without calorific value also have very little weight and secondly, the 
assumption that those potential effects would disappear just because UPFs are measured in 
terms of energy instead of weight seems unrealistic. Since it is very common to express 
nutritional exposure or risk factors in terms of energy, and no comparison of different ways of 
expressing UPFs had been made previously, I conducted the first study (chapter 4) on UPFs that 
estimated disease risks using a range of different methods for operationalizing UPF intake. Based 
on previous nutritional epidemiological research to adjust for total energy intake, I modelled 
UPF and associated diseases risks in five different ways. The analyses revealed that these 
different approaches affect the statistical results, but also that they affect the results differently 
for different diseases. For example, the differences between measures of UPF intake based on 
energy and weight were much more pronounced for T2DM as an outcome than for CVD, for 
example, suggesting that potentially different mechanisms relating to dietary energy and other 
factors common to UPFs might be responsible for different outcomes. 
Chapter 4 was also the first analysis to comprehensively test the associations between UPF and 
three important cardiometabolic disease outcomes (adiposity, T2DM, and CVD) in a prospective 
cohort with a long follow-up period. The findings of an almost consistent positive association 
provide the strongest evidence to date that UPFs are positively associated with adverse risk of 
cardiometabolic health. The secondary analyses of eight different food groups and outcomes 
indicate that greater consumption of ultra-processed meat, fish, and eggs; fast foods; and SSBs 
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are associated with an increased risk of T2DM and CVD, whereas consumption of ultra-
processed fruits and vegetables, milk and dairy, fats, and breads and cereals might not be 
associated with an increased risk of disease. Body weight is likely a very important mediator of 
the association between UPF and T2DM and CVD, while increased total energy intake through 
UPFs is likely the most important driver of the UPF-adiposity association.    
The remaining sections will examine additional methodological considerations for each chapter 
that put the findings in context across the entire thesis, sum up the findings in light of those 
considerations, and describe the implications of the findings for research and policy.   
5.3 Methodological considerations 
In this section, I provide an overview of the methodological issues that are relevant for the thesis 
as a whole. I have structured the methodological discussions according to their implications for 
internal and external validity and will address each methodological topic for each chapter. In 
short, internal validity refers to the degree to which the results are attributable to the 
explanatory variable of interest and not some other competing explanation.341 The factors that 
influence internal validity in this thesis are study design, confounding, exposures, outcomes, and 
chance and bias. External validity refers to the question of whether the estimated associations 
and potential causal relationships can be generalized to different measures, persons, settings, 
and times. Influences on external validity discussed in this section are selection and attrition 
biases, and generalisability.  
5.3.1 Internal validity  
5.3.1.1 Study design  
Studies of long-term health outcomes and their determinants are often of a non-randomized, 
observational nature.342,343 ‘Manipulation’ or ‘experimentation’ is not possible for some factors 
(i.e. genes) or not ethical or feasible for long term outcomes due to problems of adherence and 
costs. In nutritional epidemiological studies of long-term outcomes such as CVD or T2DM, these 
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problems apply (e.g. randomizing a dietary pattern and then following up for decades is 
practically impossible).341 Thus, in this context, research relies on non-randomized observational 
data, in which, ideally, the characteristics and exposures of interest are measured at multiple 
points in time. The most powerful of these study designs is the prospective cohort study, in 
which participants are followed over a long period of time; and this was the study type of the 
analyses in EPIC-Norfolk. In principle – and in contrast to cross-sectional studies – cohort studies 
can better assess causality due to the longitudinal nature of the study design (the exposure or 
risk factor precedes the outcome) and specificity (a change in risk factor is associated with a 
change in the outcome). However, a number of assumptions have to be met, such as: alternative 
explanations are either controlled for or ruled out, very little loss-to follow-up exists or is at least 
non-differential, and there is no bias in the exposure and outcome assessment.344,345 In chapter 
4 I have controlled for as many alternative explanations as possible by including a wide range of 
nutritional and non-nutritional confounding factors, there was very little loss-to-follow up 
regarding the outcome, and bias in exposure assessment was minimized through exclusion of 
participants with improbable energy intakes as well as the use of repeated measurements. 
Additionally, although two repeated measurements were used, no additional information which 
was collected after 2003 could be used, which leaves uncertainty about whether the exposure 
and covariate information measured at HE1 and HE2 can be assumed to be valid for the 
remainder of the follow-up period.  
Chapter 2 was designed as a systematic review and meta-analysis of prospective cohort studies. 
How well a meta-analysis can draw unbiased conclusions about an effect of interest is 
dependent on the validity of the studies and risk estimates that are used to derive a pooled 
estimate. I limited the inclusion criteria to only prospective cohort studies, which is the highest 
quality of study types available for long-term dietary studies of T2DM and CVD. All included 
studies fulfilled several pre-specified inclusion criteria (prospective cohort study with more than 
a duration of one year, objectively measured outcomes, use of a validated dietary assessment 
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method and a set of important confounding variables in statistical models). I also assessed the 
study quality across nine domains nested in three main areas: the selection of the study groups, 
the comparability of the groups, and the ascertainment of either the exposure or outcome of 
interest.175 Higher ratings of the domains represent a higher internal validity, and meta-
regressions demonstrated that the quality ratings did not change estimated associations. The 
main limitation of study design of the meta-analysis was the lack of ability to influence the 
exposure measurement. Because the starting point of the study was to combine different diets 
and dietary patterns, no unified definition such as NOVA to define the dietary exposure existed, 
and I had no information on the absolute values of UPF intake between the different studies. 
However, as discussed in chapter 2, the main information was derived from the relative 
comparison of diets high and low in UPFs, and the similarities between the results in the meta-
analyses and EPIC-Norfolk indicate that high versus low intakes were indeed captured. Another 
key limitation was the variability of the measures of associations of studies investigating 
adiposity, which precluded a quantitative synthesis of the data, although this had technically 
less to do with the nature of the meta-analysis but with the variation of the measures to 
operationalize adiposity and body weight.   
Experimentation or randomization in the context of nutrition and NCDs are seldom done due to 
ethics and practicalities, and this becomes impossible in the context of the nation state or at the 
food system level. Yet, social scientists attempt to undertake causal inference at the country-
level to study factors that affect entire countries or larger multiple regions, such as policies, or 
global streams of trade and investment. Arguably, trends and associations that transcend the 
individual and local levels are relevant to public health and epidemiology as well, to identify and 
quantify health-relevant factors, such as global trends in the food system and sales of UPFs. 
Many threats to internal validity exist in those studies, and I attempted to reduce those by using 
repeated longitudinal data which allows for including information of changes in exposures, 
confounders, and outcomes. I considered undertaking a quasi-experimental study in chapter 3 
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but concluded that this was not possible because the data did not fulfil the requirements for 
those analyses. For example, one of the assumptions of the instrumental-variable approach 
would have required a variable that predicts the exposure, but conditional on the exposure 
shows no independent association with the outcome and affects the outcome solely through 
the effect on the exposure. Neither variable of the dataset nor publicly available data would 
have fulfilled this criterion. The difference-in-difference approach would have required some 
sort of treatment at a specific point in time and pre- and post-treatment data, which also is not 
possible for the type of data used. Thus, when other causal inference methods are not 
applicable, longitudinal panel data analysis is considered the ‘gold standard’ in country-level 
analyses, which is what was used in chapter 3.259,346,347 
5.3.1.2 Confounding 
Confounding or omitted variable bias is a main danger for internal validity in statistical analyses. 
A confounding factor is both associated with the outcome and the exposure, but not on the 
causal path between the two, and can conceal or wrongly lead to an association if the factor is 
unaccounted for.348 In each chapter, I attempted to account as well as possible for confounding 
by adjusting for identified confounding variables in multivariable statistical models. I did not 
perform any stepwise selection model selection algorithms (such as forward selection or 
backward elimination) in which variables are included or excluded based on observed changes 
in estimates. I also did not use ‘tests’ to guide the model selection (such as coefficient estimates, 
P-values, F- or Chi-squared). Harrell (2001) provides an extensive explanation as to why this is 
problematic for most regressions, including upwards biased parameter estimates and R-squared 
values, downwards biased P-values, or exacerbated collinearity problems.180 Instead, in each 
chapter, confounding factors were identified through a review of relevant literature. 
Across all analyses, I attempted to adjust as well as possible for basic demographics such as age 
and sex, socio-economic variables such as income, education and social class, and additional 
relevant variables including physical activity, history of disease, smoking, alcohol consumption, 
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and a proxy for geographic location. Importantly, when studying dietary risk factors in nutrition 
studies, other aspects of diet could be associated with the exposure and outcomes. To capture 
this possibility, the EPIC-Norfolk analyses and the country-level study included variables of the 
consumption or sales of unprocessed foods, which combines many healthy food groups such as 
un- or minimally processed fruits, vegetables, nuts, legumes, or seeds; as well as total energy. 
In the meta-analysis, most studies adjusted for at least some proxy variables of healthy foods 
such as fruits and vegetables.  
But as is the case in analyses that are based on the evaluation of secondary data, the adjustment 
variables were bound to what data was available. In the ecological study, for example, I was able 
to only use a cross-sectional indicator for the level of physical activity in countries because no 
longitudinal information was available. In the meta-analyses, because no control over the 
inclusion of confounders existed, first only studies with a prespecified degree of confounder 
adjustment were selected (i.e. there had to be some form of adjustment for socio-economic 
position). Secondly, I elicited the risk estimates that provided the best adjustment for 
confounding (again as prespecified), which would not necessarily imply the greatest degree of 
adjustment or the models with most included variables. For example, I did not use risk estimates 
of models that included potential mediators which would lie on the causal pathway, because 
risk estimates including those would have likely biased the estimates downwards.   
Additionally, as was described in each chapter and in more detail in chapter 4, the ability of 
multivariable regressions to adequately control for confounding by including confounding 
variables as adjustment variables can be limited. Across the studies, it is likely that some residual 
confounding from adjusted variables remains. Especially in the case of CVD the remaining true 
associations could be small if residual confounding from adjusted confounders existed. I have 





To briefly refer back to the methodological background, common definitions of P-values and 
statistical significance focus on null hypotheses, treating all other assumptions that are used to 
calculate the P-value as correct.166 The P-value tests all the assumptions about how the data 
were generated, including the entire model, and not only the hypothesis of interest. However, 
these assumptions usually encompass a number of assumptions, such as that no intermediate 
results from analysis were used to determine which results and which analyses would be 
presented, or that no contingencies in the data processing existed in the construction of the 
data. Thus, a low P-value does not imply a low possibility of a chance finding, if considered in 
isolation.  
I have attempted to use this type of thinking on P-values and confidence intervals to guide 
interpreting and dealing with chance throughout my PhD. Although I started each chapter with 
this intention in mind, I took slightly different approaches in the three chapters as a reflection 
of both my own methodological development throughout my PhD as well as my attempt to 
mitigate the partially contrasting goals of up-to-date statistical definition and following 
reporting practices of journals.  
For example, a systematic review and meta-analysis must follow a certain protocol to be 
considered by most general medical journals. Statistically, most statistical packages compute 
and report summary risk estimates and their 95% CIs in forest plots that are mandatory. I have 
reported P-values wherever possible, but in most published meta-analyses the focus remains on 
whether the CIs include 1.00 or not. In the country-level panel analysis, I came as close as 
possible to my ideal of reporting by presenting a multiverse of statistical results and displaying 
and interpreting P-values in a continuous manner. In the EPIC analysis, I again attempted to 
adhere to established reporting practices (i.e. having a large table reporting the estimates and 
confidence intervals across quintiles and continuously) in the main analysis but presented 
continuous P-values in the secondary analyses.  
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Overall, across the chapters, P-values were very small, especially regarding T2DM, where they 
were often below 0.001 or even 0.0001. A very clean interpretation would suggest a strong 
incompatibility of the data with model assumptions. For each chapter, I can exclude the 
possibility that the assumption of no selection on statistical significance was violated. Secondly, 
assumptions of the statistical models underlying the analyses of each chapter were fulfilled. 
Random-effects meta-analyses have no assumption about a common effect and assumes no 
specific distributional form.349 I am not aware of an assumption that could have affected the 
standard error estimates in the meta-analyses. In the panel analyses, the series of Econometric 
tests guided model specifications mostly regarding the calculation of standard error. Violations 
of statistical models such as autocorrelation, heteroscedastic residuals, or the presence of unit-
roots were either accounted for in the model specifications or could be excluded. The multiverse 
analyses also made transparent that data dependent estimation of the models was unlikely. In 
EPIC-Norfolk, the examination of Schoenfeld residuals as well as a complete presentation of the 
results across different ways of operationalizing the exposure, and a wide range of both 
unadjusted and adjusted models, indicate that a chance finding is unlikely. Thus, I judge it to be 
unlikely that the results presented in my PhD are due to chance. In addition to this statistical 
discussion of chance, the biological plausibility and consistency of the findings across all three 
chapters make it additionally unlikely that the main findings in this thesis resulted from chance.  
5.3.1.4 Error and bias in measurement 
To validly assess associations between UPF consumption and cardiometabolic health, the 
exposure and the outcomes need to be accurately defined and quantified. In all three studies, I 
have used the NOVA classification as the basis to classify foods according to the degree of food 
processing. Overall, it is relatively straightforward to classify existing foods and food groups 
according to the NOVA classification. However, in a few instances, it is not – additional 
information about the preparation process of the foods and their exact composition is needed 
for accurate classification. In population studies that use standardized dietary assessment 
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methods, this information is often not available. In each chapter, foods were classified 
independently by at least, me and another co-author, and in each case, agreements of the 
applied classifications were very high, and disagreements were resolved by consensus. Thus, in 
the chapters that included data from prospective cohort studies, the validity of the UPF measure 
was mostly dependent on the validity of the dietary assessment tool, and both the review 
chapter as well as the EPIC-cohort included only validated dietary assessment tools.  
However, misreporting of energy is a well-known and serious issue. As discussed in chapter 3, 
the validity of food sales is somewhat difficult to assess, but it is unlikely that the measurement 
error in the data provided by Euromonitor would work in way that biases the exposure-disease 
association in a systematic way. In EPIC-Norfolk, the FFQs have been validated and calibrated 
against weighed food diaries, 24h-recall instruments, as well biomarkers. In addition, I identified 
improbable energy reporting by using Henry equations and Goldberg cut-offs to determine and 
exclude improbable energy reporting. Yet, the potential for measurement error regarding the 
exposure across the different studies remains. However, for this to be a serious issue, the UPF 
intake of individuals or countries with a higher risk or prevalence of disease would have to be 
systematically overestimated, or the UPF intake of individuals or countries with a lower risk or 
prevalence of disease would have to be systematically underestimated, or both. I judge this 
possibility to be unlikely to have happened in this manner across each of the three different 
analyses.   
The chapters that included individual-level analysis used objective and validated measurements 
of the outcomes. The use of objective outcome data offers reductions in measurement error 
and removes recall, interviewer, or responder bias. In the meta-analyses of T2DM and CVD, 20 
of the 24 included publications used outcome ascertainment methods that were considered as 
objective according to the assessments of study quality of the Newcastle-Ottawa scale. In the 
panel study, I used only high-quality publicly available data on national prevalence from the 
Institute of Health Metrics and the NCD-RisC factor collaboration. These data represent the best 
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available assessments of country-level prevalence of diseases, which have maximized the use of 
objective outcome data in each country with validated methods to estimate outcomes in cases 
in regions with sparse objective data.2,39 In EPIC-Norfolk, as described, cases are ascertained 
based on objective measures.  
5.3.2 External validity  
Selection bias and Generalisability  
Selection bias can substantially alter the accuracy of the findings and impact how applicable 
study findings are. Selection bias in epidemiology and public health research occurs when 
systematic differences between the study population and the wider population exist (affecting 
generalisability).350 Selection bias in cohorts can be introduced due to a number of reasons, the 
most prominent being loss-to-follow up or attrition bias. In EPIC-Norfolk, general practice 
registers operated as a population sampling frame, thus EPIC-Norfolk was representative of the 
overall UK population at the onset of the study. It is possible however that some groups of the 
population were systematically absent from the GP registers in the early 90’s. The study 
population was followed-up for vital status though the Office of National Statistics and for 
disease incidence through local health authority databases. Given the almost complete coverage 
through the NHS, the loss-to-follow up for T2DM and CVD events is negligible. Yet, as is common 
in cohort studies, the representativeness of the EPIC-Norfolk cohort for exposure and covariate 
information at subsequent (health) examinations was affected by participant attrition. This 
affected the repeated measurement of participant characteristics, implying that for 
approximately half of the sample only information on exposure and covariates from the first 
health examination could be used. The consumption of UPFs decreased a small amount between 
the first and the second health examination, suggesting a differential loss-to-follow up between 
the first and the second health examination. This has likely influenced the cross-sectional 
estimates regarding adiposity at the second health examination, which were lower than those 
at the first. Regarding the prospective associations, this would have biased the results if those 
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that were not included in the second health examination had changed their diets during follow-
up in a systematically different manner than those who continued to participate in the study, 
and additionally, in a way that would have influenced their disease risk. Specifically, those that 
were not followed up between HE1 and HE2 were participants with higher intakes of UPFs. The 
results would have overestimated the prospective UPF-disease association if those with higher 
UPFs that were not interviewed at HE2 decreased their UPF consumption during the late 90s 
and 2000s. To the best of my knowledge, I am not aware of any evidence of a reduction of UPF 
consumption in general or among high consumers of UPFs in the UK during this period. It thus 
seems unlikely that there was an overestimation of effects due to differential loss-to-follow up 
between HE1 and HE2. As outlined, no such loss to follow-up occurred regarding the CVD and 
T2DM outcomes.  
Additionally, while the long follow-up period in EPIC-Norfolk is positive for assessing long-term 
outcomes such as T2DM and CVD, the age of the study and dietary assessment somewhat limits 
the generalisability and relevance for the present day. As discussed in chapter 4, the UPFs sold 
during the 90s and early 2000s were likely slightly different from those available today, and the 
relative contribution of the UPF food groups might have been different as well.  
The cohorts that were pooled in the meta-analysis were mostly large population-based cohorts 
such as EPIC-Spain or EPIC-Netherlands, the Malmoe Diet and Cancer Study, or the REGARDS 
study. However, some included cohorts were occupational, and thus not necessarily 
representative of the underlying population. Also, given that all included studies were cohorts, 
some attrition bias is likely. In over 70% of the cohorts, the follow-up was judged to be adequate 
according to the Newcastle-Ottawa scale criterion. In the analysis of the panel data, data for all 
76 countries were available for the period under study, hence there was full follow-up and an 
overall a low risk of selection bias (as here defined), except for four countries for which sufficient 
exposure data was not available for the year 2001.    
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The wider generalisability of the epidemiological findings was strengthened by the replication 
of associations across three independent analyses. The inclusion of 41 prospective cohort 
studies from three different continents and the EPIC-Norfolk analysis from the UK provide a basis 
for the generalisability across the developed world. The analysis that includes data from 
countries with a combined population of about 6 billion individuals further extends the 
generalisability to the context of countries with lower income. However, as EPIC-Norfolk is a 
cohort from the UK and only six out of 41 studies in the systematic review were from countries 
outside of the EU and North America, the generalisability of the findings from prospective 
cohorts in particular are somewhat limited to developed contexts. 
5.4 Conclusion of the evidence  
Thus, my thesis and each of its chapters have important strengths and limitations. Despite the 
limitations, there was consistency of the estimated associations across different individual- and 
population-level datasets, as well as similarities of the meta-analyses and EPIC-Norfolk analyses 
regarding the CVD and T2DM risk estimates. Also, previous research has established causal 
associations between UPFs and adiposity, as well as solid evidence of an association with CVD 
and hypertension.140,141,144,351 These findings from previous research and the research in my 
thesis indicate that UPFs are adversely associated with cardiometabolic health. The strength of 
the estimated associations is stronger for T2DM than for CVD. The estimated associations also 
depended on the way UPF intake is expressed and total energy intake is accounted for, and this 
affects risk of T2DM and adiposity more than CVD, most likely due to the different relative 
contributions of ultra-processed foods groups to the two measures, such as SSBs. Although 
individuals who consume more UPFs consume less healthy foods, this does not explain the 
findings because associations remained after the consumption of un- and minimally processed 
foods (fruits and vegetables, seeds, nuts, etc.) were accounted for.    
The estimated associations are likely to be attributable to a combination of unhealthy macro- 
and micronutrient profiles of UPFs, increased energy intake due to the hyper palatability of UPFs 
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which result from specifically designed nutrient combinations (e.g. salt, sugar, fat) in 
combination with food additives, and potentially further negative effects from food additives 
and newformed compounds. These properties of UPFs are intrinsically related to the processing 
processes because those have been specifically designed to give UPFs exactly those properties. 
Thus, some of the current food processing technologies create foods that are associated with 
an increased risk of adverse cardiometabolic health.  
However, not all UPFs might be equally associated with diseases. As the analyses of the ultra-
processed food groups revealed, some food groups were associated with the outcomes while 
some were not. An updated hypothesis regarding UPFs might thus be that not all UPFs are 
unhealthy, but most unhealthy food groups are ultra-processed. The next sections address the 
implication of my findings for dietary public health policy and research.  
5.5 Recommendations for research 
This section outlines overarching and cross-cutting recommendations for future studies that 
emerged from the research I conducted in this thesis.  
My analyses have shown that many distinctly named unhealthy dietary patterns are broadly 
comparable in that they are defined by higher relative intakes UPFs. Many of the dietary 
patterns defined as unhealthy are often characterized by high intakes of UPFs and low intakes 
of minimally processed foods. Rather than finding new names for dietary patterns (i.e. junk, fast 
food, convenience, etc.) that are specific to the cohort in which they are tested, I would suggest 
narrowing the focus on a few key concepts of unhealthy diets (such as those high in UPFs) that 
are extensively tested until all aspects have been exhaustively understood. While much of the 
research on healthy dietary patterns is currently concerned with a few key diets such 
Mediterranean and DASH diets, a similar focus could happen regarding unhealthy diets. 
Additionally, the relationship between other established ways of categorising unhealthy foods 
such as the UK Nutrient Profiling Model or the Nutri-Score should be tested to identify potential 
similarities and differences, as well as their predictive powers for disease. In a similar manner, 
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relationships between UPFs and healthy dietary patterns such as the Mediterranean diet, DASH 
diet, or Healthy Eating Indices should be investigated to see how the distributions of those 
scores, or index values correlate with intakes of UPF.  
Almost every study that had investigated the share of UPFs in diets or looked at dietary quality, 
used energy from UPFs as the measure to operationalize UPFs. Yet, oddly, almost every 
prospective cohort study that estimated disease associations measured UPFs as weight. One 
possible interpretation of this could be that those measures were consciously or unconsciously 
chosen due to the very fact that they produce the strongest disease associations. In the analyses 
of EPIC-Norfolk (chapter 4) I used a full range of possible approaches to operationalize 
measurement of UPFs. The weight measures consistently produced stronger associations than 
the energy measures. Future research should develop theory and investigate empirically what 
each of the two main approaches are measuring and which should be used for which outcome 
and why. If for example, the relative contributions of ultra-processed food groups are different 
for weight and energy measures in different cohorts, then using the same measure might yield 
different results even though the underlying association is the same. Theoretical and empirical 
work should use such a range of approaches and, based on this, argue for and against the 
selection of one or the other measure in each specific context as well as in general.  
The investigation of ultra-processed food groups and their relation to the overall aggregate 
group of UPFs should be of main future importance. In this thesis, a likely reason for the different 
findings using different measurement metrics, were differences in contributing food groups. If 
it repeatedly turns out to be the case that certain UPF food groups produce lower disease 
associations (e.g. UPF breads), than this has implications for the concept of UPFs itself. One line 
of investigation could estimate the associations of the unprocessed and ultra-processed versions 
of the same food groups to test whether there are any differences between the two to 
disentangle whether it is the processing or the food groups themselves that are associated with 
health outcome. This is, of course, only possible for those food groups for which unprocessed 
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and ultra-processed versions exist. This could potentially shed light on the hypothesis that not 
all UPFs are unhealthy but most unhealthy food groups are ultra-processed. This would 
contribute to an improved and more differentiated concept of UPFs.   
Regarding nutritional epidemiological methods, a central issue is residual confounding from 
adjusted confounders. If people who eat more UPFs (or have an unhealthy diet in general), 
smoke more, drink more alcohol, do less physical activity, or live in deprived areas, can we fully 
adjust for these differences in multivariable Cox-regressions, and can the residual confounding 
from this be quantified? Future nutritional epidemiology research needs to test and compare 
different methods to adjust for imbalances in the covariate structure. One possible way would 
be to use propensity-scores to match individuals with similar values on the confounding 
variables but differences in the exposure variable. Especially if sample sizes are large, matching 
could enable estimation of  ‘treatment effects’ in survival analysis, for example in the context of 
the counterfactual or potential outcomes framework as, for example, suggested by Rubin and 
Imbens (2015).228,352,353 In brief, the potential outcomes framework provides a way to quantify 
causal effects by attempting to approximate the ideal situation of a randomized experiment in 
non-randomized observational data. The causal effect is defined for a hypothetical intervention 
as the difference between the outcomes that would be observed for participants (or study 
subjects) that were exposed versus those that were not exposed.354 VanderWeele (2017) argues 
that in non-randomized observational epidemiology, the potential outcomes framework is able 
to provide the conceptual and mathematical link between data and causal effect estimates in 
the context of non-randomized observational epidemiology and that very few (if any) 
satisfactory alternatives to do so exist.354   
Another issue that has repeatedly come up throughout this thesis is the influence that 
researcher degrees of freedom can exert on the results.  In some of my analyses, estimates of 
different equivalent choice combinations led to two- or even three-fold differences in the 
magnitude of the coefficient estimates and sometimes even a different sign. This might not be 
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a coincidence. In one large scale replication study, over 25% of 100 replicated effect sizes that 
were previously positive were negative in the replication.355  If this is what data processing and 
analytical choices can do to statistical results, researchers should embrace the messiness 
surrounding empirical analyses that involve a lot of equivalent choices and to display the range 
of results, rather than presenting only selected results that give a sense of precision which may 
not necessarily reflect the true underlying uncertainties. Displaying results in a multiverse or a 
similar way can contribute to transparency on the possible range of results while also increasing 
replicability and reproducibility of research, because the focus on very specific ‘significant’ point 
estimates would be reduced.  
As outlined in the introduction, calls for a radical reform of nutritional epidemiology have 
suggested to largely replace nonrandomized with randomized studies. To me, the conclusion of 
this criticism is out of touch with the progress that researchers have made on the topic of causal 
inference from nonrandomized data in the past decade. Issues like confounding, selective 
results, and selective reporting can be addressed by choosing the right methodological, 
conceptual, and statistical approaches, by testing whether all the assumptions necessary are 
met, as well as being transparent about the potential multiverse of results and a commitment 
to not select favourable results. In that sense, I agree with the idea of reforming certain aspects 
of the field, but rather than abandoning nonrandomized evidence altogether, my suggestions is 
to make the causal question central to nonrandomized nutrition research from the outset. 
Nutrition research should not give up on the wealth of epidemiological data that has been 
generated in the past decades to narrowly focus on randomized approaches that cannot address 
important research question that require lifelong study. Instead, reforming should mean 
embracing the advances from the causal inference literature that stem from the intersection of 
computer science and statistics. As has been proposed by authors such as Imbens, Robins, 
Hernan, Gelman, and others, we should be doubling down on the task to elicit the best causal 
estimate from nonrandomized data as possible.227,342,353  
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Additionally, previous research has argued that the concept of highly or UPFs is easier to 
understand for the public and might therefore improve the communication of dietary 
guidelines.66,356 This might make sense intuitively due to the simplicity of the concept, but 
further research needs to test whether this is true. Furthermore, the meta-analysis in chapter 2 
has demonstrated a strong variability of the association measures of adiposity and body weight. 
Future research should reach a consensus regarding which measures should be used as a best 
practice and how associations can be quantified. Finally, the impact of dietary public health 
recommendations, including those in the next section, should be subject of research to 
determine whether the proposed policies and already implemented measures have their 
desired effects.   
5.6 Implications for dietary public health policy 
Given rising prevalence rates globally, adiposity and T2DM continue to be major public health 
concerns.357,358 Governments, international and national health agencies, civil society 
organisations, and other key stakeholders are prioritizing the promotion of healthy nutrition and 
actions to tackle diet-related NCDs.359–361 For example, in April 2016, the United Nations General 
Assembly agreed on a resolution proclaiming the UN Decade of Action on Nutrition, calling on 
the WHO and FAO to lead the implementation in collaboration with other agencies such as the 
World Food Programme.362 The findings presented in this thesis have multiple implications for 
the field of dietary public health and public health policy. 
The trends of sales of UPFs and their associations with adiposity and diabetes in LMICs suggest 
that a stronger focus on unhealthy nutrition and UPFs should be prioritized in those countries. 
While additional research is needed to establish further associations, my findings suggest that 
UPFs might be one of the key drivers behind the current obesity and T2DM crises, and thus 
deserve more attention in the future. The associations between UPFs and T2DM demonstrated 
in all three chapters, alongside the previously established evidence on adiposity, CVD, and 
mortality, provide additional motivation for strategies to reduce consumption of UPFs. To 
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suggest potential policies, it is helpful to identify individual and other influences on diet and 
health.   
There are various ways to conceptualize the factors affecting what people eat. The ‘ecological 
approach’, for example, suggests three levels that affect individual diets.363 First, intrapersonal 
factors include attitudes, beliefs, and perceptions that individuals have regarding dietary 
behaviours. Secondly, social and cultural environments include the interactions that people 
have with their families, their friends, their colleagues, the institutions and organizations in 
which they spend their professional and leisure time (e.g. workplaces, schools and universities, 
sport facilities, etc.), as well as government, laws, and policy. Thirdly, the physical environment 
concerns the availability of different types of foods at home, in the neighbourhood, and more 
generally the characteristics of the physical infrastructure that affects what foods are consumed. 
More recently, the recognition of the importance of systems dynamics and different feedback 
mechanisms that influence diets have led to various complex multi-level representations and 
modelling studies of food systems and the food environment.364  
Figure 5.1 depicts a more generally accepted attempt to capture those dynamics in an integrated 
framework of food systems. It has been adopted by multiple international organizations and 
committees, such as the Committee on World Food Security, the High Panel of Experts on Food 
Security and Nutrition, and the Global Panel on Agriculture and Food Systems for Nutrition.364,365 
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According to the framework, diet quality is influenced by an individual’s income, time, 
purchasing power, knowledge, and preferences. 
Figure 5.1 Linkages between food systems, food environment and diet quality 
Taken from: Global Panel on Agriculture and Food Systems for Nutrition. Food Systems and Diets: Facing 
the Challenges of the 21st Century. London, UK; 2016.365 
 
The way that money is spent and knowledge and preference form and express themselves are 
in turn influenced by the food environment, which affects and interacts with these individual 
factors through food prices, food promotion, food labelling, the physical access to food, and the 
nutrient quality and taste of the foods available. Hence, the food environment can be seen as 
the space in which consumers interact with the food system to decide what foods to buy, 
prepare, and consume, and it directly influences individuals’ dietary choices and their nutritional 
status.366 The food environment itself is influenced by broader food systems: agricultural 
production; food storage, transport, and trade; food transformation; food retail and 
provisioning.  UPFs, for example, are easier to purchase, cost less, and are more widely available 
than more healthy foods as a result of developments in technology and trade.356,367 Taking a 
food systems approach to improving diets at the population-level is potentially advantageous 
over individual-oriented approaches for reasons of leverage and sustainability.3,361,368 A higher 
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leverage means that more people are affected due to the greater scale and extent of the policy. 
As an extreme example, a ban on trans fats at the food systems-level sets their availability in a 
given context effectively to zero, under the assumption of full compliance by food producers. 
This result would have been almost impossible to reach with individual-level intervention (e.g. 
‘avoid foods that contain trans fats’), due to a range of variables including differential 
distributions of knowledge, motivation, and resources in the population. Addressing diets at the 
food systems-level also increases sustainability of the desired change. A ban on trans fats 
eliminates consumption until the ban is reversed, while an individual-level approach in contrast 
might change individuals’ preferences and behaviours only for a short period of time.  This is 
partially because preferences are generally ‘time-inconsistent’. As Hoch and Loewenstein 
argued in their seminal paper “Time-inconsistent Preferences and Consumer Self-Control”, 
almost 30 years ago, consumers often override their long-term preferences as a result of sudden 
increases for desires and products.369 Moreover, a change in circumstances such as location, 
income, or social networks might additionally endanger established or newly formed 
preferences and behaviours. The following recommendations for dietary public health policy to 
reduce UPF intake will therefore focus on policies addressing the food environment via the four 
food systems levels but also include suggestions that address individual-level factors.  
Since agricultural products provide the basic inputs and ingredients to the food processing 
process, the agricultural production subsystem provides some, but limited opportunities, to 
reduce the consumption of UPFs in a given food environment. The suggestions in this area thus 
focus on maximizing the nutrient-density of fruits, vegetables, and legumes. Improving the 
nutritional quality and ‘richness’ of little or unprocessed agricultural products might indirectly 
affect UPF intake by increasing the opportunity costs for eating UPFs in comparison to 
consuming fresh produce. Reducing or limiting agricultural produce that is predominantly 
destined for further food processing might also increase the relative prices of such inputs while 
reducing the prices for products not entering a more complex food processing chain. Maximizing 
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nutrient-density could be achieved by, for example, introducing productivity metrics that 
evaluate production in terms of kg of nutrients produced per unit of land or labour.365  
The food storage, transport, and trade subsystem offers additional opportunities to influence 
the food environment and the consumption of UPFs. Non-tariff trade barriers and increased 
tariffs on UPFs could decrease the amount of UPFs that are imported, reducing the availability 
of UPFs.370,371 This might be especially useful for small or island countries with low or negligible 
domestic UPF production. Countries with a lot of domestic production of UPFs could increase 
barriers for crucial ingredients of UPFs, such as sugars, already refined ingredients, or food 
additives that are produced elsewhere and imported for the production process. Additionally, 
increasing food composition trading standards could improve the nutrient quality of specific 
imported foods or ingredients. More generally, dietary quality aspects need to be included in 
trade negotiations, and existing trade mechanisms could be used to put in place standards that 
reduce trade in UPFs and increase trade in nutrient-rich foods.366  
The food transformation subsystem carries the most potential to reducing the consumption of 
UPFs and changing the overall food supply through various measures such as food 
reformulation, food taxes, restriction on advertising, nutrition labelling, or the development of 
new processing technologies. Previous research on policies that aim to promote the 
reformulation of foods has demonstrated considerable potential impact in comparison to 
policies aimed at changing individual behaviour.372,373 A recent systematic review on food 
reformulation and modelling strategies has shown stronger effects on nutrient intake and health 
for sodium reformulation strategies compared to sugar and fats.372 Although cross-study 
comparability was limited, the results showed a consistent relationship between percentages 
reformulated and reductions in consumption, as well as for health outcomes and quality of life 
measures. As shown in this thesis, the unhealthy nutritional profile of UPFs, high energy content, 
and increased total energy intake through UPFs are important mechanisms and characteristics 
that potentially drive exposure-disease associations. A core reformulation aim should be to 
 
158 
substantially reduce the energy content of UPFs. If everyone followed the suggested portion 
sizes (e.g. 30g of crisps per serving or three-five cans of SSBs per week), individuals that regularly 
consume these products would likely not be at particular risk. However, many consumers 
overconsume UPFs in multiple amounts of the suggested serving sizes.374–376 Substantial 
reduction of the energy-density of UPFs could therefore potentially reduce the effects on body 
weight. Furthermore, reducing the fat, salt, and sugar content in food products has been a part 
of national strategies in countries such as the UK and Germany.5,377 However, the German plan 
only contains voluntary measures and targets, while the UK’s Childhood Obesity Strategy 
restricts marketing to children but not to the general population. While voluntary measures 
have been partially successful in reducing sodium content, these measures would be unlikely to 
reduce the consumption UPFs in general population. As experiences from food safety have 
shown, obligatory reformulations are more likely to produce the desired results compared to 
simple voluntary approaches.378 A previously unexplored avenue of reformulation could be 
addressing the ‘bliss point’ of UPFs. Food scientists have argued that by using highly refined 
ingredients in the process of making UPFs, the full and natural ‘hedonic’ properties of the 
ingredients are lost.326 Thus, by using raw sugars, sea salt, and other more natural ingredients, 
bliss points could potentially be achieved at lower concentrations of these ingredients. 
Additionally, new primary food processing techniques could also help to design foods with 
similar hedonic properties but based on mixtures of fruits, vegetables, and whole grains, 
resulting in better overall nutritional qualities. Additional investment and funding possibilities 
for research and start-ups that develop healthier forms of processing and processed foods could 
also encourage change in the food environment. 
There are more policy options with the potential to improving food environments that can be 
implemented in the food transformations subsystem. Fiscal measures such as food taxes have 
received widespread attention in recent years. By 2018, taxes on SSBs; foods high in salt, fat, 
and/or sugar; or subsidies to improve diets and health had been adopted across 29 countries.340 
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Thus, taxes on certain UPFs subgroups have already been implemented, although not with the 
explicit aim to limit UPFs. Applying food taxes to UPFs is, however, not straightforward. UPFs 
consists of a number of diverse foods which makes the development of metrics to determine 
when and how taxes should be applied to the overall group of UPFs impractical. Also, if the 
hypothesis posited above is true (not all UPFs are unhealthy but most unhealthy foods that are 
unhealthy are ultra-processed), taxing all UPFs may not be necessary. There are two main ways 
in which food taxes on UPFs could be set-up. A simplistic approach would be to classify all ultra-
processed foods and food groups and add an excise tax of, for example, £1 or 1€ per unit of 
weight or energy. The energy approach would have the advantage of disincentivizing the 
consumption of UPFs that weigh little (like chocolate or crisps) but have a very high energy 
density. To make the tax more acceptable in the population, the revenue should exclusively be 
used for programs that prevent and address diet-related disease problems in both children and 
adults. A second way would be to identify the main UPF food groups with clear disease 
associations such as SSBs or fast foods and tax those. When designing potential taxes on UPFs, 
some general lessons from previous experiences with food taxes should be considered. The tax 
(or the taxes) should be applied to a geographical unit as large as possible; an excise tax applied 
to volume, weight, or energy should be used; the tax should be motivated by health and not 
revenue reasons; the revenue of the tax should be used for health-related expenditures; the 
implementation of the tax should be assigned to the health ministry and not the agricultural 
ministry; and an understanding of the political and corporate environment when designing the 
tax should be considered.340,361,379,380 
Another already used approach that could be extended are restrictions on advertising and 
marketing. In the UK, marketing restriction to children exist for foods that are high in salt, fat, 
and sugars (which are mostly ultra-processed).381 This was aimed at reducing the appeal to 
children and potentially incentivize industry to reformulate their products. A government report 
from March 2019 has concluded, however, that, despite restrictions, children see significant 
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level of adverts through the media they engage with (e.g. online media), influencing their 
preferences, food choices, and their health status.382 Advertising restrictions should therefore 
be improved by expanding to online media. Furthermore, spending on food advertising is, in 
general, very high. In the UK, for example, spending on junk foods (or UPFs) has been found to 
be 30 times of what is being spent by the UK government on promoting healthy eating.383 Food 
companies spend on marketing because it works, otherwise, they would not do it. The high 
societal costs of diet-related NCDs provide a strong rationale for more drastic and widespread 
curtailing of marketing, and this should not be restricted to only children. Sports-related 
marketing of UPFs, large-scale advertisements in cities, and online and TV ads could be 
prohibited or massively reduced, by increasing the price or limiting the licensing to a fraction of 
available advertising spaces. Given the available evidence on SSBs and emerging evidence on 
UPFs, as well as an established scientific consensus on dietary risk factors contributing to the 
global burden of diseases, a strong narrative can potentially be created which might enable the 
implementation of these more drastic measures.   
Suggestions regarding the retail and provisioning subsystem have often been concerned with 
the promotion of local foods or the promotion of healthy foods in retail environments.384 
However, sales of UPFs could be reduced by restricting or prohibiting special advertising and 
price promotions in retail environments. Also, previous experiments of the choice architecture 
have demonstrated that redesigning the layout and positioning of foods in retail such as 
supermarkets can increase the sales of healthy foods and decrease the consumption of 
unhealthy foods.385–387 Positioning UPFs in locations in which they are less likely to be bought 
could reduce the sales of these products. Lastly, changing licensing laws to limit the density of 
food outlets such as takeaways in sensible locations such as in proximity to schools could further 
reduce the availability of UPFs in the food environment.  
Consumption of UPFs could also be reduced through approaches that do not directly change the 
food environment but aim at changing the preferences and knowledge of consumers through 
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dietary guidelines and public awareness and media campaigns. The concepts of food processing 
and the comparison of minimally processed foods with foods that are highly processed are likely 
easy to understand and can be communicated effectively. In terms of nutritional guidelines, 
dietary recommendations communicated around the concepts of UPFs might therefore be 
easier to understand due to the simplicity of having to make decisions along only one dimension 
– the degree of food processing. A recent (2019) review and comparison of 90 food-based 
dietary guidelines (FBDGs) found almost universal inclusion of certain aspects of diets, e.g. to 
consume a greater variety of foods and to consume some foods in a higher proportion than 
others; to eat more fruits, vegetables, and legumes; and to limit sugar, fat, and salt.359 About 
25% of the FBDGs included recommendations to reduce the consumption of UPFs or related 
junk foods. The guidance is more common in newer dietary guidelines, for example Brazil, 
Uruguay, or Canada, which specifically advise consumers to limit the intake of UPFs.336,359 
Countries can generally adopt guidelines to limit the intake of UPFs or certain groups of UPFs. 
Targeted public awareness campaigns via conventional and social media could also contribute 
to shifting the social perception of UPFs, like it has happened with smoking and tobacco in many 
countries.388–390  
None of the above suggested measures are likely to work in isolation. To be effective, 
combinations of multiple approaches should be used to increase the likelihood of success.  
5.7 Final conclusion 
Overall this dissertation revealed consistent associations between the consumption and the 
sales of ultra-processed foods and cardiometabolic health, showing evidence that data 
processing and analytical choices affect the strength of those associations. Although there was 
no explicitly formulated goal to establish causality in this thesis, it is likely that estimated 
associations in this thesis are at least partially causal. This judgement derives from evidence 
from previous research, biological plausibility, the nature of the findings throughout this thesis 
(consistency, strength, dose-response relationships, temporality), and the fact that alternative 
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explanations are unlikely to account for the estimated associations across the entire thesis, 
despite the methodological limitations discussed above. Regarding the initial aim of the thesis 
to find out ‘what it is about UPFs’, one conclusion is yes, it is highly probable that food processing 
changes unprocessed foods and ingredients into something that poses a health risk – regardless 
of whether the underlying mechanisms are adverse nutritional quality, the ‘bliss-point’ design 
of UPFs which, coupled with high energy content of UPFs, leads to overeating and excess energy 
consumption, or the effects of newly formed compounds. However, it is also true that food 
groups matter. The combination of foods, ingredients, and food processing technology seem to 
influence whether an UPF is unhealthy, neutral, or maybe even healthy. In this context, it would 
be logical that certain ultra-processed food groups such as SSBs, fast foods, or savoury ultra-
processed snacks are likely to have a stronger influence on health than, for example, ultra-
processed fruits and vegetables or breads and cereals. Not all UPFs are created equal, and future 
research would enable this concept to be unpacked and improve our understanding. Until then, 
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No UPF food or DP exposure of subjects 1-40 
Cross-sectional / retrospective study design 41-73 
Superior publication from same cohort available 74-84 
Review or qualitative publication 85-95 
Subjects not disease-free at baseline 96-103 
Risk estimate reference category not comparable 104-108 
No cardiometabolic health outcome 109-113 
Exposure level negligible 114 
Population with special dietary needs 115 
Commentary 116 
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Main Characteristics of Included Studies 



















Number and List of UPF 
Items (loadings >·2) / 
















































Biscuits and pudding (0·46); 
chocolate and sweets 
(0·41); sweet spreads (0·36); 







Age, energy intake, 
smoking status, alcohol 
intake, physical activity, 





US 6·9 69582 
FFQ 




Hotdogs, hamburgers, fried 
chicken, fried fish, fish 
sandwiches, pizza, French 








Age, sex, energy intake, 
race/ethnicity, marital 
status, income, BMI at 
age 45, self-rated health, 
current use of disease-
relevant medication, 
history of CVD, family 
history of heart attack, 
physical activity, smoking 
status, alcohol intake, 
mammogram in past 2 





Adiposity Spain 28·5 7194 
FFQ  
(136 items) 
HPS A priori 
Hamburgers, pizza, 
sausages; Q1 <3·3 g/d, Q2 
3·3-13·2 g/d, Q3 13·3-23·2, 
Q4 23·3-34·7 g/d, Q5 ≥ 34·8 
g/d  




Age, sex, total energy 
intake from non-fast-food 
sources, fiber intake, 
alcohol intake, leisure-
time physical activity, 
smoking status, snacking, 
television watching, 
baseline weight, and 















Condiments (0·52); fast 
food (0·36); sweets and 
desserts (0·33); French fries 
and potato chips (0·29); 






0·6 (0·32 to 
1·13) 
Female: 
0·79 (0·36 to 
1·72) 
Age, physical activity, 
energy intake, education 
level, community ladder, 
smoking status and 
alcohol use, BMI and 
hypertension history 
5 









Only used loadings for 
young boys (similar for 
girls): Chocolate bars (0·46); 
Odds ratio Quartiles 
Older girls: 
0·97 (0·83 to 
1·14) 
Race/ethnicity, SES, 
physical activity, and time 




other candy bars (0·53); 
candy with chocolate (0·45); 
brownies (0·55); cake (0·50); 
pie (0·41); sweet rolls 
(0·47); snack cakes (0·43); 
donuts (0·42); ice cream 
(0·42); chocolate chip 
cookies (0·34); popsicles 
(0·37); and 8 more 
Older boys: 
0·86 (0·72 to 
1·03) 
Young girls: 
0·92 (0·71 to 
1·19) 
Young boys: 












Corn tortilla (0·6); pastries 




2·98 (1·46 to 
6·1) 
Age, sex, time, energy 
intake, smoking, 
multivitamin use, 
parental history of 
myocardial infarction, 
history of hypertension, 













Pancakes / convenience 
foods (an aggregated food 
group based on multiple 




2·25 (2·01 to 
2·49) 
Baseline BMI, sex, 
maternal overweight, 
high paternal education, 
gestational age, birth 






Spain 10·2 3048 
FFQ  
(136 items) 
HPS A priori 
Hamburgers, pizza, 
sausages; Q1 0-3 
servings/month, Q2 > 3 & < 
two servings/week, Q3 ≥ 2 
servings/week 
Odds ratio Tertiles 
1·81 (1·1 to 
2·99) 
Age, energy intake, 
smoking, physical activity, 






pattern score, alcohol 





Durao, 2017 Adiposity Portugal 3 1533 
FFQ 







Processed meats, crisps, 
pizza/burger, sweets, soft 










BMI) and child (any 
breast-feeding, physical 
exercise, screen time, 
exact age and each 












Processed meat (0·59); 
sweets/desserts (0·47); 
French fries (0·46); SSBs¥ 







Age, family history of 





margarine (0·34); loadings 
from Hu 2000, may differ 
from this study! 
hypercholesterolemia, 
smoking, menopausal 
status, calories, history of 
hypertension, physical 
activity, alcohol intake, 











SSBs (0·47), refined grains 
(0·46), diet soft drinks 








Age, smoking status, BMI, 
menopausal status, 
aspirin use, energy 
intake, alcohol 
intake, and hours of 











Fried potatoes (0·66); 
processed red meat (0·48); 
sauces and Mayonnaise 











physical activity at work, 
physical activity at home, 
physical activity during 







therapy, total energy 
intake, and stratified by 
age at recruitment, sex, 












1984 dietary pattern: 
processed meat (0·57); 
French Fries (0·47); 
condiments (0·45); sweets 
and desserts (0·43); pizza 








Age, follow-up period, 
body mass index, physical 
activity, smoking, 
hormone replacement 
therapy, history of 
hypertension, use of 
multivitamin 
supplements, missing 
FFQ during follow-up, and 







Sweden 13 4999 
7-day menu 















Age, total energy, season 
of data collection, body 
fat percentage, waist to 
hip ratio, smoking and 





US 8 44875 FFQ 





Processed meat (0·59); 
sweets/desserts (0·47); 
French fries (0·46); SSBs 










smoking, parental history 
of myocardial infarction 
before age 60 y, 
multivitamin and vitamin 
E supplement use, 
alcohol consumption, 
history of hypertension, 
physical activity, total 







Spain 4·3 7216 FFQ 





High-fat processed meats 
(0·55); processed meals 
(0·32); commercial bakery 
(0·29); chocolates 0·29) 
Hazard 
ratio 
Quartiles 1·05  
(0·73 to 1·5) 
Sex, age, recruitment 
center, interventional 
group, smoking status, 
baseline body mass 
index, physical activity 





























Age, sex, energy 
misreporting, ethnicity, 
employment grade, 














White bread (0·27); fried 
potatoes (0·26); burgers & 







Age, sex, energy 
misreporting, ethnicity, 
employment grade, 
smoking, alcohol, physical 
activity, BMI 
5 








Q1 1·5 servings/d, Q2 2·7 
s/d, Q3 3·8 s/d, Q4 6·1 s/d 
Hazard 
ratio 
Quartiles 1·26  
(1·1 to 1·45) 








status, snacking between 
meals, following a special 
diet at baseline, baseline 
BMI, and consumption of 





Spain 3·9 14790 FFQ 







Q1 2·1 servings/d, Q2 3·1 







Sex, age, physical activity, 
hours of TV watching, 
baseline body mass 
index, smoking status, 
use of analgesics, 
following a special diet at 




total energy intake, olive 
oil intake, and 







UK 12 1838 FFQ 






White bread (0·37); chips 
(0·30); SSBs (0·26); 




 (1·1 to 1·67) 
Age, smoking habits, 
social class, leisure time 
physical activity, total 













Hamburger (0·67); pizza 




Quartiles 1·33  
(0·65 to 3·6) 
Age and sex, education, 
residency, smoking 
status, daily physical 



















Women: processed meats 
(0·45); confectionaries 
(0·30); mayonnaise (0·38); 
SSBs (0·35); dressing (0·53)  
Men: processed meats 
(0·51); confectionaries 
(0·35), SSBs (0·43); sauce 






Age, study area (11 
areas), smoking status, 
family history of diabetes 
mellitus, total physical 
activity, history of 
hypertension and total 




(0·47); mayonnaise (0·43); 
dressing (0·52) 1·15  













Processed meats (0·64); 
fried potatoes (0·60); salty 
snacks (0·50); desserts 
(0·48); pizza (0·42); sweet 
breads (0·41), ice cream 








Study center, age, sex, 
race-ethnicity, and 
energy intake, education, 
physical activity, smoking 








Singapore 4·7 43176 FFQ 






French fries; pizza; other 
sandwiches; deep-fried 
chicken; and hot dogs; Q1 
no intake, Q2 1-3 
times/month, Q3 








Age, sex, year of 
interview, dialect, 
education, smoking, 
alcohol, sleep, and 
physical activity, 
nutritional factors (intake 
of soft drinks, juice, 
Eastern snacks and dim 
sum, vegetables, fruit, 
soy, rice, noodles, other 















Many, i.e.: Siew mai (0·44); 
Otar Otar (0·4); Steamed 
meat bao (0·38); Bakes buns 
with meat(0·2), flavored rice 
porridge (0·2)m balachan 
(0·2), hot dogs (0·21), 
hamburgers (0·21), western 
cakes (0·22), ice cream 
(0·23), French fries (0·25), 
salted fish (0·25), soft 
drinks(0·29), deep-fried 
snacks (0·32), pork belly 
(0·32), dry noodle dish 







(1·07 to 1·4) 
Age, sex, dialect, 
education, and year of 
interview, smoking, 
moderate and vigorous 
activity, sleep, BMI, 
history of hypertension, 
and energy intake 
7 
Oellingrath, 2011 Adiposity Norway 3 427 FFQ 






(4th grade only): French 
fries restaurant (0·6), 
hamburger/kebab (0·56), 
French fries dinner (0·49), 
biscuits etc· (0·51), 
sausages/hot dogs (0·44), 
processed pizza (0·41), 
waffles (0·47), sweets 
(0·32), salty snacks (0·32), 
white bread (0·34), ice 
cream (0·44), processed 
Beta-
coefficient 
Continuous -0·15  
(-0·5 to 0·19) 
Age, study area (11 
areas), smoking status, 
family history of diabetes 
mellitus, total physical 
activity, history of 
hypertension and total 




meat for dinner (0·26), 
pancakes (0·45), biscuits 
etc· between meals (0·34), 
ice-cream between meals 
(0·25), SSB (0·34), sugar 





Denmark 8·3 7316 FFQ 





White bread (0·51); cakes 
and biscuits (0·43); 
candy/chocolate (0·44); ice-









education, BMI and 
alcohol intake 
4 










Chocolate spreads on bread 
(0·38); cakes, pudding, 
cookies (0·35); 
candy/sweets (0·33); fried 
meat (0·28); SSBs (0·24); 
mayonnaise (0·24); cured 
meat and sausages (0·21) 




Adjusted by age, sex, 
country (as the grouping 
variable), baseline BMI 
(continuous), physical 














(Approx· loadings) SSB's 
(0·43), klik (0·44), 
cookies/cakes/pastries 
(0·42), chocolate/candy 
(0·4), fries (0·33), margarine 
(0·22) 




Age, sex, WC, IL-6 and 
adiponectin 
5 











Black girls: SSBs (469g); 
flavored Milk (82g); cereals 
(77g); processed meat and 
sandwiches (54g); ice cream 
(53g); pizza (23g); fried 
Potatoes (27g); baked 
desserts (30g); other 
desserts (29g); 
White girls: SSBs (396g); 
flavored milk (90g); cereal 
(80g); ice Cream (57g); 
processed meats and 
sandwiches (40g); fried 














Age of menarche, 
pregnancy, parental 
education, physical 






US 7·6 124651 FFQ 





SSBs (0·47); refined grains 




Age, BMI, physical 










hormone use, and energy 
intake 








meats (0·58); French fries 
(0·50); sweets and desserts 
(0·42); snacks (0·39); 
margarine (0·36); pizza 




Continuous 7·45  
(0·12 to (SE)) 
Age, baseline alcohol 
intake, physical activity, 
smoking, 
postmenopausal 
hormone use, oral 
contraceptive use, cereal 
fiber intake, total fat 
intake, and BMI, changes 
in confounders between 











Candy (0·40); chocolate 
(0·46); desserts (0·53); 
margarine (0·37); pizza 
(0·20); fried potatoes (0·28); 
salty snacks (0·30); sweet 







Age, sex, race, and age-
race interaction, 
education, household 
income, and region, total 
energy intake, smoking, 
physical activity, body 
mass index, waist 
circumference, and 







Netherlands 13 35910 FFQ 





Processed meat (0·25); SSBs 
(0·52); cereals (0·43); 








Age, gender, physical 
activity, smoking status, 
education, systolic- and 
diastolic blood pressure 
and energy intake 
8 
Togo, 2004 Adiposity Denmark 11 2190 














Men, sweet dietary pattern: 
cake, biscuits, other baked 
goods (0·70); 
candy/chocolate (0·66); 
SSB’s or ice-cream (0·42); 
jam or honey (0·48);  
Female, sweet-traditional: 
candy/chocolate (0·61); 
cake, biscuits, other baked 
goods (0·58); white bread 
(0·40), SSBs or ice-cream 
(0·41) 
Odds ratio Continuous 
Female: 
3·8 






Age, education, smoking, 
BMI, physical activity in 













Processed meat (0·61); 
French fries (0·48); sweets 
and desserts (0·42); 
Relative 
risk 
Quintiles 1·59  
Age, BMI, PA, total 






condiments (0·41); SSBs 
(0·36); snacks (0·36); 
mayonnaise (0·34); pizza 




hypertension (yes or no), 
and family history of type 




US 10 129501 
FFQ 



















Age, total physical activity 
level, physical inactivity 
level, body mass index, 
total caloric intake, 














Voortman, 2016 Adiposity Netherlands 5 1980 FFQ 







Savory snacks (0·59); 








Age, BMI at enrollment, 
parity, folic acid 
supplement use, smoking 
and alcohol use during 
pregnancy; paternal 
smoking and education; 
household income; and 
child sex, breastfeeding in 
the first 4 months of life, 
timing of introduction of 
complementary feeding, 
age at dietary 
measurement, total 
energy, intake at 1 year, 
and television watching 





US 8 13110 FFQ 





Not clear, processed meat, 
sweets and deserts; French 




(1·2 to 2·21) 
Age, parity, BMI, 
race/ethnicity, cigarette 
smoking status, family 
history of diabetes in a 
first-degree relative, 
alcohol intake, physical 
activity and total energy 
3 
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APPENDIX TABLE 3. STUDY QUALITY  
Due to word limits of the thesis, the table with the study quality assessment of the studies 








ness of the 
Exposed Cohort 







Was not Present 
at Start of Study 
Comparability of Cohorts based on 
the Design or Analysis (for Age, Sex, a 
Marker of Socioeconomic Position 
[Education/Income/Occupation/Area
-based Marker] (all of these) 
Comparability of Cohorts 
Based on the Design or 
Analysis (other Health-related 
Behaviours, Race/Ethnicity, 

















Ambrosini, 2012 1 1 1 0 1 0 1 1 0 6 
Atkins, 2016 1 1 0 1 1 0 1 1 0 6 
Barrington, 2016 0 1 0 1 1 1 1 1 1 7 
Bes-Rastrollo, 2006 0 1 0 1 0 0 0 1 1 4 
Chan, 2013 0 1 0 1 1 0 1 1 0 5 
Cutler, 2013 1 1 0 1 1 0 0 0 0 4 
Denova-Gutierrez, 
2016 
0 1 0 1 0 0 1 1 1 5 
Diethelm, 2014 0 1 1 1 0 0 1 1 0 5 
Dominguez, 2014 0 1 0 1 1 1 0 1 1 6 
Durao, 2017 1 1 0 1 1 0 1 1 1 7 
Fung, 2004a 0 1 0 1 0 1 0 1 1 5 
Fung, 2004b 0 1 0 1 0 0 1 1 1 5 
Guallar-Castillion, 
2012 
0 1 1 1 1 0 1 1 1 7 
Heidemann, 2008 0 1 0 1 0 0 1 1 1 5 
Hlebowicz, 2011 1 1 1 1 0 0 1 1 1 7 
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Hu, 2000 0 1 0 1 1 1 0 1 1 6 
Martinez-Gonzales, 
2015 
0 1 0 0 1 0 1 1 1 5 
McNaughton, 2008 0 1 0 1 1 0 0 1 1 5 
McNaughton, 2009 0 1 0 1 1 0 1 1 0 5 
Mendonca, 2016 0 1 0 1 1 0 0 1 1 5 
Mendonca, 2017 0 1 0 1 1 0 0 1 1 5 
Mertens, 2017 0 1 0 0 1 0 1 1 0 4 
Mohammadifard, 2017 1 1 0 1 1 0 1 1 0 6 
Nanri, 2013 0 1 0 1 0 0 0 1 1 4 
Nettleton, 2009 0 1 0 1 1 0 1 1 1 6 
Odegaard, 2012 1 1 0 1 0 0 1 1 1 6 
Odegaard, 2014 1 1 0 1 0 1 1 1 1 7 
Oellingrath, 2011 0 1 0 1 1 0 1 0 0 4 
Osler, 2002 0 1 0 1 1 0 0 0 1 4 
Pala, 2013 1 1 0 1 0 0 1 1 0 5 
Reeds, 2016 1 1 0 1 0 0 0 1 1 5 
Ritchie, 2007 0 1 1 1 1 1 1 1 0 7 
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Schulze, 2005 0 1 0 1 0 0 0 1 0 3 
Schulze, 2006 0 1 1 1 0 0 1 1 1 6 
Shikany, 2015 0 1 0 1 1 1 0 1 0 5 
Stricker, 2013 1 1 0 1 1 1 1 1 1 8 
Togo, 2004 0 1 0 1 1 0 1 1 0 5 
Vandam, 2002 0 1 0 1 0 1 0 1 1 5 
Varraso, 2012 0 1 0 1 1 1 1 1 1 7 
Voortman, 2016 0 1 1 1 1 1 1 1 0 7 
Zhang, 2006 0 1 0 1 0 1 0 0 0 3 
* To get a point in this category, a study must include: smoking (if adult population), alcohol (if adult population), and physical activity as health-related behaviours; and family history of disease (all of these)  
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APPENDIX TABLE 4. COUNTRY DATA OF SALES OF 
ULTRA-PROCESSED FOODS  
 
Country  
UPF sales in 2016 
(g/day/capita) 
Change in UPF sales between 
2001 and 2016 (in %) 
Algeria 550 152 
Argentina 716 128 
Australia 682 97 
Austria 664 99 
Azerbaijan 322 132 
Belarus 341 106 
Belgium 831 104 
Bolivia 391 211 
Bosnia-Herzegovina 287 121 
Brazil 421 128 
Bulgaria 629 124 
Cameroon 61 142 
Canada 694 89 
Chile 899 150 
China 140 299 
Colombia 325 115 
Costa Rica 394 111 
Croatia 475 99 
Czech Republic 512 89 
Denmark 602 101 
Dominican Republic 348 143 
Ecuador 314 124 
Egypt 430 102 
Estonia 451 110 
Finland 656 95 
France 570 98 
Georgia 402 194 
Germany 845 103 
Greece 425 87 
Guatemala 199 50 
Hungary 462 98 
India 32 267 
Indonesia 64 216 
Iran 470 113 
Ireland 650 76 
Israel 491 95 
Italy 490 86 
Japan 412 103 
Kazakhstan 261 87 
Latvia 332 89 
Lithuania 369 132 
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Macedonia 558 134 
Malaysia 165 141 
Mexico 886 92 
Morocco 186 175 
Netherlands 746 109 
New Zealand 621 104 
Nigeria 64 170 
Norway 726 108 
Pakistan 42 213 
Peru 330 181 
Philippines 185 133 
Poland 528 103 
Portugal 340 81 
Romania 477 137 
Russia 378 146 
Saudi Arabia 749 119 
Serbia 572 136 
Slovakia 546 116 
Slovenia 360 80 
South Africa 403 147 
South Korea 208 96 
Spain 548 85 
Sweden 600 93 
Switzerland 630 103 
Taiwan 180 106 
Thailand 194 172 
Tunisia 442 145 
Turkey 690 108 
USA 899 82 
Ukraine 345 129 
United Arab Emirates 333 61 
United Kingdom 799 110 
Uruguay 623 197 
Uzbekistan 211 172 







APPENDIX FIGURE 1. FUNNEL PLOTS OF SUMMARY 











Funnel plots of summary random-effects meta-analysis of highest versus lowest UPF 
intake or UPF dietary patterns score category and CVD risk (top) and T2DM risk (bottom) 
 
 
 
 
 
 
 
 
